
<html lang="en"     class="pb-page"  data-request-id="2147a825-6296-4fe5-934a-01cbce609d4d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01345;issue:issue:10.1021/jmcmar.2018.61.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci" /></meta><meta name="dc.Creator" content="Dongliang  Guan" /></meta><meta name="dc.Creator" content="Feifei  Chen" /></meta><meta name="dc.Creator" content="Lun  Xiong" /></meta><meta name="dc.Creator" content="Feng  Tang" /></meta><meta name="dc.Creator" content=" Faridoon" /></meta><meta name="dc.Creator" content="Yunguang  Qiu" /></meta><meta name="dc.Creator" content="Naixia  Zhang" /></meta><meta name="dc.Creator" content="Likun  Gong" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Creator" content="Lefu  Lan" /></meta><meta name="dc.Creator" content="Wei  Huang" /></meta><meta name="dc.Description" content="Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogues against drug-resistant bacteria by enhancing bacterial cell wall interactions. Howev..." /></meta><meta name="Description" content="Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogues against drug-resistant bacteria by enhancing bacterial cell wall interactions. Howev..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 2, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01345" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01345" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01345" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01345" /></link>
        
    
    

<title>Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01345" /></meta><meta property="og:title" content="Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0014.jpeg" /></meta><meta property="og:description" content="Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogues against drug-resistant bacteria by enhancing bacterial cell wall interactions. However, hydrophobic structures usually lead to long elimination half-life and accumulative toxicity; therefore, hydrophilic fragments were also introduced to the lipo-vancomycin to regulate their pharmacokinetic/pharmacodynamic properties. Here, we synthesized a series of new vancomycin analogues carrying various sugar moieties on the seventh-amino acid phenyl ring and lipophilic substitutions on vancosamine with extensive structure–activity relationship analysis. The optimal analogues indicated 128–1024-fold higher activity against methicillin-susceptible S. aureus, vancomycin-intermediate resistant S. aureus (VISA), and vancomycin-resistant Enterococci (VRE) compared with that of vancomycin. In vivo pharmacokinetics studies demonstrated the effective regulation of extra sugar motifs, which shortened the half-life and addressed concerns of accumulative toxicity of lipo-vancomycin. This work presents an effective strategy for lipo-vancomycin derivative design by introducing extra sugars, which leads to better antibiotic-like properties of enhanced efficacy, optimal pharmacokinetics, and lower toxicity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01345"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01345">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01345&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01345&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01345&amp;href=/doi/10.1021/acs.jmedchem.7b01345" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 286-304</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01342" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01399" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant <i>Staphylococcus aureus</i> and Vancomycin-Resistant <i>Enterococci</i></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dongliang++Guan">Dongliang Guan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feifei++Chen">Feifei Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∇</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7251-1956" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lun++Xiong">Lun Xiong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Tang">Feng Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=+Faridoon"> Faridoon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunguang++Qiu">Yunguang Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naixia++Zhang">Naixia Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Likun++Gong">Likun Gong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lefu++Lan">Lefu Lan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5551-5496" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Huang">Wei Huang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6432-1848" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="AFF-d136e148-autogenerated"><span class="aff-text"><sup>†</sup>CAS Key Laboratory of Receptor Research, CAS Center for Excellence in Molecular Cell Science, <sup>∥</sup>State Key Laboratory of Drug Research, and <sup>⊥</sup>Center for Bio-drug Development, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai 201203, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div><div class="corresp-info"><strong>*</strong>Tel: +86-21-50806600; fax: +86-21-50807088; e-mail: <a href="/cdn-cgi/l/email-protection#e08c8c818ea093898d8dce8183ce838e"><span class="__cf_email__" data-cfemail="87ebebe6e9c7f4eeeaeaa9e6e4a9e4e9">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Tel: +86-21-20231000 ext. 2517; fax: +86-21-50807088; e-mail: <a href="/cdn-cgi/l/email-protection#254d50444b4252404c65564c48480b44460b464b"><span class="__cf_email__" data-cfemail="59312c38373e2e3c30192a30343477383a773a37">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01345&amp;href=/doi/10.1021%2Facs.jmedchem.7b01345" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 286–304</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 15, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 September 2017</li><li><span class="item_label"><b>Published</b> online</span>2 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01345" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01345</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D286%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDongliang%2BGuan%252C%2BFeifei%2BChen%252C%2BLun%2BXiong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D1%26contentID%3Dacs.jmedchem.7b01345%26title%3DExtra%2BSugar%2Bon%2BVancomycin%253A%2BNew%2BAnalogues%2Bfor%2BCombating%2BMultidrug-Resistant%2BStaphylococcus%2Baureus%2Band%2BVancomycin-Resistant%2BEnterococci%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D304%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01345"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2706</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01345" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dongliang&quot;,&quot;last_name&quot;:&quot;Guan&quot;},{&quot;first_name&quot;:&quot;Feifei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Lun&quot;,&quot;last_name&quot;:&quot;Xiong&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;&quot;,&quot;last_name&quot;:&quot;Faridoon&quot;},{&quot;first_name&quot;:&quot;Yunguang&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Naixia&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Likun&quot;,&quot;last_name&quot;:&quot;Gong&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Lefu&quot;,&quot;last_name&quot;:&quot;Lan&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Huang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;286-304&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01345&quot;},&quot;abstract&quot;:&quot;Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogues against drug-resistant bacteria by enhancing bacterial cell wall interactions. However, hydrophobic structures usually lead to long elimination half-life and accumulative toxicity; therefore, hydrophilic fragments were also introduced to the lipo-vancomycin to regulate their pharmacokinetic/pharmacodynamic properties. Here, we synthesized a series of new vancomycin analogues carrying various sugar moieties on the seventh-amino acid phenyl ring and lipophilic substitutions on vancosamine with extensive structure–activity relationship analysis. The optimal analogues indicated 128–1024-fold higher activity against methicillin-susceptible S. aureus, vancomycin-intermediate resistant S. aureus (VISA), and vancomycin-resistant Enterococci (VRE) compared with that of vancomycin. In vivo pharmacokinetics studies demonstrated the effective regulation of extra sugar motifs, which shortened the half-life and &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01345&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01345" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01345&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01345" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01345&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01345" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01345&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01345&amp;href=/doi/10.1021/acs.jmedchem.7b01345" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01345" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01345" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01345%26sid%3Dliteratum%253Aachs%26pmid%3D29243921%26genre%3Darticle%26aulast%3DGuan%26date%3D2018%26atitle%3DExtra%2BSugar%2Bon%2BVancomycin%253A%2BNew%2BAnalogues%2Bfor%2BCombating%2BMultidrug-Resistant%2BStaphylococcus%2Baureus%2Band%2BVancomycin-Resistant%2BEnterococci%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D1%26spage%3D286%26epage%3D304%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/jmcmar.2018.61.issue-1/20180111/jmcmar.2018.61.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Lipophilic substitution on vancomycin is an effective strategy for the development of novel vancomycin analogues against drug-resistant bacteria by enhancing bacterial cell wall interactions. However, hydrophobic structures usually lead to long elimination half-life and accumulative toxicity; therefore, hydrophilic fragments were also introduced to the lipo-vancomycin to regulate their pharmacokinetic/pharmacodynamic properties. Here, we synthesized a series of new vancomycin analogues carrying various sugar moieties on the seventh-amino acid phenyl ring and lipophilic substitutions on vancosamine with extensive structure–activity relationship analysis. The optimal analogues indicated 128–1024-fold higher activity against methicillin-susceptible <i>S. aureus</i>, vancomycin-intermediate resistant <i>S. aureus</i> (VISA), and vancomycin-resistant <i>Enterococci</i> (VRE) compared with that of vancomycin. In vivo pharmacokinetics studies demonstrated the effective regulation of extra sugar motifs, which shortened the half-life and addressed concerns of accumulative toxicity of lipo-vancomycin. This work presents an effective strategy for lipo-vancomycin derivative design by introducing extra sugars, which leads to better antibiotic-like properties of enhanced efficacy, optimal pharmacokinetics, and lower toxicity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Vancomycin, as the first member of glycopeptide antibiotics, was approved for clinical use in the 1950s.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Its structure was not fully characterized until 1983.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In antibacterial history, vancomycin opened a new era for fighting drug-resistant Gram-positive bacteria, including multidrug-resistant <i>Staphylococcus aureus</i> (MRSA), and was rewarded as “the last resort to fight against untreatable bacterial pathogens” and “ace antibiotics”.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In recent years, because of the abuse of antimicrobial agents, drug-resistant bacterial infection has become a life-threatening problem in public health. In an estimated survey, drug-resistant bacterial infection may cause 10 million deaths annually worldwide by 2050.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The emergence of vancomycin-resistant bacteria deteriorates the situation. In 1988, vancomycin-resistant <i>Enterococci</i> (VRE) was first reported;<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> thereafter, vancomycin-intermediate resistant <i>Staphylococcus aureus</i> (VISA) and vancomycin-resistant <i>Staphylococcus aureus</i> (VRSA) were discovered in 1997 and 2002.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12">(7-12)</a> The spread of MRSA and vancomycin-resistant relevant pathogens resulted in serious concerns regarding the outbreak of drug-resistant bacterial infection, and new antibiotics has become an urgent need for combating these pathogens.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">The new-generation glycopeptide antibiotics derived from vancomycin demonstrated improved antibacterial activities against various vancomycin-resistant strains, thereby providing a strategy to tackle the crisis of drug-resistant infections.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a> Three semisynthetic vancomycin analogues, Telavancin, Dalbavancin, and Oritavancin, were recently launched on the market in 2009 and 2014 for the treatment of MRSA infection.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> These analogues are also called lipoglycopeptides because their structures bear a linear lipid or biphenyl hydrophobic appendix (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). These lipo-structures anchor the antibiotics to the bacterial cell wall and dramatically enhance the antibacterial effect.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The rigid structure of chlorobiphenyl substitution could directly inhibit transglycosylase<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and contribute to the binding with pentaglycyl bridge segments of cell wall peptidoglycan.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, hydrophobic groups caused a longer half-life and lower clearance rate in vivo that may lead to accumulative toxicity such as nephrotoxicity.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Hence, hydrophilic groups such as extra sugar moieties (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) were usually introduced to the scaffold to optimize their pharmacokinetics and toxicity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of vancomycin and its lipo-analogues. Extra sugar moieties or hydrophilic groups are displayed in red color.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In structures of Dalbavancin, Oritavancin, and Teicoplanin (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), extra sugar moieties such as mannose, <i>N</i>-acetylglucosamine, and epi-vancosamine were substituted onto different hydroxyls of the glycopeptide core and play important roles in structural optimization. These extra sugar substitutions were all derived from the corresponding fermentation products<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28-31)</a> by biosynthesis, which hampers the diversification of various sugar substitutions for new analogue design. Telavancin carries a phosphonomethylaminomethyl group as the hydrophilic tail onto the phenyl of the seventh-amino acid via a selective Mannich reaction.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> With the same reaction, direct assembly of an extra sugar glucosamine<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> was previously reported, but the antibacterial activities of these analogues were significantly reduced even with a linear lipid tail on vancosamine. These results implicated the systematic structure–activity relationship (SAR) investigation with various sugar moieties and hydrophobic fragments are required for this strategy. Recently, the Haldar group reported<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> a series of novel vancomycin analogues employing “lipophilic-vancomycin-carbohydrate” conjugation by coupling of different sugars onto the C-terminal carboxylic acid and introducing linear lipid groups onto vancosamine. The successful improvement of antibacterial activity against VISA and VRE demonstrated the assembly of extra sugar moieties also modulated the drug efficacy. These examples indicated that introducing the extra sugar to vancomycin by chemical modification presented a new strategy for structural optimization on vancomycin analogues. However, there are still many questions to address, such what kind of sugar to assemble, what position on vancomycin to introduce the sugar, especially when a rigid lipophilic tail like chlorobiphenyl was linked on vancosamine, and how the extra sugar moieties influence the activity and pharmacokinetics. We sought to answer these questions by investigation on precise SAR of extra-sugar-bearing vancomycin analogues.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of New Vancomycin Analogues Carrying an Extra Saccharide Motif</h3><div class="NLM_p">To investigate the role of extra sugar moieties on lipo-vancomycin for PK/PD optimization, we introduced various monosaccharides and a disaccharide to the seventh-amino acid phenyl group of lipo-vancomycin via a two-step synthesis (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). First, decylaminoethyl (derived from Telavancin) and chlorobiphenylmethyl (derived from Oritavancin) were assembled onto the amino group of vancomycin by reductive amidation. Then, sugar motifs including glucose (Glc), mannose (Man), galactose (Gal), glucosamine (GlcN), mannosamine (ManN), galactosamine (GalN), and open-ring glucose (orGlc) and lactose (orLac) were attached on the seventh-amino acid resorcinol via Mannich reaction (compounds <b>5</b>–<b>14</b> from decylaminoethyl-vancomycin and compounds <b>15</b>–<b>21</b> from chlorobiphenylmethyl-vancomycin). In vitro anti-MRSA and anti-VISA assays suggested GalN, Gal, and orGlc were the optimal sugar structures; therefore, in the second-round structural modification, we chose these three saccharides to investigate SAR with various lipophilic fragments on vancosamine including linear alkyls and acyls and rigid hydrophobic structures containing benzene rings (compounds <b>22</b>–<b>46</b>). Some of the lipo-fragments were selected from previous reports on the basis of the SAR studies.<a onclick="showRef(event, 'ref25 ref31'); return false;" href="javascript:void(0);" class="ref ref25 ref31">(25, 31)</a> The full structures of compounds <b>5</b>–<b>46</b> are listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Molecular Structures of Vancomycin Analogues <b>5</b>–<b>46</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0011.gif" alt="" id="fx2" /></img><div></div></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of New Vancomycin Derivatives <b>5</b>–<b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for synthesis of <b>3a</b>–<b>3n</b>, (a) <b>2a</b>–<b>n</b>, DIPEA, DMF, room temperature or 55 °C, 2–4 h; (b) NaCNBH<sub>3</sub>, TFA, MeOH, room temperature, 1 h (for <b>3a</b>, additional treatment of 20% piperidine in DMF for 20 min); for synthesis of <b>3o</b>–<b>3p</b>, (c) <b>2o</b>–<b>p</b>, DIPEA, DMF, 0 °C, 2 h; (ii) HCHO, <b>4a</b>–<b>k</b>, DIPEA, H<sub>2</sub>O:MeCN = 1:1, −10 °C, 12 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Saccharide Intermediates <b>4a</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NIS, TfOH, MS4A, dry DCM, 0 °C to room temperature, 12 h; (ii) MeOH, NaOMe, room temperature, 4 h; (iii) H<sub>2</sub>, Pd–C, MeOH, 2 h; (iv) BF<sub>3</sub>Et<sub>2</sub>O (for <b>51a</b>, <b>51b</b>) or SnCl<sub>4</sub> (for <b>51c</b>), dry MeCN, 0 °C to room temperature, 12 h; (v) CH<sub>3</sub>OH, reflux, 4 h; (vi) 2 N HCl, MeOH, room temperature, 2 h.</p></p></figure><div class="NLM_p">To understand how the C-terminus modification influences the antibacterial activity of he lipo-vancomycin-carbohydrate structure, we introduced dimethylaminopropylamine (derived from Dalbavancin) to the C-terminus carboxylic acid by coupling reaction and synthesized compounds <b>54</b>–<b>56</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> and <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). We also utilized aminoglycoside antibiotics (kanamycin and amikacin), which consist of trisaccharide-like motifs, to assemble them onto vancomycin (compounds <b>58</b>–<b>63</b>) and test their antibacterial activities (see details in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Molecular Structures of Vancomycin Analogues <b>54</b>–<b>56</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0013.gif" alt="" id="fx4" /></img><div></div></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Vancomycin Analogues <b>54</b>–<b>56</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIPEA, HBTU, DMF, room temperature, 24 h; (ii) HCHO, <b>4a</b> or <b>4j</b>, DIPEA, H<sub>2</sub>O:MeCN = 1:1, −10 °C, 12 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> NMR Characterization of Vancomycin Analogues</h3><div class="NLM_p">Although chemical modification on vancomycin seventh-amino acid resorcinol via Mannich reaction has been previously reported, and NMR chemical shifts of the aryl protons (Ar–Hs) of the modified position were described in the literature,<a onclick="showRef(event, 'ref26 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref26 ref32 ref33 ref34">(26, 32-34)</a> the detailed assignment of these Ar–Hs with clear 2D spectral data was lacking and not yet reported. Herein, we presented the precise characterization with 2D NMR to confirm the assembly position via Mannich reaction (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Ha (6.41 ppm) and Hb (6.25 ppm) of intermediate <b>3m</b> were assigned based on <sup>1</sup>H NMR, <sup>1</sup>H–<sup>1</sup>H COSY, <sup>1</sup>H–<sup>13</sup>C HSQC, and <sup>1</sup>H–<sup>13</sup>C HMBC. In the HMBC spectrum (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, panel B), Hb-Cα but no Ha-Cα correlation was observed that clearly distinguished these two protons. After Mannich reaction, although the chemical shift of Hb (product <b>46</b>) changed downfield (6.56 ppm), Hb-Cα correlation was still clearly identified, and the disappearance of Ha suggested it was substituted during the reaction. This is the first time report on the precise identification of vancomycin derivatives via selective Mannich reaction with solid spectral data and is helpful for future characterization on compounds of this type.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NMR characterization and signal assignment of vancomycin analogues. (Panel A) <sup>1</sup>H NMR spectra of compounds <b>3m</b> (upper) and <b>46</b> (bottom); (Panel B) <sup>1</sup>H–<sup>13</sup>C HMBC spectra of compounds <b>3m</b> (left) and <b>46</b> (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Anti-methicillin-susceptible <i>S. aureus</i> (anti-MSSA) and Anti-VISA Assay of Vancomycin Analogues and SAR Analysis</h3><div class="NLM_p">With these newly synthesized vancomycin analogues in hand, we sought to investigate the SAR by in vitro antibacterial assays. First, we chose an MSSA strain (Newman)<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> and a VISA strain (Mu50)<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> to perform the assay and measure the MIC<sub>90</sub> values of our compounds. As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, for decylaminoethyl-vancomycins (compounds <b>5</b>–<b>14</b> and Telavancin), extra sugar moieties of GalN, Gal, and orGlc indicated 4–16-fold higher antibacterial activity than other sugars like Glc, GlcN, Man, ManN, orLac, and so forth at a similar MIC<sub>90</sub> level of Telavancin in both Newman and Mu50 strains. For chlorobiphenylmethyl-vancomycins (compounds <b>15</b>–<b>21</b>), GalN, Gal, and orGlc substitution also led to 8–64-fold higher activity than that of other sugars and the phosphonomethylaminomethyl group (derived from Telavancin) in the Newman strain and 4–32-fold higher in the Mu50 strain. For lipophilic structures on vancosamine (compounds <b>22</b>–<b>46</b>), decyl and biphenyl groups exhibited 8–128-fold better efficacy against MSSA and VISA than other linear or rigid hydrophobic tails (<b>18</b>/<b>36</b>/<b>40</b> vs <b>11</b>; <b>32</b> vs <b>13</b>; <b>46</b> vs <b>6</b>). For C-terminus-modified compounds (<b>54</b>–<b>56</b>), MIC<sub>90</sub> increased to 1–2 μg/mL compared with corresponding unmodified compound <b>16</b> (MIC<sub>90</sub>, 0.06 μg/mL) and <b>19</b> (MIC<sub>90</sub>, 0.06 μg/mL), which implicated the limited tolerance on C-terminus modification for biphenyl-vancomycin and suggested the assembling position of extra sugar moieties on seventh-amino acid resorcinol would be better than that on the C-terminus for MSSA and VISA. In summary, the extra sugar attachment combined with suitable lipophilic modifications is an effective strategy for developing new vancomycin analogues against MSSA and VISA. The optimal compounds (<b>18</b>/<b>32</b>/<b>36</b>/<b>40</b>/<b>46</b>) bearing GlcN/Gal/orGlc and decyl/biphenyl groups achieved the best activities as 64–128-fold higher than vancomycin, 8–16-fold higher than Telavancin, and comparable activity with Oritavancin in MSSA and VISA in vitro models.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Activities of Vancomycin Derivatives <b>5</b>–<b>56</b> against MSSA and VISA<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MIC<sub>90</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MIC<sub>90</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MIC<sub>90</sub> (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Newman</th><th class="colsep0 rowsep0" align="center" char=".">Mu 50</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Newman</th><th class="colsep0 rowsep0" align="center" char=".">Mu 50</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Newman</th><th class="colsep0 rowsep0" align="center" char=".">Mu 50</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">Vanco.</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="left">Tela.</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="left">Orita.</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Newman strain, vancomycin-susceptible MSSA, ATCC 5904;<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> Mu 50 strain, a Healthcare-associated methicillin-resistant <i>S. aureus</i> (HA-MRSA) and VISA strain isolated in Japan.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a></p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Anti-VRE Assay of Vancomycin Analogues and SAR Analysis</h3><div class="NLM_p">Next, we investigated the anti-VRE activities of selected compounds (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Five strains of three different subtypes of VRE (<i>vanA</i>, <i>vanM</i>, and <i>vanB</i>)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> were used for the examination. On the basis of the results, compounds containing the rigid hydrophobic tails demonstrated higher activities than the linear lipophilic structures in all three VRE subtypes, but extra sugar moieties and C-terminus modification indicated a different influence in three subtypes. For <i>vanA</i> and <i>vanM</i> subtypes, C-terminus modification enhanced the anti-VRE activity in 4–8-fold (<b>55</b> vs <b>16</b>; <b>56</b> vs <b>19</b>), but for <i>vanB</i>, C-terminus modification decreased 8–32-fold. The extra sugar motifs also implicated complicated influence against different VRE subtypes. For <i>vanA</i>, the optimal sugar of GalN/Gal (compounds <b>16</b>/<b>18</b>/<b>40</b>/<b>46</b>) indicated similar MIC<sub>90</sub> compared with no extra sugar compounds (<b>17</b>/<b>44</b>) and phosphonomethylaminomethyl compound <b>21</b>. For <i>vanM</i>, the extra sugar caused a 2–4-fold decrease in activity compared with that of no extra sugar compounds (<b>16</b>/<b>19</b> vs <b>17</b>; <b>40</b>/<b>46</b> vs <b>44</b>) and 8–64-fold decrease compared with phosphonomethylaminomethyl compound (<b>16</b>/<b>19</b> vs <b>21</b>). However, for <i>vanB</i>, the optimal sugar modification exhibited excellent activities with MIC<sub>90</sub> at 0.06 μg/mL (compounds <b>40</b> and <b>46</b>), which was 1024-fold better than vancomycin, 16-fold of Telavancin, and 4-fold of Oritavancin. These data suggested that VRE subtypes may have diverse drug-resistant mechanisms that caused the different responses to different vancomycin analogues via various modification strategies. The systematic SAR studies would help to understand their individual mechanisms and to develop personalized treatments. After all, the optimal compounds (<b>15</b>/<b>40</b>/<b>46</b>/<b>55</b>) bearing extra sugars exhibited dramatically enhanced activities against VREs, especially for the <i>van</i>B subtype.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Activities of Vancomycin Derivatives against Resistant <i>Enterococci</i><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">MIC (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>vanA</i></th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>vanM</i></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Efm-HS-0649</th><th class="colsep0 rowsep0" align="center" char=".">Efm-HS-06188</th><th class="colsep0 rowsep0" align="center" char=".">Efm-HS-0847</th><th class="colsep0 rowsep0" align="center" char=".">Efm-HS-08257</th><th class="colsep0 rowsep0" align="center" char="."><i>vanB</i> (Efm-HS-vb01)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">⩽0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">⩽0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">⩽0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">⩽0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vanco.</td><td class="colsep0 rowsep0" align="char" char=".">>128</td><td class="colsep0 rowsep0" align="char" char=".">>128</td><td class="colsep0 rowsep0" align="char" char=".">>128</td><td class="colsep0 rowsep0" align="char" char=".">>128</td><td class="colsep0 rowsep0" align="char" char=".">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tela.</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Orita.</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Efm-HS-0649 and Efm-HS-06188: glycopeptide-resistant <i>E. faecium</i>, <i>vanA</i> phenotype, isolated in China;<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Efm-HS-0847 and Efm-HS-08257: glycopeptide-resistant <i>E. faecium</i>, <i>vanM</i> phenotype, isolated in China;<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Efm-HS-vb01: glycopeptide-resistant <i>E. faecium</i>, <i>vanB</i> phenotype, isolated in China.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Antibacterial Assay of Vancomycin Analogues</h3><div class="NLM_p">To test the in vivo efficacy, we established two animal models, lethal challenge and abscess formation assays. Compounds <b>18</b>, <b>32</b>, <b>40</b>, <b>44</b>, and <b>46</b> were selected for lethal challenge assay on a mouse model infected by MRSA strain USA300 LAC.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Each group contains 15 infected mice and was treated with five selected compounds and control compounds of vancomycin and Telavancin via ip injection at a single dose of 7 mg/kg. During 10 days of monitoring, the survival numbers of each group were recorded as shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. The survival rate of the vancomycin group after 10 days was 6.67% (1/15), whereas that of the compound <b>18</b> group was 93.3% (14/15), the same as Telavancin. Treatment of compound <b>46</b> also led to a survival rate of 86.7% (13/15), and the other three compounds all indicated much better efficacy than that of vancomycin.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Survival chart of USA300 LAC (MRSA)-infected mice after treatment with vancomycin derivatives in an in vivo lethal challenge assay. All compounds and positive controls were administrated with a single dose of 7 mg/kg via ip injection at the first day of infection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the in vivo abscess formation assay, each group contains 12 mice infected by the VISA strain (Mu50). Compounds <b>18</b>, <b>46</b>, vancomycin, and Telavancin were administrated to the infected mice via ip injection twice at 7 mg/kg in a 24 h interval. Five days post infection, the mice were sacrificed, and the liver colony-forming units (CFUs) were counted for each mouse as shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. The vancomycin group did not show a significant difference in the liver CFU level compared with that of the control group, whereas compounds <b>18</b>, <b>46</b>, and the Telavancin groups significantly reduced the liver CFU to a similar lower level. These results demonstrated the in vivo efficacy of our new compounds exceeding vancomycin and achieved similar activity as that of the launched drug Telavancin in MRSA and VISA.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Liver CFU counts of Mu50 (VISA and MRSA)-infected mice after treatment with vancomycin derivatives in an in vivo abscess formation assay. All compounds and positive controls were administrated via ip injection twice at 7 mg/kg. Statistical significance determined by the Mann–Whitney test (two-tailed): *<i>p</i> < 0.05, **<i>p</i> < 0.01, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Pharmacokinetic Assay of Vancomycin Analogues</h3><div class="NLM_p">Furthermore, we selected compounds <b>18</b>, <b>32</b>, <b>40</b>, and <b>46</b> to investigate how extra sugar moieties regulate the in vivo pharmacokinetics (PK) properties in normal CD-1 mice compared with trifluoromethylbiphenyl-vancomycin (<b>3m</b>) and control groups of vancomycin and Telavancin (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Compound <b>3m</b> indicated a dramatic increase in <i>T</i><sub>1/2</sub> (∼6 h) and AUC (64,194 h ng mL<sup>–1</sup>) compared with vancomycin (<i>T</i><sub>1/2</sub> 0.6 h, AUC 1242 h ng mL<sup>–1</sup>) that will cause high accumulation in organs, whereas our four compounds containing extra sugars reduced the half-life ∼2-fold and AUC 3–6-fold, implicating that the extra sugar motifs are good fragments for enhancing in vivo clearance and addressing the concerns of accumulative toxicity. Moreover, comparing their PK properties with Telavancin, these compounds exhibited comparable <i>T</i><sub>1/2</sub> and AUC values, which suggested that the extra sugar attachment is a good strategy for improving the druglike features.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Properties of Selected Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>last</sub> (h ng mL<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>INF_obs</sub> (h ng mL<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±">CL<sub>_obs</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±">MRT<sub>INF_obs</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>V</i><sub>SS_obs</sub> (mL/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3m</b></td><td class="colsep0 rowsep0" align="char" char="±">6.04 ± 0.30</td><td class="colsep0 rowsep0" align="char" char="±">64194 ± 6049</td><td class="colsep0 rowsep0" align="char" char="±">67452 ± 6633</td><td class="colsep0 rowsep0" align="char" char="±">1.24 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">6.83 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">509 ± 39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">3.81 ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">12112 ± 2483</td><td class="colsep0 rowsep0" align="char" char="±">12238 ± 2486</td><td class="colsep0 rowsep0" align="char" char="±">7.0 ± 1.38</td><td class="colsep0 rowsep0" align="char" char="±">4.18 ± 0.34</td><td class="colsep0 rowsep0" align="char" char="±">1754 ± 380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char="±">3.72 ± 0.70</td><td class="colsep0 rowsep0" align="char" char="±">10666 ± 2063</td><td class="colsep0 rowsep0" align="char" char="±">13450 ± 2725</td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 1.39</td><td class="colsep0 rowsep0" align="char" char="±">4.79 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">1826 ± 334</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char="±">3.45 ± 1.26</td><td class="colsep0 rowsep0" align="char" char="±">20105 ± 1714</td><td class="colsep0 rowsep0" align="char" char="±">24345 ± 2804</td><td class="colsep0 rowsep0" align="char" char="±">3.45 ± 0.40</td><td class="colsep0 rowsep0" align="char" char="±">4.41 ± 1.23</td><td class="colsep0 rowsep0" align="char" char="±">900 ± 180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char="±">2.94 ± 1.39</td><td class="colsep0 rowsep0" align="char" char="±">16631 ± 4960</td><td class="colsep0 rowsep0" align="char" char="±">20047 ± 5489</td><td class="colsep0 rowsep0" align="char" char="±">4.42 ± 1.42</td><td class="colsep0 rowsep0" align="char" char="±">4.21 ± 2.08</td><td class="colsep0 rowsep0" align="char" char="±">1077 ± 449</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vanco.</td><td class="colsep0 rowsep0" align="char" char="±">0.60 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1242 ± 335</td><td class="colsep0 rowsep0" align="char" char="±">1271 ± 347</td><td class="colsep0 rowsep0" align="char" char="±">68.7 ± 18</td><td class="colsep0 rowsep0" align="char" char="±">0.79 ± 0.26</td><td class="colsep0 rowsep0" align="char" char="±">3076 ± 175</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tela.</td><td class="colsep0 rowsep0" align="char" char="±">1.13 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">17143 ± 5611</td><td class="colsep0 rowsep0" align="char" char="±">17304 ± 5745</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">1.71 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">520 ± 121</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last"><i>T</i><sub>1/2</sub>, half-life; AUC<sub>last</sub>, area under the concentration–time curve up to the last sampling time; AUC<sub>INF_obs</sub>, area under the concentration–time curve up to infinity time; CL<sub>_obs</sub>, clearance; MRT<sub>INF_obs</sub>, mean retention time up to infinity time; <i>V</i><sub>SS_obs</sub>, volume of distribution at steady state.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cytotoxicity Assay of Vancomycin Analogues</h3><div class="NLM_p">To evaluate the toxicity of our compounds, we performed cytotoxicity assays of compounds <b>16</b> and <b>46</b> on human renal proximal tubule epithelial cells (HK-2) and a human liver cell line (HL-7702). As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, compounds <b>16</b> and <b>46</b> indicated significant lower toxicity in HL-7702 compared with vancomycin and Telavancin at three tested concentrations. On HK-2 cells, these two compounds exhibited a similar effect on cell viability as that of Telavancin and slightly reduced toxicity compared with that of vancomycin. These data demonstrated the advantage of safety of our selected compounds.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxicity assays of selected compounds. (Panel A) Cell viability test on HL-7702 cells (human liver cells); (Panel B) cell viability test on HK-2 cells (human renal proximal tubule epithelial cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Interaction of Vancomycin Analogue <b>46</b> with Bacterial Peptidoglycan Precursor Peptide</h3><div class="NLM_p">Vancomycin binds to the peptidoglycan precursor peptide Lys-<i>d</i>Ala-<i>d</i>Ala on the bacterial cell wall, thereby breaking the cell wall biosynthesis and killing the bacteria.<a onclick="showRef(event, 'ref34 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref41 ref42 ref43">(34, 41-43)</a> To test whether the attached extra sugar is involved in this peptide ligand recognition, we investigated the interaction of compound <b>46</b> with the peptidoglycan precursor tripeptide Ac<sub>2</sub>Lys-<i>d</i>Ala-<i>d</i>Ala by NMR measurement. Constant-time <sup>1</sup>H–<sup>13</sup>C HSQC NMR analysis was performed for solo compound <b>46</b> and after adding the precursor tripeptide. The changes in chemical shifts represented that the corresponding signals were involved in the interaction. <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> summarizes all the changed <sup>1</sup>H–<sup>13</sup>C correlation signals observed in this assay. The signals of x1, x2, x3, x5, V1, and V5 significantly changed or disappeared, which means these positions on the original vancomycin structure interacted with the target tripeptide ligand. Interestingly, we also observed a signal change of Gal C<sub>3</sub>/H<sub>3</sub> or C<sub>5</sub>/H<sub>5</sub> (these two signals are difficult to distinguish from each other) that suggested the Gal structure of <b>46</b> might also contribute to the interaction with the tripeptide. These results explained a possible mechanism of the extra sugar moiety with enhanced interaction with the bacterial cell wall.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Interaction of compound <b>46</b> with bacterial peptidoglycan precursor peptide ligand Ac<sub>2</sub>Lys-<i>d</i>Ala-<i>d</i>Ala via <sup>1</sup>H–<sup>13</sup>C HSQC NMR measurement. The spectral signals in red represent solo compound <b>46</b> and the signals in green represent the mixture of <b>46</b> and peptide ligand. The significantly changed signals of <b>46</b> after adding the peptide ligand were displayed in the selected spectral regions and assigned with their position information (x1, x2, x3, x5, V1, V5, Gal C<sub>2–5</sub>/H<sub>2–5</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Then, we used the molecular modeling program Maestro (Schrödinger) to investigate the binding mode of <b>46</b> and the tripeptide. Molecular modeling was performed starting with X-ray crystal structure of vancomycin cocrystallized with the precursor tripeptide ligand (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FVM">1FVM</a><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>). Vancomycin was replaced with <b>46</b>; then, the complex was optimized via energy minimalization to give a rational binding model (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_001.pdf" class="ext-link">Figure S1</a>). In this model, a H-bond interaction of the Gal motif with tripeptide was observed. Combining the modeling result and NMR data, it is very likely the extra sugar moiety participated in the bacterial cell wall binding and therefore enhanced the antibacterial activity. This mechanism is important and helpful for the future designs on novel vancomycin derivatives against drug-resistant bacteria.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The carbohydrate structure of vancomycin plays important roles in the in vivo activity, PK properties, and drug distribution.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Although vancomycin aglycon also indicated good in vitro antibacterial activity,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> glycosylation is still indispensable for vancomycin-based drug development. Previous studies reported various strategies to replace the vancosamine/glucose with diverse sugar moieties by enzymatic glycosylation<a onclick="showRef(event, 'ref44 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref46">(44, 46)</a> or chemical synthesis.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Recently, assembly of extra sugars on the vancomycin C-terminus<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> or seventh-amino acid<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> presented alternative chemistry in vancomycin analogue design.</div><div class="NLM_p">Lipidation on vancosamine is an efficient approach to prepare lipo-vancomycin derivatives and has been extensively reported.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24">(19-24)</a> Introducing lipid structures to other hydroxyl groups of vancomycin by various catalysts broadened the diversity of lipo-vancomycins.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The advantage of these lipo-analogues comes with dramatically enhanced antibacterial activities against drug-resistant bacteria. Meanwhile, these compounds usually led to long half-lives and brought concerns about accumulative toxicities.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Recently launched glycopeptide antibiotics (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) feature with lipophilic fragments and extra sugar motifs on the vancomycin core implicates the balance of lipophilic/hydrophilic groups is important in the structural design.</div><div class="NLM_p">Here, we synthesized a vancomycin analogue library with various sugar motifs and lipophilic structures (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) to understand the SAR and optimal combination of lipo-fragments and extra sugars. The in vitro antibacterial assay revealed that GalN, Gal, and orGlc were the optimal sugar moieties relative to those of other tested sugars for better antibacterial activity, and decyl or biphenyl substitution indicated better activity than that of other lipo structures when combined with the sugar attachment in vancomycin modification. The rigid lipo-vancomycin prefers the assembly of extra sugar moieties on seventh-amino acid resorcinol rather than on the C-terminus for anti-MSSA and VISA activities. In vitro anti-VRE assays on three VRE subtypes indicated different responses to C-terminus-modified and extra-sugar-attached lipo-vancomycin derivatives and suggested diverse drug-resistant mechanisms of these subtypes. The optimal vancomycin derivatives exhibited excellent antibacterial activity against MSSA, VISA, and VRE with 64–1024-fold enhanced activity compared with that of vancomycin.</div><div class="NLM_p">We evaluated the in vivo activity of the optimal compounds on two infected mouse models for lethal challenge and abscess formation assays. The mice were infected by retro-orbital injection with MRSA or VISA strains following published literature.<a onclick="showRef(event, 'ref37 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref37 ref50 ref51 ref52">(37, 50-52)</a> In our previous work, treatment of high-dose vancomycin (225 mg/kg within 108 h) showed an effective therapeutic effect to Mu50 infection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In the current work, because our compounds exceeded vancomycin in in vitro assays, we lowered the dosage to 7 mg/kg for comparison. In the lethal challenge experiment (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), the survival rates of compounds <b>18</b> and <b>46</b> are significantly higher than that of vancomycin. The abscess model is to mimic the <i>S. aureus</i> sepsis, a severe and life-threatening disease caused by <i>S. aureus</i> infection. The abscess was gradually developed and could be most obvious between ∼96 and 120 h after infection with <i>S. aureus</i>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> We euthanized mice for 5 day to detect the accumulation of abscess in kidney, heart, and liver. The abscess in liver is the most sensitive to antibiotic treatment, thereby providing a good model to evaluate the antibacterial efficacy. Compounds <b>18</b> and <b>46</b> indicated an excellent therapeutic effect to relieve liver abscess, but vancomycin did not show significant activity (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><div class="NLM_p">Pharmacokinetic data also showed that the extra sugar significantly regulates the half-life and clearance rate of these analogues, which proved our design strategy (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). In the time-course profiles of the blood drug concentration (<a class="ref internalNav" href="#notes-2" aria-label="Figure S3">Figure S3</a>), all the tested compounds maintain >1 μg/mL concentrations in blood after 4 h, which is significantly higher than their MIC values. These optimal PK properties explained their remarkable in vivo efficacy.</div><div class="NLM_p">The NMR binding experiment elucidated that the extra sugar motif of compound <b>46</b> is involved in the <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala ligand interaction. This result suggested an interesting mechanism of <b>46</b> in enhancing bacterial cell wall attachment. One of the vancomycin-resistant mechanisms is the mutation of <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala to <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Lac on the bacterial cell wall that reduced its binding affinity with vancomycin. The Bogar group<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> reported a series of novel [Ψ[CH<sub>2</sub>NH]Tpg<sup>4</sup>] and [Ψ[C(═NH)NH]Tpg<sup>4</sup>] vancomycin analogues with enhanced binding with <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Lac, which demonstrated fantastic antibacterial activities against VREs. These works implicate the enhancement of <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala/<span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Lac binding is a good strategy to fight against vancomycin-resistant bacteria. The extra sugar in our analogues could interact with the <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala ligand that provides a new modification strategy in vancomycin derivative design. Another possible mechanism of these vancomycin analogues with enhanced antibacterial activities may be due to the conformational change of vancomycin after modification. It is reported<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> that subtle alteration of vancomycin hydroxyl groups may lead to a significant change in conformation. On the other hand, the detailed structural mechanism still remains to be elucidated in the future.</div><div class="NLM_p last">In summary, we report here an effective strategy to introduce extra sugar moieties onto lipo-vancomycin for enhanced drug efficacy, optimal PK properties, and lower toxicity against drug-resistant bacteria including MRSA, VISA, and VRE.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Material and Instrumentation</h3><div class="NLM_p last">All reagents and solvents were commercially purchased from Sinopharm, Bide Pharmatech Ltd., and Shanghai Titan Ltd. (Shanghai, China) and used without further purification. Analytical thin layer chromatography (TLC) was performed on TLC plates precoated with silica gel HSGF<sub>254</sub> (200 ± 30 μm thickness). Analytic RP-HPLC analysis was performed on a Beijing Chuang Xin Tong Heng LC-3000 (analytic model) instrument with a C-18 column (5 μm, 4.6 × 150 mm) at 40 °C. The column was eluted with a gradient of 2–90% acetonitrile containing 0.1% TFA in 30 min at a flow rate of 1 mL/min. Preparative RP-HPLC preparation was performed on a Beijing Chuang Xin Tong Heng LC-3000 (preparative model) instrument with a C-18 column (10 μm, 19 × 250 mm) at room temperature. The column was eluted with a gradient of 2–70% acetonitrile containing 0.1% TFA in 30 min at a flow rate of 10 mL/min. HPLC analysis showed that the purities of all final products were more than 95%. <sup>1</sup>H NMR, <sup>13</sup>C NMR, HSQC, and HMBC spectra were recorded on a BRUKER Ascend 400 or 600 MHz instrument. Chemical shifts were assigned in ppm, and coupling constants were assigned in Hz. Constant-time <sup>1</sup>H NMR and HSQC were recorded on an AVANCE III HD BRUKER Ascend 600 MHz instrument. All the final products were added 20 μL of D<sub>2</sub>O to exchange the active hydrogen of the target products when the solvent was DMSO-<i>d</i><sub>6</sub>. ESI-MS spectra were measured with an Agilent 6230 LC-TOF MS spectrometer. Bacterial strains Newman,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Mu50,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and USA300 LAC<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> were from laboratory stock. Efm-HS-0649, Efm-HS-06188, Efm-HS-0847, Efm-HS-08257,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and VanB(R) were obtained from the Institute of Antibiotics, Huashan Hospital, Fudan University. Female BALB/c mice were purchased from SIPPR-BK Lab Animal Ltd. Male CD-1 mice were purchased from Shanghai Lingchang Biological Technology Co., Ltd.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis and Characterization</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Aminoethyl Glycoside (<b>4a</b>–<b>4d</b>)</h4><div class="NLM_p last">Compounds <b>49</b> and <b>51a</b>–<b>51c</b> were dissolved in methanol and treated with NaOMe to remove acetyls followed by hydrogenation<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> to generate <b>4a</b>–<b>4d</b> in 70–90% yield. Compounds <b>4a</b> and <b>4d</b> were used directly in next step.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Aminoethyl β-<span class="smallcaps smallerCapital">d</span>-Galactopyranoside <b>4b</b></h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 4.31 (d, <i>J</i> = 7.8 Hz, 1H), 3.94–3.87 (m, 1H), 3.81 (dd, <i>J</i> = 3.4, 1.0 Hz, 1H), 3.72–3.67 (m, 1H), 3.67–3.64 (m, 1H), 3.60 (ddd, <i>J</i> = 6.9, 5.0, 3.9 Hz, 1H), 3.55 (dd, <i>J</i> = 9.9, 3.5 Hz, 1H), 3.43 (dd, <i>J</i> = 9.9, 7.8 Hz, 1H), 2.94–2.87 (m, 2H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Aminoethyl β-<span class="smallcaps smallerCapital">d</span>-Glucopyranoside <b>4c</b></h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 4.38 (d, <i>J</i> = 7.8 Hz, 1H), 3.90 (ddd, <i>J</i> = 10.6, 5.7, 4.5 Hz, 1H), 3.81 (dd, <i>J</i> = 12.3, 2.3 Hz, 1H), 3.69 (ddd, <i>J</i> = 10.9, 6.1, 4.6 Hz, 1H), 3.61 (dd, <i>J</i> = 12.3, 5.9 Hz, 1H), 3.44–3.33 (m, 2H), 3.29 (d, <i>J</i> = 9.1 Hz, 1H), 3.19 (dd, <i>J</i> = 9.5, 7.9 Hz, 1H), 2.89 (ddd, <i>J</i> = 6.3, 4.4, 1.7 Hz, 2H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Glycolactone Derivatives (<b>4j</b>–<b>4k</b>)</h4><div class="NLM_p last"><span class="smallcaps smallerCapital">d</span>-Gluconic acid lactone (<b>52a</b>, 2 g, 11.2 mmol) or lactobionolactone (<b>52b</b>, 2 g, 5.9 mmol) were refluxed with <i>N</i>-Boc-1,3-propanediamine (1.2 equiv) or <i>N</i>-Cbz-1,3-propanediamine (1.2 equiv) in methanol for 4 h, respectively. The solvent was removed, and the residue was washed with enough ethyl acetate to remove excess <i>N</i>-Boc-1,3-propanediamine or <i>N</i>-Cbz-1,3-propanediamine. The corresponding products were obtained after being dried under a vacuum (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for <sup>1</sup>H NMR characterization of these intermediates). Then, the protection groups of Boc and Cbz were removed by 2 N HCl and H<sub>2</sub> hydrogenation to give <b>4j</b> and <b>4k</b>, respectively, which were used in the next step directly.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Gluconic Acid Lactone Derivative (<b>4j</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 4.23 (d, <i>J</i> = 3.4 Hz, 1H), 3.98 (s, 1H), 3.73–3.68 (m, 1H), 3.64 (q, <i>J</i> = 2.0 Hz, 2H), 3.58–3.52 (m, 1H), 3.27 (ddt, <i>J</i> = 26.9, 14.0, 7.1 Hz, 2H), 2.92 (t, <i>J</i> = 7.6 Hz, 2H), 1.85–1.75 (m, 2H).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedures for Synthesis of Compounds <b>5</b>–<b>46</b></h3><div class="NLM_p">Reductive amination, acylation, and Mannich reactions were used in the synthesis of final compounds successively. First, for intermediates <b>3a</b>–<b>3n</b>, vancomycin hydrochloride (100 mg, 67 μmol), R<sup>2</sup>-CHO <b>2a</b>–<b>2n</b> (2 equiv), and DIPEA (30 μL, 172 μmol) were stirred in DMF (3 mL) for 2–4 h to form Schiff base at 55 °C. The reaction was monitored by analytic RP-HPLC until complete conversion. Then, NaCNBH<sub>3</sub> (8 mg, 127 μmol) was dissolved in methanol (1 mL), and the solution was added to the above reaction mixture. TFA (30 μL) was added to adjust the pH to 4. The residue was stirred at room temperature for 2 h to reduce the Schiff base C–N double bond to C–N single bond. In the case of <b>3a</b>, it required deprotection of Fmoc by treatment with 20% piperidine in DMF for 20 min before performing reductive amination. For intermediates <b>3o</b> and <b>3p</b>, vancomycin hydrochloride (100 mg, 67 μmol) and DIPEA (30 μL, 172 μmol) were stirred in DMF (3 mL) until the solution became clear. Then, the mixture was cooled to 0 °C, and R<sup>2</sup>-COCl <b>2o</b>–<b>2p</b> (1 equiv) was added in small portions three times every half hour. The residue was stirred at 0 °C for one more hour. Then, the crude product was precipitated by addition of diethyl ether (50 mL) and centrifuged. The supernatant was removed, and the solid cake was washed with diethyl ether (30 mL) once more to give the crude product. The crude was dissolved in water/acetonitrile and was purified by preparative RP-HPLC. The fractions containing target compound were combined and lyophilized to give the product as a white fluffy solid in 20–80% yield.</div><div class="NLM_p">Mannich reaction was performed in the next step to give the final product. R<sup>1</sup>-NH<sub>2</sub> (10 equiv) and DIPEA (800 μmol) were mixed with water (1 mL) and CH<sub>3</sub>CN (1 mL). The mixture was stirred until the solution was clear. Formaldehyde (37% in water, 4.5 μL, 60 μmol) was added; then, the solution was stirred for 20 min at room temperature. The residue was cooled to −10 °C, and the intermediates <b>3a</b>–<b>3p</b> (20 μmol) in water (0.5 mL) and CH<sub>3</sub>CN (0.5 mL) were added to the solution. The reaction was monitored by analytic RP-HPLC. After 12 h, the conversion rate reached 50–80%; then, the residue was treated with TFA to adjust the pH to 2–3. The residue was subject to preparative RP-HPLC purification to give compounds <b>5</b>–<b>46</b> as white fluffy solids in 35–95% yield.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosylethyl)aminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>5</b>)</h4><div class="NLM_p last">Yield 71% (26.5 mg, 14.2 μmol). RT = 16.188 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (s, 1H), 7.56 (br s, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.28 (dd, <i>J</i> = 7.2, 0.6 Hz, 2H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H),6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.78 (d, <i>J</i> = 8.6 Hz, 1H), 6.52 (s, 1H), 5.71 (s, 1H), 5.66 (s, 1H), 5.29 (d, <i>J</i> = 7.6 Hz, 1H), 5.26 (s, 1H), 5.12 (m, 3H), 4.83 (s, 1H), 4.65 (s, 2H), 4.44 (s, 1H), 4.40 (s, 1H), 4.11 (br s, 3H), 3.82 (m, 1H), 3.67–3.56 (m, 5H), 3.38 (t, <i>J</i> = 9.4 Hz, 1H), 3.34 (m, 2H), 3.26 (m, 3H), 3.10–3.02 (m, 2H), 2.80 (br s, 2H), 2.54 (s, 3H), 2.18–2.06 (m, 1H), 1.85–1.70 (m, 2H), 1.68–1.58 (m, 2H), 1.54–1.45 (m, 3H), 1.25–1.20 (m, 16H), 1.06 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.2 Hz, 3H), 0.85 (m, 6H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>117</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 622.9193, found <i>m</i>/<i>z</i> 622.9264.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (β-<span class="smallcaps smallerCapital">d</span>-Galactopyranosylethyl)aminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>6</b>)</h4><div class="NLM_p last">Yield 77% (28.7 mg, 15.4 μmol). RT = 16.174 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80 (s, 1H), 7.57 (br s, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 1H), 7.46 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.30 (dd, <i>J</i> = 8.1, 3.4 Hz, 2H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (s, 1H), 6.85 (d, <i>J</i> = 8.5 Hz, 1H), 6.78 (d, <i>J</i> = 8.5 Hz, 1H), 6.52 (s, 1H), 5.72 (m, 1H), 5.67 (s, 1H), 5.29 (d, <i>J</i> = 7.6 Hz, 1H), 5.25 (s, 1H), 5.14 (s, 1H), 5.11 (d, <i>J</i> = 10.0 Hz, 3H), 4.82 (s, 1H), 4.64 (d, <i>J</i> = 7.0 Hz, 1H), 4.45 (s, 1H), 4.41 (s, 1H), 4.18–4.09 (m, 5H), 3.96 (s, 1H), 3.84–3.75 (m, 1H), 3.67 (d, <i>J</i> = 10.6 Hz, 1H), 3.62 (d, <i>J</i> = 3.0 Hz, 1H), 3.40–3.37 (m, 1H), 3.34–3.23 (m, 5H), 2.83 (br s, 2H), 2.56 (s, 3H), 2.18–2.07 (m, 1H), 1.85–1.70 (m, 2H), 1.67–1.60 (m, 2H), 1.55–1.45 (m, 3H), 1.30 (s, 3H), 1.26–1.20 (m, 16H), 1.07 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (m, 6H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>117</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 622.9193, found <i>m</i>/<i>z</i> 622.9115.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (β-<span class="smallcaps smallerCapital">d</span>-Glucopyranosylethyl)aminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>7</b>)</h4><div class="NLM_p last">Yield 72% (27.1 mg, 14.5 μmol). RT = 16.423 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) 7.78 (m, 1H), 7.59 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.44 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (d, <i>J</i> = 8.3 Hz, 2H), 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.53 (s, 1H), 5.71 (d, <i>J</i> = 7.1 Hz, 1H), 5.67 (s, 1H), 5.30–5.24 (m, 2H), 5.12 (br s, 1H), 5.11–5.07 (d, <i>J</i> = 12.0 Hz, 2H), 4.81 (s, 1H), 4.68–4.62 (m, 1H), 4.44 (d, <i>J</i> = 5.3 Hz, 1H), 4.40 (d, <i>J</i> = 5.7 Hz, 1H), 4.19 (d, <i>J</i> = 7.8 Hz, 1H), 4.15 (d, <i>J</i> = 7.6 Hz, 1H), 4.12–4.05 (m, 3H), 4.01–3.94 (m, 2H), 3.86–3.77 (m, 1H), 3.70–3.62 (m, 2H), 3.25 (d, <i>J</i> = 5.8 Hz, 3H), 3.14 (dd, <i>J</i> = 10.7, 6.9 Hz, 2H), 3.09 (s, 2H), 3.00 (dt, <i>J</i> = 17.4, 8.9 Hz, 2H), 2.89 (s, 2H), 2.57 (s, 3H), 2.16–2.06 (m, 1H), 1.90 (s, 1H), 1.81 (d, <i>J</i> = 12.5 Hz, 1H), 1.69–1.58 (m, 2H), 1.54–1.48 (m, 3H), 1.32 (s, 3H), 1.25–1.20 (m, 16H), 1.08 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.0 Hz, 3H), 0.86–0.80 (m, 6H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>117</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 622.9193, found <i>m</i>/<i>z</i> 622.8183.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (β-<span class="smallcaps smallerCapital">d</span>-Acetylglucosaminylethyl)aminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>8</b>)</h4><div class="NLM_p last">Yield 65% (25.0 mg, 13.1 μmol). RT = 16.201 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (s, 1H), 7.48 (d, <i>J</i> = 8.7 Hz, 1H), 7.46(d, <i>J</i> = 8.7 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.22 (d, <i>J</i> = 8.3 Hz, 1H), 7.11 (s, 1H), 6.84 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.51 (s, 1H), 5.66 (s, 1H), 5.61 (s, 1H), 5.25 (d, <i>J</i> = 7.7 Hz, 1H), 5.22 (d, <i>J</i> = 3.8 Hz, 1H), 5.11 (s, 3H), 4.82–4.74 (m, 1H), 4.68–4.62 (m, 1H), 4.43 (s, 1H), 4.40 (s, 1H), 4.34 (d, <i>J</i> = 8.5 Hz, 1H), 4.16–4.06 (m, 5H), 3.92–3.86 (m, 1H), 3.86–3.79 (m, 1H), 3.71 (d, <i>J</i> = 10.2 Hz, 1H), 3.65 (d, <i>J</i> = 10.6 Hz, 1H), 3.30–3.21 (m, 5H), 3.18–3.13 (m, 2H), 3.08–2.96(m, 6H), 2.88 (dd, <i>J</i> = 9.4, 6.4 Hz, 2H), 2.76–2.71 (m, 1H), 2.36 (s, 3H), 1.92–1.86 (m, 1H), 1.78 (s, 3H), 1.71 (d, <i>J</i> = 12.9 Hz, 1H), 1.59–1.44 (m, 5H), 1.28 (s, 3H), 1.23–1.19 (m, 16H), 1.04 (d, <i>J</i> = 6.3 Hz, 3H), 0.87 (d, <i>J</i> = 6.1 Hz, 3H), 0.85–0.79 (m, 6H). HRMS (ESI) calcd for C<sub>89</sub>H<sub>120</sub>Cl<sub>2</sub>N<sub>12</sub>O<sub>30</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 636.5948, found <i>m</i>/<i>z</i> 636.5870.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Hydroxyethylaminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>9</b>)</h4><div class="NLM_p last">Yield 91% (30.8 mg, 18.1 μmol). RT = 16.450 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.81 (d, <i>J</i> = 1.9 Hz, 1H), 7.50 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.47 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (d, <i>J</i> = 8.3 Hz, 1H), 7.12 (s, 1H), 6.86 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.79 (d, <i>J</i> = 8.5 Hz, 1H), 6.54 (s, 1H), 5.70 (d, <i>J</i> = 7.1 Hz, 1H), 5.64 (s, 1H), 5.26 (d, <i>J</i> = 7.8 Hz, 1H), 5.24 (d, <i>J</i> = 4.0 Hz, 1H), 5.12 (s, 3H), 4.79 (br s, 1H), 4.67–4.63 (m, 1H), 4.45 (d, <i>J</i> = 4.8 Hz, 1H), 4.43 (d, <i>J</i> = 5.8 Hz, 1H), 4.17–4.07 (m, 4H), 3.70–3.64 (m, 3H),3.55 (d, <i>J</i> = 9.0 Hz, 1H), 3.30–3.23 (m, 2H), 3.17 (s, 1H), 3.08 (q, <i>J</i> = 7.3 Hz, 2H), 3.00–2.94 (m, 2H), 2.94–2.89 (m, 2H), 2.13 (q, <i>J</i> = 8.0, 7.6 Hz, 0H), 1.93–1.85 (m, 1H), 1.72 (d, <i>J</i> = 13.1 Hz, 1H), 1.63–1.50 (m, 4H), 1.29 (s, 3H), 1.28–1.19 (m, 16H), 1.08 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.0 Hz, 3H), 0.86–0.80 (m, 6H), 1.05 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.0 Hz, 3H), 0.87–0.82 (m, 6H). HRMS (ESI) calcd for C<sub>81</sub>H<sub>107</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>25</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 568.9017, found <i>m</i>/<i>z</i> 568.9059.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Mannosaminylmethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>10</b>)</h4><div class="NLM_p last">Yield 54% (19.7 mg, 10.8 μmol). RT = 16.265 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80 (s, 1H), 7.54–7.41 (m, 4H), 7.32 (d, <i>J</i> = 8.2 Hz, 1H), 7.23 (d, <i>J</i> = 8.6 Hz, 1H), 7.13 (s, 1H), 6.86 (d, <i>J</i> = 8.2 Hz, 1H), 6.78 (d, <i>J</i> = 8.2 Hz, 1H), 6.55 (s, 1H), 5.69 (d, <i>J</i> = 7.1 Hz, 1H), 5.64 (s, 1H), 5.26 (d, <i>J</i> = 7.6 Hz, 1H), 5.24 (d, <i>J</i> = 3.9 Hz, 1H), 5.17–5.07 (m, 3H), 4.78 (br s, 1H), 4.69–4.62 (m, 1H), 4.47 (s, 1H), 4.43 (d, <i>J</i> = 5.6 Hz, 1H), 4.28 (s, 1H), 4.12 (d, <i>J</i> = 11.7 Hz, 1H), 3.74–3.62 (m, 3H), 3.57–3.51 (m, 1H), 3.34–3.21 (m, 4H), 3.16 (s, 1H), 3.03 (br s, 1H), 2.93–2.85 (m, 3H), 2.19–2.10 (m, 1H), 1.90 (d, <i>J</i> = 13.1 Hz, 1H), 1.72 (d, <i>J</i> = 13.1 Hz, 1H), 1.59–1.50 (m, 4H), 1.41–1.34 (m, 1H), 1.29 (s, 3H), 1.27–1.22 (m, 16H), 1.06 (d, <i>J</i> = 6.3 Hz, 3H), 0.89 (d, <i>J</i> = 6.0 Hz, 3H), 0.87–0.82 (m, 6H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>113</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 911.8619, found <i>m</i>/<i>z</i> 911.8621.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Glucosaminylmethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>11</b>)</h4><div class="NLM_p last">Yield 45% (16.6 mg, 9.1 μmol). RT = 16.400 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (d, <i>J</i> = 4.7 Hz, 1H), 7.50–7.41 (m, 2H), 7.31 (d, <i>J</i> = 8.1 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 6.76 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.68 (d, <i>J</i> = 7.2 Hz, 1H), 5.63 (s, 1H), 5.48 (d, <i>J</i> = 3.4 Hz, 1H), 5.25 (d, <i>J</i> = 7.7 Hz, 1H), 5.23 (s, 1H), 5.12–5.07 (m, 3H), 4.76 (br s, 1H), 4.67–4.62 (m, 1H), 4.48–4.44 (m, 1H), 4.41 (d, <i>J</i> = 5.5 Hz, 1H), 4.25 (s, 1H), 4.10 (s, 1H), 3.71–3.63 (m, 2H), 3.62–3.57 (m, 2H), 3.30–3.20 (m, 3H), 3.19–3.10 (m, 3H), 2.94–2.84 (m, 4H), 2.18–2.08 (m, 1H), 1.88 (d, <i>J</i> = 10.6 Hz, 1H), 1.71 (d, <i>J</i> = 13.1 Hz, 1H), 1.60–1.50 (m, 4H), 1.44–1.36 (m, 1H), 1.28 (s, 3H), 1.25–1.20 (m, 16H), 1.04 (d, <i>J</i> = 6.4 Hz, 3H), 0.89 (d, <i>J</i> = 6.2 Hz, 3H), 0.86–0.78 (m, 6H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>113</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>29</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 608.2439, found <i>m</i>/<i>z</i> 608.2428.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Galactosaminylmethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>12</b>)</h4><div class="NLM_p last">Yield 43% (15.7 mg, 8.6 μmol). RT = 16.685 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.69 (br s, 1H), 7.79 (d, <i>J</i> = 8.5 Hz, 1H), 7.59 (br s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.18 (d, <i>J</i> = 8.3 Hz, 1H), 7.13 (s, 1H), 6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.6 Hz, 1H), 6.52 (s, 1H), 5.71 (d, <i>J</i> = 7.5 Hz, 1H), 5.67 (s, 1H), 5.51 (d, <i>J</i> = 3.6 Hz, 1H), 5.28 (d, <i>J</i> = 4.4 Hz, 1H), 5.26 (d, <i>J</i> = 7.9 Hz, 1H), 5.12 (s, 1H), 5.09 (s, 2H), 4.80 (s, 1H), 4.66 (t, <i>J</i> = 6.8 Hz, 1H), 4.47 (s, 1H), 4.40 (t, <i>J</i> = 5.5 Hz, 1H), 4.23 (s, 1H), 4.00 (s, 1H), 3.84 (dd, <i>J</i> = 10.6, 3.0 Hz, 1H), 3.80 (t, <i>J</i> = 6.5 Hz, 1H), 3.75 (d, <i>J</i> = 3.2 Hz, 1H), 3.65 (d, <i>J</i> = 10.7 Hz, 1H), 3.29–3.21 (m, 4H), 3.20–3.09 (m, 4H), 3.07–3.00 (m, 1H), 2.91 (t, <i>J</i> = 7.7 Hz, 3H), 2.57 (s, 3H), 1.91 (d, <i>J</i> = 11.8 Hz, 1H), 1.82 (d, <i>J</i> = 13.0 Hz, 1H), 1.68–1.59 (m, 2H), 1.56–1.46 (m, 4H), 1.34 (s, 3H), 1.25–1.20 (m, 16H), 1.08 (d, <i>J</i> = 6.2 Hz, 3H), 0.90 (d, <i>J</i> = 5.9 Hz, 4H), 0.85 (d, <i>J</i> = 6.9 Hz, 3H), 0.82 (d, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>113</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>29</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 608.2439, found <i>m</i>/<i>z</i> 608.2521.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>13</b>)</h4><div class="NLM_p last">Yield 52% (19.7 mg, 10.4 μmol). RT = 16.110 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.62 (s, 1H), 7.79 (s, 1H), 7.60 (br s, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 1H), 7.30 (d, <i>J</i> = 8.2 Hz, 1H), 7.20 (d, <i>J</i> = 8.3 Hz, 1H), 7.10 (s, 1H), 6.84 (d, <i>J</i> = 9.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.71 (s, 2H), 5.68 (s, 1H), 5.30–5.24 (m, 3H), 5.11 (s, 2H), 5.08 (s, 1H), 4.80 (s, 1H), 4.65 (d, <i>J</i> = 6.0 Hz, 1H), 4.45 (br s, 1H), 4.40 (d, <i>J</i> = 6.0 Hz, 1H), 4.10 (s, 1H), 4.06 (s, 2H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (t, <i>J</i> = 2.9 Hz, 1H), 3.65 (d, <i>J</i> = 10.8 Hz, 1H), 3.57–3.54 (m, 1H), 3.36 (dd, <i>J</i> = 10.8, 5.1 Hz, 1H), 3.28–3.23 (m, 3H), 3.21–3.09 (m, 5H), 2.95–2.88 (m, 4H), 2.56 (s, 3H), 1.86–1.78 (m, 3H), 1.69–1.59 (m, 2H), 1.56–1.47 (m, 3H), 1.34 (s, 3H), 1.27–1.21 (m, 16H), 1.08 (d, <i>J</i> = 6.1 Hz, 3H), 0.90 (d, <i>J</i> = 6.0 Hz, 3H), 0.87–0.79 (m, 6H). HRMS (ESI) calcd for C<sub>88</sub>H<sub>120</sub>Cl<sub>2</sub>N<sub>12</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 948.3883, found <i>m</i>/<i>z</i> 948.3892.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (Acyclic-lactobionolactone)acylaminopropylaminomethyl-<i>N</i>-decylaminoethyl Vancomycin (<b>14</b>)</h4><div class="NLM_p last">Yield 51% (21.0 mg, 10.2 μmol). RT = 16.054 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.62 (s, 1H), 7.79 (s, 1H), 7.61 (s, 1H), 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 7.45 (d, <i>J</i> = 8.6 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.84 (d, <i>J</i> = 8.5 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.72 (d, <i>J</i> = 7.4 Hz, 1H), 5.68 (s, 1H), 5.29 (s, 1H), 5.27 (d, <i>J</i> = 7.7 Hz, 1H), 5.11 (s, 2H), 5.08 (s, 1H), 4.80 (s, 1H), 4.65 (d, <i>J</i> = 6.7 Hz, 1H), 4.45 (s, 1H), 4.41 (d, <i>J</i> = 5.6 Hz, 1H), 4.27 (d, <i>J</i> = 6.6 Hz, 1H), 4.11 (d, <i>J</i> = 2.3 Hz, 2H), 4.06 (s, 3H), 4.02–3.96 (m, 2H), 3.71–3.62 (m, 3H), 3.61–3.49 (m, 6H), 3.40 (d, <i>J</i> = 6.5 Hz, 1H), 3.32–3.28 (m, 2H), 3.26 (s, 3H), 3.22–3.08 (m, 6H), 3.07–2.97 (m, 1H), 2.94–2.88 (m, 4H), 2.79–2.67 (m, 1H), 2.56 (s, 3H), 1.92 (d, <i>J</i> = 13.4 Hz, 1H), 1.86–1.77 (m, 3H), 1.68–1.61 (m, 2H), 1.55–1.47 (m, 3H), 1.34 (s, 3H), 1.27–1.21 (m, 16H), 1.09 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.0 Hz, 3H), 0.88–0.82 (m, 6H). HRMS (ESI) calcd for C<sub>94</sub>H<sub>130</sub>Cl<sub>2</sub>N<sub>12</sub>O<sub>35</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 1029.4148, found <i>m</i>/<i>z</i> 1029.4148.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (β-<span class="smallcaps smallerCapital">d</span>-Mannopyranosylethyl)aminomethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>15</b>)</h4><div class="NLM_p last">Yield 71% (26.7 mg, 14.2 μmol). RT = 15.744 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 1H), 8.67 (s, 1H), 7.83 (d, <i>J</i> = 2.0 Hz, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.70 (d, <i>J</i> = 8.6 Hz, 2H), 7.58 (d, <i>J</i> = 1.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.45 (d, <i>J</i> = 8.3 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.19 (d, <i>J</i> = 8.5 Hz, 1H), 7.10 (s, 1H), 6.86 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.54 (s, 1H), 5.87 (d, <i>J</i> = 2.1 Hz, 1H), 5.65 (d, <i>J</i> = 7.4 Hz, 1H), 5.35 (d, <i>J</i> = 7.7 Hz, 1H), 5.30 (d, <i>J</i> = 4.2 Hz, 1H), 5.12 (d, <i>J</i> = 12.6 Hz, 2H), 5.07 (d, <i>J</i> = 2.0 Hz, 1H), 4.76 (s, 1H), 4.66 (d, <i>J</i> = 6.7 Hz, 1H), 4.64 (d, <i>J</i> = 1.7 Hz, 1H), 4.46 (s, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.19–4.08 (m, 3H), 4.06–3.99 (m, 1H), 3.98–3.92 (m, 1H), 3.88–3.80 (m, 1H), 3.69–3.60 (m, 3H), 3.57 (t, <i>J</i> = 8.5 Hz, 1H), 3.50 (dd, <i>J</i> = 9.0, 3.4 Hz, 1H), 3.38 (t, <i>J</i> = 9.4 Hz, 1H), 3.36–3.31 (m, 2H), 3.29–3.23 (m, 3H), 3.11 (d, <i>J</i> = 5.6 Hz, 2H), 2.73 (d, <i>J</i> = 15.5 Hz, 1H), 2.10 (d, <i>J</i> = 12.1 Hz, 1H), 1.95–1.86 (m, 1H), 1.82 (d, <i>J</i> = 13.1 Hz, 1H), 1.51 (s, 3H), 1.10 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (t, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI) calcd for C<sub>88</sub>H<sub>101</sub>Cl<sub>3</sub>N<sub>10</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 942.2954, found <i>m</i>/<i>z</i> 942.2943.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (β-<span class="smallcaps smallerCapital">d</span>-Galactopyranosylethyl)aminomethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>16</b>)</h4><div class="NLM_p last">Yield 76% (28.6 mg, 15.2 μmol). RT = 15.840 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (s, 1H), 7.82 (d, <i>J</i> = 2.1 Hz, 1H), 7.72 (d, <i>J</i> = 8.1 Hz, 2H), 7.70 (d, <i>J</i> = 8.6 Hz, 2H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.53–7.51 (m, 2H), 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 7.46 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H), 6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.51 (s, 1H), 5.72 (s, 1H), 5.70 (s, 1H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (s, 1H), 5.12 (s, 2H), 5.10 (s, 1H), 4.81 (s, 1H), 4.69–4.62 (m, 1H), 4.45 (s, 1H), 4.40 (s, 1H), 4.21–3.88 (m, 7H), 3.86–3.71 (m, 1H), 3.66 (d, <i>J</i> = 10.6 Hz, 1H), 3.61 (d, <i>J</i> = 3.0 Hz, 1H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.53–3.49 (m, 2H), 3.38–3.33 (m, 2H), 3.32–3.22 (m, 5H), 2.52 (s, 3H), 2.17–2.03 (m, 2H), 1.81 (d, <i>J</i> = 13.1 Hz, 1H), 1.69–1.56 (m, 3H), 1.48 (s, 3H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.3 Hz, 3H), 0.85 (d, <i>J</i> = 6.2 Hz, 3H). HRMS (ESI) calcd for C<sub>88</sub>H<sub>101</sub>Cl<sub>3</sub>N<sub>10</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 942.2954, found <i>m</i>/<i>z</i> 942.3032.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Hydroxyethylaminomethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>17</b>)</h4><div class="NLM_p last">Yield 90% (31.0 mg, 18.0 μmol). RT = 15.920 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.64 (s, 1H), 7.82 (s, 1H), 7.73 (d, <i>J</i> = 8.2 Hz, 2H), 7.70 (d, <i>J</i> = 8.6 Hz, 2H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.53 (d, <i>J</i> = 8.5 Hz, 2H), 7.49 (d, <i>J</i> = 8.7 Hz, 1H), 7.48–7.45 (m, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.53 (s, 1H), 5.75–5.69 (m, 2H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.1 Hz, 1H), 5.12 (s, 2H), 5.09 (d, <i>J</i> = 1.9 Hz, 1H), 4.81 (s, 1H), 4.67–4.63 (m, 1H), 4.46 (d, <i>J</i> = 5.3 Hz, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.18–3.96 (m, 6H), 3.68–3.64 (m, 3H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.51 (d, <i>J</i> = 7.2 Hz, 1H), 3.31–3.21 (m, 4H), 2.98–2.93 (m, 2H), 2.57 (s, 3H), 2.10 (d, <i>J</i> = 9.6 Hz, 2H), 1.81 (d, <i>J</i> = 13.2 Hz, 1H), 1.68–1.66 (m, 2H), 1.49 (s, 3H), 1.11 (d, <i>J</i> = 6.1 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>82</sub>H<sub>91</sub>Cl<sub>3</sub>N<sub>10</sub>O<sub>25</sub> [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 574.5152, found <i>m</i>/<i>z</i> 574.5170.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Galactosaminylmethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>18</b>)</h4><div class="NLM_p last">Yield 42% (15.4 mg, 8.4 μmol). RT = 15.835 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (br s, 1H), 8.72 (br s, 1H), 7.83 (s, 1H), 7.61 (br s, 1H), 7.55 (d, <i>J</i> = 8.1 Hz, 2H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 7.49 (d, <i>J</i> = 8.5 Hz, 0H), 7.46 (d, <i>J</i> = 8.5 Hz, 1H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.13 (s, 1H), 6.86 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.7 Hz, 1H), 6.53 (s, 1H), 5.72 (d, <i>J</i> = 11.0 Hz, 2H), 5.51 (d, <i>J</i> = 3.6 Hz, 1H), 5.33 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.2 Hz, 1H), 5.12 (s, 1H), 5.10 (d, <i>J</i> = 2.0 Hz, 2H), 4.80 (s, 1H), 4.66 (q, <i>J</i> = 6.7 Hz, 1H), 4.50–4.44 (m, 1H), 4.40 (t, <i>J</i> = 5.8 Hz, 1H), 4.23 (s, 1H), 4.14 (d, <i>J</i> = 10.3 Hz, 1H), 4.04–3.97 (m, 3H), 3.84 (dd, <i>J</i> = 10.5, 3.0 Hz, 1H), 3.80 (t, <i>J</i> = 6.5 Hz, 1H), 3.75 (d, <i>J</i> = 3.2 Hz, 1H), 3.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.42–3.38 (m, 1H), 3.30–3.21 (m, 2H), 3.15 (dd, <i>J</i> = 10.5, 3.5 Hz, 1H), 2.76–2.68 (m, 1H), 2.57 (s, 3H), 2.10 (d, <i>J</i> = 13.4 Hz, 1H), 1.82 (d, <i>J</i> = 13.2 Hz, 1H), 1.69–1.60 (m, 2H), 1.49 (s, 3H), 1.22–1.19 (m, 1H), 1.10 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>86</sub>H<sub>97</sub>Cl<sub>3</sub>N<sub>10</sub>O<sub>29</sub> [M+2H]<sup>2+</sup><i>m</i>/<i>z</i> 920.2822, found <i>m</i>/<i>z</i> 920.2862.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>19</b>)</h4><div class="NLM_p last">Yield 55% (21.0 mg, 11.0 μmol). RT = 15.747 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.82 (s, 1H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H), 7.70 (d, <i>J</i> = 8.5 Hz, 2H), 7.55 (d, <i>J</i> = 8.1 Hz, 2H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 7.49 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 7.46 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (s, 1H), 6.85 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.52 (s, 1H), 5.72 (s, 1H), 5.71 (s, 1H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.1 Hz, 1H), 5.12 (d, <i>J</i> = 3.8 Hz, 2H), 5.09 (s, 1H), 4.80 (s, 1H), 4.68–4.61 (m, 1H), 4.44 (s, 1H), 4.40 (s, 1H), 4.10 (s, 1H), 4.05 (s, 2H), 4.02 (d, <i>J</i> = 6.7 Hz, 2H), 4.00 (d, <i>J</i> = 3.6 Hz, 2H), 3.89 (t, <i>J</i> = 2.8 Hz, 1H), 3.66 (d, <i>J</i> = 10.6 Hz, 1H), 3.59–3.53 (m, 3H), 3.36 (dd, <i>J</i> = 10.7, 5.2 Hz, 1H), 3.30–3.23 (m, 3H), 3.22–3.16 (m, 1H), 3.16–3.10 (m, 1H), 2.95–2.87 (m, 2H), 2.55 (s, 3H), 2.15–2.05 (m, 2H), 1.87–1.77 (m, 3H), 1.68–1.59 (m, 2H), 1.49 (s, 3H), 1.11 (d, <i>J</i> = 6.7 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>89</sub>H<sub>104</sub>Cl<sub>3</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 956.8086, found <i>m</i>/<i>z</i> 956.8070.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (Acyclic-lactobionolactone)acylaminopropylaminomethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>20</b>)</h4><div class="NLM_p last">Yield 51% (21.2 mg, 10.2 μmol). RT = 15.695 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.65 (s, 1H), 7.82 (d, <i>J</i> = 1.9 Hz, 1H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H), 7.70 (d, <i>J</i> = 8.5 Hz, 2H), 7.62 (s, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 7.48–7.44 (m, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.78–5.68 (m, 2H), 5.34 (d, <i>J</i> = 7.6 Hz, 1H), 5.29 (d, <i>J</i> = 4.1 Hz, 1H), 5.13 (s, 2H), 5.09 (s, 1H), 4.81 (s, 1H), 4.69–4.62 (m, 1H), 4.44 (d, <i>J</i> = 4.9 Hz, 1H), 4.41 (d, <i>J</i> = 5.7 Hz, 1H), 4.26 (d, <i>J</i> = 6.8 Hz, 1H), 4.10 (d, <i>J</i> = 2.3 Hz, 2H), 4.09–3.97 (m, 8H), 3.71–3.64 (m, 3H), 3.62–3.54 (m, 3H), 3.51 (dd, <i>J</i> = 11.4, 4.7 Hz, 1H), 3.39 (t, <i>J</i> = 6.3 Hz, 1H), 3.33–3.23 (m, 4H), 3.22–3.17 (m, 1H), 3.17–3.11 (m, 1H), 2.92 (t, <i>J</i> = 6.7 Hz, 2H), 2.57 (s, 3H), 2.10 (d, <i>J</i> = 11.1 Hz, 2H), 1.87–1.76 (m, 3H), 1.69–1.60 (m, 2H), 1.49 (s, 3H), 1.11 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>95</sub>H<sub>114</sub>Cl<sub>3</sub>N<sub>11</sub>O<sub>35</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 1037.8350, found <i>m</i>/<i>z</i> 1037.8290.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (Phosphonomethyl)aminomethyl-<i>N</i>-4′-chlorobiphenylmethyl Vancomycin (<b>21</b>)</h4><div class="NLM_p last">Yield 81% (28.9 mg, 16.3 μmol). RT = 15.855 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.86 (s, 1H), 7.72 (d, <i>J</i> = 8.1 Hz, 2H), 7.70 (d, <i>J</i> = 8.6 Hz, 2H), 7.46 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.13 (s, 1H), 6.79 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.72 (d, <i>J</i> = 8.6 Hz, 1H), 6.44 (s, 1H), 5.75 (s, 1H), 5.63 (s, 1H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.28 (s, 1H), 5.14 (d, <i>J</i> = 8.4 Hz, 2H), 5.09 (s, 1H), 4.86 (s, 1H), 4.69–4.62 (m, 1H), 4.43 (s, 1H), 4.41 (s, 1H), 4.31–4.24 (m, 2H), 4.16 (s, 2H), 4.02 (s, 2H), 3.67 (d, <i>J</i> = 10.8 Hz, 1H), 3.56 (d, <i>J</i> = 8.5 Hz, 1H), 3.30–3.21 (m, 3H), 2.70–2.60 (m, 2H), 2.55 (s, 1H), 2.08 (d, <i>J</i> = 22.6 Hz, 2H), 1.82 (d, <i>J</i> = 13.1 Hz, 1H), 1.64 (s, 2H), 1.48 (s, 3H), 1.11 (d, <i>J</i> = 6.2 Hz, 3H), 0.90 (d, <i>J</i> = 6.4 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>81</sub>H<sub>90</sub>Cl<sub>3</sub>N<sub>10</sub>O<sub>27</sub>P [M + 3H]<sup>3+</sup><i>m</i>/<i>z</i> 591.1671, found <i>m</i>/<i>z</i> 591.1677.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-nonyl Vancomycin (<b>22</b>)</h4><div class="NLM_p last">Yield 52% (19.1 mg, 10.4 μmol). RT = 14.193 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.81 (s, 1H), 7.61 (br s, 1H), 7.48 (d, <i>J</i> = 8.7 Hz, 1H), 7.44 (d, <i>J</i> = 8.7 Hz, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.53 (s, 1H), 5.72 (s, 1H), 5.70 (s, 1H), 5.30 (d, <i>J</i> = 7.7 Hz, 1H), 5.27 (d, <i>J</i> = 1.2 Hz, 1H), 5.11 (s, 2H), 5.07 (s, 1H), 4.79 (s, 1H), 4.09 (s, 1H), 4.08–4.03 (m, 3H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (dd, <i>J</i> = 3.7, 2.2 Hz, 1H), 3.66 (d, <i>J</i> = 10.8 Hz, 1H), 3.58–3.48 (m, 4H), 3.36 (dd, <i>J</i> = 10.6, 4.9 Hz, 1H), 3.28–3.21 (m, 3H), 3.21–3.17 (m, 1H), 3.17–3.11 (m, 1H), 2.96–2.88 (m, 2H), 2.74 (s, 1H), 2.68 (s, 1H), 2.54 (s, 3H), 2.15–2.07 (m, 1H), 1.96 (d, <i>J</i> = 11.9 Hz, 1H), 1.86–1.80 (m, 1H), 1.77 (d, <i>J</i> = 13.1 Hz, 1H), 1.68–1.61 (m, 2H), 1.55–1.46 (m, 3H), 1.33 (s, 3H), 1.27–1.21 (m, 14H), 1.06 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H), 0.83 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>113</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 919.8594, found <i>m</i>/<i>z</i> 919.8655.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-decyl Vancomycin (<b>23</b>)</h4><div class="NLM_p last">Yield 53% (19.6 mg, 10.6 μmol). RT = 14.283 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (br s, 1H), 8.64 (br s, 1H), 7.80 (d, <i>J</i> = 1.8 Hz, 1H), 7.60 (s, 1H), 7.48 (d, <i>J</i> = 8.6 Hz, 1H), 7.44 (d, <i>J</i> = 8.6 Hz, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.3 Hz, 1H), 7.10 (s, 1H), 6.84 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.77 (d, <i>J</i> = 8.4 Hz, 1H), 6.53 (s, 1H), 5.71 (d, <i>J</i> = 8.5 Hz, 1H), 5.69 (s, 1H), 5.30 (d, <i>J</i> = 7.7 Hz, 1H), 5.27 (d, <i>J</i> = 4.2 Hz, 1H), 5.12 (s, 2H), 5.07 (d, <i>J</i> = 2.0 Hz, 1H), 4.80 (s, 1H), 4.62–4.56 (m, 1H), 4.43 (s, 1H), 4.41 (d, <i>J</i> = 5.9 Hz, 1H), 4.11–4.07 (m, 1H), 4.07–4.03 (m, 2H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (dd, <i>J</i> = 3.6, 2.2 Hz, 1H), 3.65 (d, <i>J</i> = 10.7 Hz, 1H), 3.56 (t, <i>J</i> = 3.0 Hz, 1H), 3.55–3.53 (m, 1H), 3.53–3.50 (m, 1H), 3.50–3.48 (m, 1H), 3.36 (dd, <i>J</i> = 10.7, 5.0 Hz, 1H), 3.28–3.23 (m, 3H), 3.21–3.17 (m, 1H), 3.16–3.11 (m, 1H), 2.95–2.88 (m, 2H), 2.77–2.72 (m, 1H), 2.70–2.64 (m, 1H), 2.56 (s, 3H), 2.15–2.07 (m, 1H), 1.96 (d, <i>J</i> = 12.0 Hz, 1H), 1.82 (dt, <i>J</i> = 14.0, 7.0 Hz, 1H), 1.77 (d, <i>J</i> = 12.8 Hz, 1H), 1.68–1.60 (m, 2H), 1.55–1.45 (m, 3H), 1.33 (s, 3H), 1.25–1.19 (m, 16H), 1.06 (d, <i>J</i> = 6.2 Hz, 3H), 0.90 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (d, <i>J</i> = 6.3 Hz, 3H), 0.83 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) calcd for C<sub>86</sub>H<sub>115</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 926.8672, found <i>m</i>/<i>z</i> 926.8674.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4-ethylbenzyl Vancomycin (<b>24</b>)</h4><div class="NLM_p last">Yield 46% (16.8 mg, 9.2 μmol). RT = 12.123 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 7.82 (s, 1H), 7.61 (br s, 1H), 7.48 (d, <i>J</i> = 8.8 Hz, 1H), 7.45 (d, <i>J</i> = 8.8 Hz, 1H), 7.35 (d, <i>J</i> = 7.9 Hz, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 2H), 7.22 (d, <i>J</i> = 8.6 Hz, 1H), 7.10 (s, 1H), 6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.52 (s, 1H), 5.75–5.69 (m, 2H), 5.33 (d, <i>J</i> = 7.6 Hz, 1H), 5.28 (d, <i>J</i> = 2.0 Hz, 1H), 5.12 (s, 2H), 5.09 (s, 1H), 4.80 (s, 1H), 4.63 (d, <i>J</i> = 6.6 Hz, 1H), 4.44 (s, 1H), 4.40 (s, 1H), 4.10 (s, 1H), 4.05 (br s, 3H), 4.00 (d, <i>J</i> = 3.6 Hz, 2H), 3.97–3.91 (m, 1H), 3.90–3.87 (m, 1H), 3.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.58–3.52 (m, 2H), 3.50 (d, <i>J</i> = 6.0 Hz, 1H), 3.36 (dd, <i>J</i> = 10.5, 4.8 Hz, 1H), 3.30–3.22 (m, 3H), 3.21–3.16 (m, 1H), 3.16–3.11 (m, 1H), 2.92 (s, 2H), 2.61 (q, <i>J</i> = 6.0 Hz, 2H), 2.56 (s, 3H), 2.15–2.05 (m, 2H), 1.85–1.75 (m, 3H), 1.68–1.60 (m, 3H), 1.46 (s, 3H), 1.60 (t, <i>J</i> = 5.4 Hz 3H), 1.09 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.2 Hz, 3H), 0.86 (d, <i>J</i> = 6.2 Hz, 3H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>105</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 915.8281, found <i>m</i>/<i>z</i> 915.8275.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-pentylbenzyl Vancomycin (<b>25</b>)</h4><div class="NLM_p last">Yield 47% (17.6 mg, 9.4 μmol). RT = 13.959 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (br s, 1H), 8.66 (br s, 1H), 7.84 (s, 1H), 7.62 (br s, 2H), 7.51 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.48 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.36 (d, <i>J</i> = 7.8 Hz, 2H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.24 (d, <i>J</i> = 8.4 Hz, 3H), 7.12 (s, 1H), 6.86 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.79 (d, <i>J</i> = 8.5 Hz, 1H), 6.54 (s, 1H), 5.78–5.69 (m, 2H), 5.35 (d, <i>J</i> = 7.7 Hz, 1H), 5.30 (d, <i>J</i> = 4.2 Hz, 1H), 5.14 (s, 2H), 5.11 (s, 1H), 4.82 (s, 1H), 4.66 (q, <i>J</i> = 6.6 Hz, 1H), 4.46 (d, <i>J</i> = 3.0 Hz, 1H), 4.43 (s, 1H), 4.42 (s, 1H), 4.14–4.11 (m, 1H), 4.07 (s, 2H), 4.02 (d, <i>J</i> = 3.5 Hz, 1H), 3.96 (t, <i>J</i> = 12.0 Hz, 2H), 3.91 (t, <i>J</i> = 2.9 Hz, 1H), 3.68 (d, <i>J</i> = 10.7 Hz, 1H), 3.60–3.55 (m, 2H), 3.52 (d, <i>J</i> = 7.3 Hz, 1H), 3.38 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 3.31–3.24 (m, 2H), 3.24–3.18 (m, 1H), 3.18–3.13 (m, 1H), 2.96–2.90 (m, 2H), 2.59–2.55 (m, 6H), 2.16–2.06 (m, 2H), 1.87–1.78 (m, 3H), 1.70–1.62 (m, 2H), 1.55 (p, <i>J</i> = 7.5 Hz, 2H), 1.48 (s, 3H), 1.33–1.20 (m, 6H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.92 (d, <i>J</i> = 6.1 Hz, 3H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H), 0.85 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) calcd for C<sub>88</sub>H<sub>111</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 936.8515, found <i>m</i>/<i>z</i> 936.8536.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-butoxybenzyl Vancomycin (<b>26</b>)</h4><div class="NLM_p last">Yield 45% (16.9 mg, 9.0 μmol). RT = 12.757 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.66 (br s, 1H), 7.84 (s, 1H), 7.61 (br s, 1H), 7.51 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.48 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H), 6.96 (d, <i>J</i> = 8.5 Hz, 2H), 6.86 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.79 (d, <i>J</i> = 8.5 Hz, 1H), 6.54 (s, 1H), 5.77–5.68 (m, 2H), 5.35 (d, <i>J</i> = 7.6 Hz, 1H), 5.29 (d, <i>J</i> = 4.2 Hz, 1H), 5.14 (s, 2H), 5.11 (s, 1H), 4.82 (s, 1H), 4.66 (q, <i>J</i> = 6.6 Hz, 1H), 4.46 (d, <i>J</i> = 5.4 Hz, 1H), 4.42 (s, 1H), 4.15–4.10 (m, 1H), 4.07 (s, 2H), 4.02 (d, <i>J</i> = 3.6 Hz, 1H), 3.97 (t, <i>J</i> = 6.5 Hz, 2H), 3.94–3.86 (m, 3H), 3.68 (d, <i>J</i> = 10.7 Hz, 1H), 3.60–3.55 (m, 2H), 3.40–3.36 (dd, <i>J</i> = 12.0, 4.3 Hz, 1H), 3.31–3.24 (m, 2H), 3.24–3.18 (m, 1H), 3.18–3.13 (m, 1H), 2.96–2.88 (m, 2H), 2.56 (s, 3H), 2.09 (d, <i>J</i> = 14.8 Hz, 2H), 1.87–1.77 (m, 3H), 1.71–1.64 (m, 5H), 1.47 (s, 3H), 1.42 (h, <i>J</i> = 7.4 Hz, 2H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.94–0.90 (m, 6H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>109</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>31</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 937.8412, found <i>m</i>/<i>z</i> 937.8439.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4-(trimethylsilyl)ethynylbenzyl Vancomycin (<b>27</b>)</h4><div class="NLM_p last">Yield 49% (18.8 mg, 9.9 μmol). RT = 14.595 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (br s, 1H), 8.67 (br s, 1H), 7.84 (s, 1H), 7.63 (br s, 1H), 7.57–7.49 (m, 3H), 7.49–7.42 (m, 3H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H), 6.86 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 6.79 (d, <i>J</i> = 8.5 Hz, 1H), 6.55 (s, 1H), 5.77–5.69 (m, 2H), 5.35 (d, <i>J</i> = 7.7 Hz, 1H), 5.30 (d, <i>J</i> = 4.2 Hz, 1H), 5.14 (s, 2H), 5.11 (d, <i>J</i> = 1.9 Hz, 1H), 4.82 (s, 1H), 4.66 (q, <i>J</i> = 6.6 Hz, 1H), 4.46 (d, <i>J</i> = 5.4 Hz, 1H), 4.43 (d, <i>J</i> = 5.7 Hz, 1H), 4.15–4.10 (m, 1H), 4.08 (s, 2H), 4.02 (d, <i>J</i> = 3.6 Hz, 1H), 4.01–3.97 (m, 3H), 3.91 (dd, <i>J</i> = 3.6, 2.3 Hz, 1H), 3.68 (d, <i>J</i> = 10.7 Hz, 1H), 3.60–3.55 (m, 2H), 3.53 (d, <i>J</i> = 7.5 Hz, 1H), 3.39–3.36 (m, 1H), 3.31–3.24 (m, 2H), 3.21 (p, <i>J</i> = 6.8 Hz, 1H), 3.16 (p, <i>J</i> = 6.6 Hz, 1H), 2.94 (t, <i>J</i> = 7.5 Hz, 2H), 2.59 (s, 3H), 2.17–2.07 (m, 2H), 1.89–1.78 (m, 3H), 1.70–1.62 (m, 2H), 1.48 (s, 3H), 1.11 (d, <i>J</i> = 6.2 Hz, 3H), 0.93 (d, <i>J</i> = 6.1 Hz, 3H), 0.87 (d, <i>J</i> = 6.1 Hz, 3H), 0.23 (s, 9H). HRMS (ESI) calcd for C<sub>88</sub>H<sub>109</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub>Si [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 949.8322, found <i>m</i>/<i>z</i> 949.8331.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4-ethynylbenzyl Vancomycin (<b>28</b>)</h4><div class="NLM_p last">Yield 49% (17.9 mg, 9.8 μmol). RT = 10.384 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.65 (s, 1H), 7.81 (br s, 1H), 7.61 (s, 1H), 7.52 (d, <i>J</i> = 7.9 Hz, 2H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 3H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.84 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.71 (t, <i>J</i> = 6.8 Hz, 2H), 5.32 (d, <i>J</i> = 7.7 Hz, 1H), 5.28 (d, <i>J</i> = 4.1 Hz, 1H), 5.12 (d, <i>J</i> = 3.4 Hz, 2H), 5.08 (d, <i>J</i> = 1.9 Hz, 1H), 4.80 (s, 1H), 4.64 (d, <i>J</i> = 6.7 Hz, 1H), 4.44 (d, <i>J</i> = 5.2 Hz, 1H), 4.41 (d, <i>J</i> = 5.7 Hz, 1H), 4.25–4.19 (m, 1H), 4.08 (s, 1H), 4.06 (s, 2H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (t, <i>J</i> = 2.8 Hz, 1H), 3.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.57–3.53 (m, 2H), 3.50 (d, <i>J</i> = 7.6 Hz, 1H), 3.36 (d, <i>J</i> = 7.0 Hz, 1H), 3.29–3.22 (m, 2H), 3.19 (p, <i>J</i> = 6.7 Hz, 1H), 3.13 (p, <i>J</i> = 13.4, 6.6 Hz, 1H), 2.92 (t, <i>J</i> = 7.4 Hz, 2H), 2.56 (s, 3H), 2.16–2.02 (m, 2H), 1.86–1.75 (m, 3H), 1.68–1.60 (m, 3H), 1.45 (s, 3H), 1.09 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.0 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>101</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 913.8124, found <i>m</i>/<i>z</i> 913.8131.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-coumaronemethyl Vancomycin (<b>29</b>)</h4><div class="NLM_p last">Yield 39% (14.4 mg, 7.8 μmol). RT = 11.220 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.64 (br s, 1H), 7.81 (s, 1H), 7.61 (br s, 1H), 7.49 (d, <i>J</i> = 8.7 Hz, 1H), 7.46 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.29 (s, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.15 (d, <i>J</i> = 8.3 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.7 Hz, 2H), 6.52 (s, 1H), 5.72 (s, 1H), 5.71 (s, 1H), 5.33 (d, <i>J</i> = 7.7 Hz, 1H), 5.27 (d, <i>J</i> = 3.9 Hz, 1H), 5.12 (s, 2H), 5.09 (d, <i>J</i> = 2.0 Hz, 1H), 4.80 (s, 1H), 4.66–4.60 (m, 1H), 4.53 (t, <i>J</i> = 8.6 Hz, 2H), 4.45 (d, <i>J</i> = 5.5 Hz, 1H), 4.41 (d, <i>J</i> = 6.2 Hz, 1H), 4.16–4.04 (m, 4H), 4.00 (d, <i>J</i> = 10.5 Hz, 1H), 3.88 (d, <i>J</i> = 12.0 Hz, 2H), 3.69–3.63 (m, 3H), 3.54 (d, <i>J</i> = 8.7 Hz, 1H), 3.29–3.22 (m, 3H), 3.15 (t, <i>J</i> = 8.8 Hz, 2H), 2.98–2.93 (m, 2H), 2.56 (s, 3H), 2.15–2.03 (m, 2H), 1.77 (d, <i>J</i> = 13.2 Hz, 1H), 1.69–1.59 (m, 3H), 1.54–1.48 (m, 1H), 1.45 (s, 3H), 1.22–1.20 (m, 1H), 1.09 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.0 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>103</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>31</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 827.2781, found <i>m</i>/<i>z</i> 827.2785.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-2-menaphthyl Vancomycin (<b>30</b>)</h4><div class="NLM_p last">Yield 48% (17.8 mg, 9.6 μmol). RT = 11.363 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.65 (br s, 1H), 7.99 (s, 1H), 7.96 (d, <i>J</i> = 8.6 Hz, 1H), 7.94 (dd, <i>J</i> = 8.0, 7.2 Hz, 1H), 7.90 (dd, <i>J</i> = 8.0, 7.2 Hz, 1H), 7.82 (s, 1H), 7.60 (br s, 1H), 7.58–7.53 (m, 3H), 7.49 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.46 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.76–5.67 (m, 2H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.2 Hz, 1H), 5.12 (s, 2H), 5.09 (s, 1H), 4.81 (s, 1H), 4.67 (q, <i>J</i> = 6.6 Hz, 1H), 4.45 (d, <i>J</i> = 5.7 Hz, 1H), 4.41 (d, <i>J</i> = 5.7 Hz, 1H), 4.15 (q, <i>J</i> = 12.8 Hz, 2H), 4.06 (s, 2H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (t, <i>J</i> = 2.9 Hz, 1H), 3.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.59–3.51 (m, 3H), 3.35 (dd, <i>J</i> = 10.7, 6.0 Hz, 1H), 3.30–3.23 (m, 2H), 3.19 (p, <i>J</i> = 6.6 Hz, 1H), 3.14 (d, <i>J</i> = 6.4 Hz, 1H), 2.92 (t, <i>J</i> = 7.5 Hz, 2H), 2.57 (s, 3H), 2.15–2.08 (m, 2H), 1.86–1.77 (m, 3H), 1.68–1.60 (m, 2H), 1.51 (s, 3H), 1.12 (d, <i>J</i> = 6.4 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>103</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 926.8202, found <i>m</i>/<i>z</i> 926.8226.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4-pyridylbenzyl Vancomycin (<b>31</b>)</h4><div class="NLM_p last">Yield 44% (16.5 mg, 8.8 μmol). RT = 12.380 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.72 (d, <i>J</i> = 6.2 Hz, 2H), 8.64 (br s, 1H), 8.22 (d, <i>J</i> = 7.1 Hz, 2H), 8.03 (d, <i>J</i> = 8.4 Hz, 2H), 7.82 (s, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 2H), 7.62 (br s, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.46 (d, <i>J</i> = 8.5 Hz, 1H), 7.31 (d, <i>J</i> = 8.2 Hz, 1H), 7.22 (d, <i>J</i> = 8.7 Hz, 1H), 7.10 (s, 1H), 6.87–6.82 (m, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (d, <i>J</i> = 5.9 Hz, 1H), 5.73 (s, 1H), 5.72 (s, 2H), 5.34 (d, <i>J</i> = 7.6 Hz, 1H), 5.29 (s, 1H), 5.12 (s, 2H), 5.11–5.06 (m, 1H), 4.80 (s, 1H), 4.66 (d, <i>J</i> = 7.0 Hz, 1H), 4.49–4.43 (m, 1H), 4.41 (d, <i>J</i> = 5.6 Hz, 1H), 4.13–4.03 (m, 6H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (dd, <i>J</i> = 3.6, 2.3 Hz, 1H), 3.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.56 (d, <i>J</i> = 7.0 Hz, 1H), 3.53 (dd, <i>J</i> = 7.0, 2.0 Hz, 0H), 3.36 (dd, <i>J</i> = 10.7, 5.0 Hz, 1H), 3.30–3.22 (m, 3H), 3.21–3.16 (m, 1H), 3.16–3.10 (m, 1H), 2.99 (t, <i>J</i> = 7.9 Hz, 1H), 2.93 (t, <i>J</i> = 7.0 Hz, 1H), 2.85 (t, <i>J</i> = 7.6 Hz, 1H), 2.56 (s, 3H), 2.15–2.06 (m, 2H), 1.97–1.90 (m, 1H), 1.87–1.75 (m, 3H), 1.69–1.61 (m, 2H), 1.49 (s, 3H), 1.21 (s, 1H), 1.11 (d, <i>J</i> = 6.0 Hz, 3H), 0.91 (d, <i>J</i> = 6.3 Hz, 3H), 0.85 (d, <i>J</i> = 5.9 Hz, 3H). HRMS (ESI) calcd for C<sub>88</sub>H<sub>104</sub>Cl<sub>2</sub>N<sub>12</sub>O<sub>30</sub> [M + K + H]<sup>2+</sup><i>m</i>/<i>z</i> 959.3037, found <i>m</i>/<i>z</i> 959.3402.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4′-trifluoromethylbiphenylmethyl Vancomycin (<b>32</b>)</h4><div class="NLM_p last">Yield 49% (19.1 mg, 9.8 μmol). RT = 16.450 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 2H), 7.83 (s, 1H), 7.82 (d, <i>J</i> = 8.3 Hz, 2H), 7.80 (d, <i>J</i> = 8.1 Hz, 2H), 7.59 (d, <i>J</i> = 8.1 Hz, 2H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (s, 1H), 6.85 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.52 (s, 1H), 5.75–5.69 (m, 2H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (s, 1H), 5.12 (s, 2H), 5.10 (s, 1H), 4.80 (s, 1H), 4.69–4.63 (m, 1H), 4.45 (s, 1H), 4.41 (s, 1H), 4.11 (s, 1H), 4.00 (d, <i>J</i> = 3.6 Hz, 1H), 3.89 (dd, <i>J</i> = 3.7, 2.2 Hz, 1H), 3.67 (d, <i>J</i> = 10.6 Hz, 1H), 3.58–3.53 (m, 3H), 3.51 (d, <i>J</i> = 7.0 Hz, 1H), 3.36 (dd, <i>J</i> = 10.3, 4.7 Hz, 1H), 3.30–3.23 (m, 3H), 3.22–3.16 (m, 1H), 3.16–3.10 (m, 1H), 2.92 (s, 2H), 2.56 (s, 3H), 2.16–2.06 (m, 2H), 1.86–1.76 (m, 3H), 1.68–1.59 (m, 3H), 1.50 (s, 3H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.2 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>90</sub>H<sub>104</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>11</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 973.8218, found <i>m</i>/<i>z</i> 973.8216.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-3-chloro-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxyl)benzyl Vancomycin (<b>33</b>)</h4><div class="NLM_p last">Yield 43% (17.5 mg, 8.6 μmol). RT = 18.750 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.65 (s, 1H), 7.82 (s, 1H), 7.62 (s, 1H), 7.58 (d, <i>J</i> = 1.9 Hz, 1H), 7.49 (d, <i>J</i> = 9.1 Hz, 1H), 7.47 (d, <i>J</i> = 9.1 Hz, 1H), 7.45 (d, <i>J</i> = 7.6 Hz, 2H), 7.43 (d, <i>J</i> = 7.6 Hz, 2H), 7.40 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 7.38–7.37 (m, 1H), 7.36 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.27 (dd, <i>J</i> = 7.2, 1.2 Hz, 4H), 7.26 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (d, <i>J</i> = 9.6 Hz, 1H), 7.19 (d, <i>J</i> = 9.6 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.77–5.64 (m, 2H), 5.33 (d, <i>J</i> = 7.6 Hz, 1H), 5.27 (d, <i>J</i> = 9.4 Hz, 2H), 5.12 (s, 2H), 5.09 (d, <i>J</i> = 2.0 Hz, 1H), 4.80 (s, 1H), 4.68–4.61 (m, 1H), 4.44 (d, <i>J</i> = 5.6 Hz, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.13–4.03 (m, 4H), 4.00 (d, <i>J</i> = 3.6 Hz, 2H), 3.93 (s, 2H), 3.89 (dd, <i>J</i> = 3.6, 2.3 Hz, 1H), 3.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.58–3.53 (m, 2H), 3.51 (d, <i>J</i> = 7.3 Hz, 1H), 3.36 (dd, <i>J</i> = 10.7, 5.0 Hz, 1H), 3.30–3.22 (m, 2H), 3.22–3.17 (m, 1H), 3.16–3.10 (m, 1H), 2.92 (t, <i>J</i> = 7.4 Hz, 2H), 2.78–2.69 (m, 1H), 2.57 (s, 3H), 2.19 (s, 3H), 1.87–1.75 (m, 3H), 1.69–1.60 (m, 2H), 1.54–1.48 (m, 1H), 1.45 (s, 3H), 1.10 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.2 Hz, 3H). HRMS (ESI) calcd for C<sub>97</sub>H<sub>112</sub>Cl<sub>3</sub>N<sub>11</sub>O<sub>31</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 1016.8374, found <i>m</i>/<i>z</i> 1016.8385.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-decanoyl Vancomycin (<b>34</b>)</h4><div class="NLM_p last">Yield 47% (17.5 mg, 9.4 μmol). RT = 16.718 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (br s, 1H), 8.55 (br s, 1H), 7.77 (s, 1H), 7.47 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 7.44 (d, <i>J</i> = 8.6 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H), 7.07 (d, <i>J</i> = 8.3 Hz, 1H), 6.85 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.79 (d, <i>J</i> = 8.4 Hz, 1H), 6.53 (s, 1H), 5.66 (d, <i>J</i> = 7.8 Hz, 1H), 5.59 (s, 1H), 5.28–5.19 (m, 3H), 5.16 (s, 1H), 5.12 (s, 2H), 4.75 (br s, 1H), 4.70–4.62 (m, 1H), 4.47 (d, <i>J</i> = 5.8 Hz, 1H), 4.44 (d, <i>J</i> = 6.0 Hz, 1H), 4.14–4.08 (m, 1H), 4.08–4.04 (m, 2H), 4.01 (d, <i>J</i> = 3.5 Hz, 1H), 3.90 (t, <i>J</i> = 2.8 Hz, 1H), 3.66 (d, <i>J</i> = 10.8 Hz, 1H), 3.58–3.52 (m, 3H), 3.37 (dd, <i>J</i> = 10.3, 4.5 Hz, 1H), 3.29–3.25 (m, 3H), 3.23–3.18 (m, 1H) 3.17–3.11 (m, 2H), 2.97–2.89 (m, 2H), 2.85 (s, 3H), 2.43–2.37 (m, 1H), 2.37–2.30 (m, 1H), 2.15–2.07 (m, 1H), 1.90 (d, <i>J</i> = 11.4 Hz, 1H), 1.86–1.78 (m, 2H), 1.72 (d, <i>J</i> = 13.1 Hz, 1H), 1.59–1.50 (m, 4H), 1.39 (dq, <i>J</i> = 13.7, 6.9 Hz, 1H), 1.29 (s, 3H), 1.25–1.19 (m, 14H), 1.07 (d, <i>J</i> = 6.4 Hz, 3H), 0.89 (d, <i>J</i> = 6.5 Hz, 3H), 0.83 (t, <i>J</i> = 6.9 Hz, 3H), 0.81 (d, <i>J</i> = 6.0 Hz, 3H). HRMS (ESI) calcd for C<sub>86</sub>H<sub>113</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>31</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 933.8568, found <i>m</i>/<i>z</i> 933.8577.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (Acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-undecanoyl Vancomycin (<b>35</b>)</h4><div class="NLM_p last">Yield 45% (16.7 mg, 8.9 μmol). RT = 17.583 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.68 (br s, 1H), 8.55 (br s, 1H), 7.78 (s, 1H), 7.48 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 7.45 (d, <i>J</i> = 8.6 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H), 7.07 (d, <i>J</i> = 8.3 Hz, 1H), 6.85 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.79 (d, <i>J</i> = 8.4 Hz, 1H), 6.53 (s, 1H), 5.66 (d, <i>J</i> = 7.8 Hz, 1H), 5.59 (s, 1H), 5.28–5.19 (m, 3H), 5.16 (s, 1H), 5.12 (s, 2H), 4.75 (br s, 1H), 4.70–4.62 (m, 1H), 4.47 (d, <i>J</i> = 5.8 Hz, 1H), 4.44 (d, <i>J</i> = 6.0 Hz, 1H), 4.14–4.08 (m, 1H), 4.08–4.04 (m, 2H), 4.01 (d, <i>J</i> = 3.5 Hz, 1H), 3.90 (t, <i>J</i> = 2.8 Hz, 1H), 3.66 (d, <i>J</i> = 10.8 Hz, 1H), 3.58–3.52 (m, 3H), 3.37 (dd, <i>J</i> = 10.3, 4.5 Hz, 1H), 3.29–3.25 (m, 3H), 3.17–3.11 (m, 2H), 2.97–2.89 (m, 2H), 2.85 (s, 3H), 2.43–2.37 (m, 1H), 2.37–2.30 (m, 1H), 2.15–2.07 (m, 1H), 1.90 (d, <i>J</i> = 11.4 Hz, 1H), 1.86–1.78 (m, 2H), 1.72 (d, <i>J</i> = 13.1 Hz, 1H), 1.59–1.50 (m, 4H), 1.39 (dq, <i>J</i> = 13.7, 6.9 Hz, 1H), 1.29 (s, 3H), 1.26–1.20 (m, 16H), 1.07 (d, <i>J</i> = 6.4 Hz, 3H), 0.88 (d, <i>J</i> = 6.5 Hz, 3H), 0.84 (t, <i>J</i> = 6.9 Hz, 3H), 0.81 (d, <i>J</i> = 6.0 Hz, 3H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>115</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>31</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 940.8647, found <i>m</i>/<i>z</i> 940.8644.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Galactosaminylmethyl-<i>N</i>-decyl Vancomycin (<b>36</b>)</h4><div class="NLM_p last">Yield 40% (14.2 mg, 8.0 μmol). RT = 14.790 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81 (s, 1H), 8.73 (s, 1H), 7.83 (s, 1H), 7.62 (s, 1H), 7.50 (d, <i>J</i> = 8.6 Hz, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 1H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.5 Hz, 1H), 7.15 (s, 1H), 6.87 (d, <i>J</i> = 8.8 Hz, 1H), 6.78 (d, <i>J</i> = 8.0 Hz, 1H), 6.54 (s, 1H), 5.76–5.65 (m, 2H), 5.13 (s, 1H), 5.11 (d, <i>J</i> = 9.2 Hz, 1H), 4.82 (s, 1H), 4.61 (q, <i>J</i> = 6.8 Hz, 1H), 4.52–4.45 (m, 1H), 4.42 (t, <i>J</i> = 5.9 Hz, 1H), 4.25 (s, 1H), 4.16–4.11 (m, 1H), 4.02 (s, 1H), 3.86 (d, <i>J</i> = 10.2 Hz, 1H), 3.82 (t, <i>J</i> = 6.4 Hz, 1H), 3.77 (s, 0H), 3.67 (d, <i>J</i> = 10.8 Hz, 1H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.52 (d, <i>J</i> = 9.6 Hz, 1H), 3.30–3.22 (m, 5H), 3.17 (d, <i>J</i> = 10.8 Hz, 1H), 2.79–2.72 (m, 2H), 2.71–2.65 (m, 1H), 2.58 (s, 3H), 1.98 (d, <i>J</i> = 11.9 Hz, 1H), 1.79 (d, <i>J</i> = 13.1 Hz, 1H), 1.71–1.62 (m, 3H), 1.58–1.48 (m, 3H), 1.35 (s, 3H), 1.27–1.20 (m, 16H), 1.08 (d, <i>J</i> = 6.3 Hz, 3H), 0.93 (d, <i>J</i> = 6.0 Hz, 3H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H), 0.86 (t, <i>J</i> = 6.9 Hz, 3H). HRMS (ESI) calcd for C<sub>83</sub>H<sub>108</sub>Cl<sub>2</sub>N<sub>10</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 890.3408, found <i>m</i>/<i>z</i> 890.3413.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Galactosaminylmethyl-<i>N</i>-pentylbenzyl Vancomycin (<b>37</b>)</h4><div class="NLM_p last">Yield 41% (14.7 mg, 8.2 μmol). RT = 16.038 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.84 (s, 1H), 7.62 (br s, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 1H), 7.35 (d, <i>J</i> = 7.9 Hz, 2H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 2H), 7.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (s, 1H), 6.86 (d, <i>J</i> = 8.3 Hz, 1H), 6.77 (d, <i>J</i> = 8.3 Hz, 1H), 6.54 (s, 1H), 5.76–5.68 (m, 2H), 5.52 (d, <i>J</i> = 3.6 Hz, 1H), 5.34 (d, <i>J</i> = 7.6 Hz, 1H), 5.28 (s, 1H), 5.12 (s, 1H), 5.11 (d, <i>J</i> = 5.8 Hz, 1H), 4.81 (s, 1H), 4.65 (q, <i>J</i> = 6.6 Hz, 1H), 4.51–4.45 (m, 1H), 4.41 (t, <i>J</i> = 5.9 Hz, 1H), 4.24 (s, 1H), 4.03–3.98 (m, 1H), 3.94 (q, <i>J</i> = 12.8 Hz, 2H), 3.85 (d, <i>J</i> = 12.5 Hz, 1H), 3.81 (t, <i>J</i> = 6.4 Hz, 1H), 3.76 (d, <i>J</i> = 3.2 Hz, 1H), 3.67 (d, <i>J</i> = 10.7 Hz, 1H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.53–3.49 (m, 1H), 3.30–3.22 (m, 2H), 3.16 (d, <i>J</i> = 10.0 Hz, 1H), 2.57 (s, 3H), 2.57–2.52 (m, 2H), 2.10 (d, <i>J</i> = 11.4 Hz, 1H), 1.80 (d, <i>J</i> = 13.2 Hz, 1H), 1.70–1.61 (m, 2H), 1.54 (p, <i>J</i> = 7.5 Hz, 2H), 1.47 (s, 3H), 1.32–1.19 (m, 5H), 1.10 (d, <i>J</i> = 6.3 Hz, 3H), 0.92 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.2 Hz, 3H), 0.83 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>104</sub>Cl<sub>2</sub>N<sub>10</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 900.3252, found <i>m</i>/<i>z</i> 900.3265.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Galactosaminylmethyl-<i>N</i>-4-(trimethylsilyl)ethynylbenzyl Vancomycin (<b>38</b>)</h4><div class="NLM_p last">Yield 41% (15.0 mg, 8.2 μmol). RT = 14.599 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (br s, 1H), 8.72 (br s, 1H), 7.84 (s, 1H), 7.63 (br s, 1H), 7.54–7.49 (m, 3H), 7.49–7.44 (m, 3H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.21 (d, <i>J</i> = 8.3 Hz, 1H), 7.15 (s, 1H), 6.87 (d, <i>J</i> = 8.9 Hz, 1H), 6.78 (d, <i>J</i> = 8.5 Hz, 1H), 6.55 (s, 1H), 5.76–5.69 (m, 2H), 5.53 (s, 1H), 5.34 (d, <i>J</i> = 7.6 Hz, 1H), 5.29 (s, 1H), 5.16–5.08 (m, 3H), 4.81 (s, 1H), 4.66 (q, <i>J</i> = 6.8 Hz, 1H), 4.51–4.46 (m, 1H), 4.42 (t, <i>J</i> = 5.9 Hz, 1H), 4.04–3.97 (m, 3H), 3.85 (d, <i>J</i> = 10.7 Hz, 1H), 3.81 (t, <i>J</i> = 6.4 Hz, 1H), 3.76 (s, 1H), 3.68 (d, <i>J</i> = 10.8 Hz, 1H), 3.57 (t, <i>J</i> = 8.5 Hz, 1H), 3.53–3.50 (m, 1H), 3.31–3.23 (m, 2H), 3.17 (d, <i>J</i> = 11.2 Hz, 1H), 2.58 (s, 3H), 2.09 (d, <i>J</i> = 11.7 Hz, 1H), 1.81 (d, <i>J</i> = 13.2 Hz, 1H), 1.69–1.62 (m, 2H), 1.47 (s, 3H), 1.11 (d, <i>J</i> = 6.2 Hz, 3H), 0.92 (d, <i>J</i> = 6.0 Hz, 3H), 0.87 (d, <i>J</i> = 6.1 Hz, 3H), 0.22 (s, 9H). HRMS (ESI) calcd for C<sub>85</sub>H<sub>102</sub>Cl<sub>2</sub>N<sub>10</sub>O<sub>29</sub>Si [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 913.3058, found <i>m</i>/<i>z</i> 913.3060.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Galactosaminylmethyl-<i>N</i>-4-ethynylbenzyl Vancomycin (<b>39</b>)</h4><div class="NLM_p last">Yield 42% (14.7 mg, 8.4 μmol). RT = 10.494 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.85 (s, 1H), 7.63 (s, 1H), 7.56–7.52 (m, 3H), 7.52–7.45 (m, 3H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 0H), 7.15 (s, 0H), 6.87 (d, <i>J</i> = 7.7 Hz, 1H), 6.78 (d, <i>J</i> = 8.7 Hz, 1H), 6.56 (s, 0H), 5.77–5.68 (m, 2H), 5.54 (d, <i>J</i> = 3.6 Hz, 1H), 5.35 (d, <i>J</i> = 7.7 Hz, 1H), 5.30 (d, <i>J</i> = 4.3 Hz, 1H), 5.14 (s, 1H), 5.13–5.11 (m, 1H), 4.83 (s, 1H), 4.67 (q, <i>J</i> = 6.6 Hz, 1H), 4.52–4.47 (m, 1H), 4.43 (t, <i>J</i> = 5.9 Hz, 1H), 4.27 (d, <i>J</i> = 1.9 Hz, 2H), 4.06–3.94 (m, 4H), 3.86 (dd, <i>J</i> = 10.6, 3.0 Hz, 1H), 3.82 (t, <i>J</i> = 6.5 Hz, 1H), 3.77 (d, <i>J</i> = 3.3 Hz, 1H), 3.69 (d, <i>J</i> = 10.8 Hz, 1H), 3.58 (t, <i>J</i> = 8.5 Hz, 1H), 3.53 (dd, <i>J</i> = 10.7, 3.6 Hz, 1H), 3.33–3.23 (m, 3H), 3.17 (dd, <i>J</i> = 10.6, 3.4 Hz, 1H), 2.59 (s, 3H), 2.10 (d, <i>J</i> = 11.0 Hz, 1H), 1.82 (d, <i>J</i> = 13.1 Hz, 1H), 1.71–1.61 (m, 3H), 1.48 (s, 3H), 1.12 (d, <i>J</i> = 6.3 Hz, 3H), 0.93 (d, <i>J</i> = 6.0 Hz, 3H), 0.88 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>82</sub>H<sub>94</sub>Cl<sub>2</sub>N<sub>10</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 877.2860, found <i>m</i>/<i>z</i> 877.2866.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Galactosaminylmethyl-<i>N</i>-4′-trifluoromethylbiphenylmethyl Vancomycin (<b>40</b>)</h4><div class="NLM_p last">Yield 44% (16.5 mg, 8.8 μmol). RT = 16.579 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.83 (br s, 1H), 8.74 (br s, 1H), 7.92 (d, <i>J</i> = 8.1 Hz, 2H), 7.84 (d, <i>J</i> = 8.5 Hz, 3H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (s, 1H), 7.61 (d, <i>J</i> = 8.0 Hz, 2H), 7.52 (d, <i>J</i> = 8.8 Hz, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.33 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (dd, <i>J</i> = 8.5, 3.3 Hz, 1H), 7.16 (s, 1H), 6.88 (d, <i>J</i> = 8.4 Hz, 1H), 6.79 (d, <i>J</i> = 8.7 Hz, 1H), 6.55 (s, 1H), 5.78–5.69 (m, 2H), 5.53 (d, <i>J</i> = 3.5 Hz, 1H), 5.36 (d, <i>J</i> = 7.7 Hz, 1H), 5.31 (s, 1H), 5.14 (s, 1H), 5.12 (d, <i>J</i> = 4.2 Hz, 1H), 4.83 (s, 1H), 4.68 (q, <i>J</i> = 6.7 Hz, 1H), 4.54–4.46 (m, 1H), 4.43 (t, <i>J</i> = 5.8 Hz, 1H), 4.25 (s, 1H), 4.19–4.12 (m, 1H), 4.08–4.05 (m, 2H), 4.03 (d, <i>J</i> = 8.6 Hz, 1H), 3.86 (d, <i>J</i> = 11.9 Hz, 1H), 3.82 (t, <i>J</i> = 6.5 Hz, 1H), 3.77 (d, <i>J</i> = 3.1 Hz, 1H), 3.69 (d, <i>J</i> = 10.5 Hz, 1H), 3.58 (t, <i>J</i> = 8.5 Hz, 1H), 3.52 (dd, <i>J</i> = 11.8, 5.6 Hz, 1H), 3.33–3.24 (m, 2H), 3.17 (d, <i>J</i> = 10.6 Hz, 1H), 2.80–2.71 (m, 1H), 2.59 (s, 3H), 2.19–2.07 (m, 2H), 1.84 (d, <i>J</i> = 13.2 Hz, 1H), 1.72–1.60 (m, 2H), 1.51 (s, 3H), 1.13 (d, <i>J</i> = 6.3 Hz, 3H), 0.93 (d, <i>J</i> = 6.0 Hz, 3H), 0.88 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>87</sub>H<sub>97</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>10</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 937.2954, found <i>m</i>/<i>z</i> 937.2962.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Hydroxyethylaminomethyl-<i>N</i>-nonyl Vancomycin (<b>41</b>)</h4><div class="NLM_p last">Yield 80% (26.5 mg, 16.1 μmol). RT = 14.320 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (br s, 1H), 7.80 (d, <i>J</i> = 2.0 Hz, 1H), 7.59 (br s, 1H), 7.48 (d, <i>J</i> = 8.7 Hz, 1H), 7.45 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (s, 1H), 6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.6 Hz, 1H), 6.52 (s, 1H), 5.71 (s, 1H), 5.69 (s, 1H), 5.31 (d, <i>J</i> = 7.7 Hz, 1H), 5.27 (d, <i>J</i> = 4.1 Hz, 1H), 5.11 (s, 2H), 5.08 (s, 1H), 4.80 (s, 1H), 4.59 (d, <i>J</i> = 6.6 Hz, 1H), 4.44 (d, <i>J</i> = 5.6 Hz, 1H), 4.40 (s, 1H), 4.17–4.04 (m, 4H), 3.69–3.59 (m, 4H), 3.54 (t, <i>J</i> = 8.5 Hz, 1H), 3.49 (dd, <i>J</i> = 7.0, 2.0 Hz, 1H), 3.25 (s, 3H), 2.94 (br s, 2H), 2.74 (s, 1H), 2.68 (s, 1H), 2.55 (s, 2H), 2.11 (dd, <i>J</i> = 16.4, 9.4 Hz, 1H), 1.97 (d, <i>J</i> = 11.6 Hz, 1H), 1.77 (d, <i>J</i> = 13.2 Hz, 1H), 1.69–1.58 (m, 3H), 1.56–1.44 (m, 4H), 1.33 (s, 3H), 1.25–1.20 (m, 14H), 1.06 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.3 Hz, 4H), 0.85 (d, <i>J</i> = 6.4 Hz, 3H), 0.83 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) calcd for C<sub>78</sub>H<sub>100</sub>Cl<sub>2</sub>N<sub>10</sub>O<sub>25</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 824.3197, found <i>m</i>/<i>z</i> 824.3191.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Hydroxyethylaminomethyl-<i>N</i>-4-ethylbenzyl Vancomycin (<b>42</b>)</h4><div class="NLM_p last">Yield 82% (27.0 mg, 16.4 μmol). RT = 12.408 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (br s, 1H), 7.81 (s, 1H), 7.60 (br s, 1H), 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.46 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.35 (d, <i>J</i> = 7.8 Hz, 2H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (d, <i>J</i> = 7.9 Hz, 2H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.52 (s, 1H), 5.71 (s, 1H), 5.69 (s, 1H), 5.33 (d, <i>J</i> = 7.7 Hz, 1H), 5.27 (d, <i>J</i> = 4.3 Hz, 1H), 5.12 (s, 2H), 5.09 (d, <i>J</i> = 2.1 Hz, 1H), 4.81 (s, 1H), 4.66–4.60 (m, 1H), 4.45 (d, <i>J</i> = 5.4 Hz, 1H), 4.40 (s, 1H), 4.17–4.03 (m, 4H), 3.92 (q, <i>J</i> = 12.6 Hz, 3H), 3.65 (q, <i>J</i> = 5.2, 4.4 Hz, 3H), 3.54 (d, <i>J</i> = 8.4 Hz, 1H), 3.45 (d, <i>J</i> = 8.7 Hz, 0H), 3.29–3.21 (m, 3H), 2.97–2.91 (m, 2H), 2.59 (q, <i>J</i> = 7.6 Hz, 2H), 2.56 (s, 3H), 2.15–2.02 (m, 2H), 1.79 (d, <i>J</i> = 13.2 Hz, 1H), 1.68–1.61 (m, 2H), 1.46 (s, 3H), 1.14 (t, <i>J</i> = 7.6 Hz, 3H), 1.09 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>78</sub>H<sub>92</sub>Cl<sub>2</sub>N<sub>10</sub>O<sub>25</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 820.2884, found <i>m</i>/<i>z</i> 820.2875.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Hydroxyethylaminomethyl-<i>N</i>-4-pyridylbenzyl Vancomycin (<b>43</b>)</h4><div class="NLM_p last">Yield 81% (27.3 mg, 16.2 μmol). RT = 12.815 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.72 (d, <i>J</i> = 8.0 Hz, 2H), 8.64 (br s, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 2H), 8.03 (d, <i>J</i> = 8.3 Hz, 2H), 7.82 (d, <i>J</i> = 1.9 Hz, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 2H), 7.61 (br s, 1H), 7.49 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.46 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.72 (d, <i>J</i> = 9.5 Hz, 1H), 5.71 (s, 1H), 5.33 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.1 Hz, 1H), 5.15–5.11 (m, 2H), 5.10 (s, 1H), 4.81 (s, 1H), 4.66 (q, <i>J</i> = 6.7 Hz, 1H), 4.45 (d, <i>J</i> = 5.3 Hz, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.16–4.04 (m, 6H), 4.03–3.96 (m, 1H), 3.69–3.63 (m, 3H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.51 (d, <i>J</i> = 7.2 Hz, 1H), 3.26 (d, <i>J</i> = 9.6 Hz, 2H), 2.95 (dd, <i>J</i> = 6.4, 4.6 Hz, 2H), 2.13–2.08 (m, 1H), 1.83 (d, <i>J</i> = 13.1 Hz, 1H), 1.68–1.60 (m, 2H), 1.49 (s, 3H), 1.21 (s, 1H), 1.11 (d, <i>J</i> = 6.1 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.85 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>81</sub>H<sub>91</sub>Cl<sub>2</sub>N<sub>11</sub>O<sub>25</sub> [M + K + H]<sup>2+</sup><i>m</i>/<i>z</i> 863.7630, found <i>m</i>/<i>z</i> 863.8606.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Hydroxyethylaminomethyl-<i>N</i>-4′-trifluoromethylbiphenylmethyl Vancomycin (<b>44</b>)</h4><div class="NLM_p last">Yield 80% (28.1 mg, 16.0 μmol). RT = 16.781 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (br s, 1H), 8.64 (br s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 2H), 7.83 (d, <i>J</i> = 8.1 Hz, 2H), 7.82 (s, 1H), 7.80 (d, <i>J</i> = 8.0 Hz, 2H), 7.62 (s, 1H), 7.59 (d, <i>J</i> = 8.0 Hz, 2H), 7.49 (d, <i>J</i> = 10.1 Hz, 1H), 7.46 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.76–5.69 (m, 2H), 5.34 (d, <i>J</i> = 7.6 Hz, 1H), 5.30 (s, 1H), 5.12 (s, 2H), 5.10 (s, 1H), 4.81 (s, 1H), 4.70–4.62 (m, 1H), 4.46 (d, <i>J</i> = 5.2 Hz, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.16–3.97 (m, 7H), 3.70–3.63 (m, 3H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.51 (d, <i>J</i> = 7.1 Hz, 1H), 3.30–3.22 (m, 2H), 2.96 (dd, <i>J</i> = 6.4, 4.7 Hz, 2H), 2.78–2.68 (m, 1H), 2.57 (s, 3H), 2.15–2.07 (m, 2H), 1.82 (d, <i>J</i> = 13.2 Hz, 1H), 1.68–1.59 (m, 2H), 1.49 (s, 3H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>83</sub>H<sub>91</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>10</sub>O<sub>25</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 878.2821, found <i>m</i>/<i>z</i> 878.2834.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Hydroxyethylaminomethyl-<i>N</i>-3-chloro-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxyl)benzyl Vancomycin (<b>45</b>)</h4><div class="NLM_p last">Yield 78% (28.7 mg, 15.6 μmol). RT = 18.310 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (br s, 1H), 8.64 (br s, 1H), 7.82 (s, 1H), 7.62 (s, 1H), 7.57 (d, <i>J</i> = 1.9 Hz, 1H), 7.49 (d, <i>J</i> = 9.1 Hz, 1H), 7.47 (d, <i>J</i> = 9.1 Hz, 1H), 7.45 (d, <i>J</i> = 7.6 Hz, 2H), 7.43 (d, <i>J</i> = 7.6 Hz, 2H), 7.40 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 7.39–7.37 (m, 1H), 7.36 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.27 (dd, <i>J</i> = 7.2, 1.2 Hz, 4H), 7.26 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (d, <i>J</i> = 9.6 Hz, 1H), 7.19 (d, <i>J</i> = 9.6 Hz, 1H), 7.10 (s, 1H), 6.85 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.53 (s, 1H), 5.73 (d, <i>J</i> = 7.3 Hz, 1H), 5.71 (s, 1H), 5.32 (d, <i>J</i> = 7.6 Hz, 1H), 5.29–5.27 (m, 1H), 5.26 (s, 2H), 5.12 (s, 2H), 5.09 (s, 1H), 4.80 (s, 1H), 4.66–4.58 (m, 1H), 4.45 (s, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.16–4.07 (m, 3H), 4.05 (s, 1H), 4.00 (s, 1H), 3.93 (s, 2H), 3.69–3.62 (m, 3H), 3.55 (t, <i>J</i> = 8.5 Hz, 1H), 3.51 (d, <i>J</i> = 8.8 Hz, 1H), 3.41 (s, 1H), 3.29–3.22 (m, 2H), 2.96 (t, <i>J</i> = 5.6 Hz, 2H), 2.56 (s, 3H), 2.19 (s, 3H), 1.78 (d, <i>J</i> = 13.1 Hz, 1H), 1.64 (d, <i>J</i> = 9.8 Hz, 3H), 1.54–1.48 (m, 1H), 1.45 (s, 3H), 1.10 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.2 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>90</sub>H<sub>99</sub>Cl<sub>3</sub>N<sub>10</sub>O<sub>26</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 921.2977, found <i>m</i>/<i>z</i> 921.2976.</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (β-<span class="smallcaps smallerCapital">d</span>-Galactopyranosylethyl)aminomethyl-<i>N</i>-4′-trifluoromethylbiphenylmethyl Vancomycin (<b>46</b>)</h4><div class="NLM_p last">Yield 75% (28.8 mg, 15.0 μmol). RT = 16.518 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (br s, 1H), 8.65 (br s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 2H), 7.83 (s, 1H), 7.82 (d, <i>J</i> = 8.5 Hz, 2H), 7.79 (d, <i>J</i> = 8.1 Hz, 2H), 7.60 (d, <i>J</i> = 7.8 Hz, 3H), 7.50 (d, <i>J</i> = 8.6 Hz, 1H), 7.47 (d, <i>J</i> = 8.6 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (s, 1H), 6.86 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.78 (d, <i>J</i> = 8.5 Hz, 1H), 6.54 (s, 1H), 5.73 (d, <i>J</i> = 7.6 Hz, 1H), 5.71 (s, 1H), 5.34 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.1 Hz, 1H), 5.13 (s, 2H), 5.10 (d, <i>J</i> = 2.0 Hz, 2H), 4.82 (s, 1H), 4.67 (q, <i>J</i> = 6.5 Hz, 1H), 4.46 (d, <i>J</i> = 5.4 Hz, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 1H), 4.21–4.00 (m, 7H), 3.99–3.93 (m, 1H), 3.83–3.78 (m, 1H), 3.67 (d, <i>J</i> = 10.6 Hz, 1H), 3.62 (d, <i>J</i> = 3.0 Hz, 1H), 3.57 (t, <i>J</i> = 8.5 Hz, 1H), 3.38 (t, <i>J</i> = 6.4 Hz, 1H), 3.33–3.23 (m, 4H), 3.10 (t, <i>J</i> = 5.3 Hz, 2H), 2.58 (s, 3H), 2.12 (d, <i>J</i> = 10.0 Hz, 1H), 1.83 (d, <i>J</i> = 13.1 Hz, 1H), 1.69–1.60 (m, 2H), 1.50 (s, 3H), 1.11 (d, <i>J</i> = 6.2 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>89</sub>H<sub>101</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>10</sub>O<sub>30</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 959.3085, found <i>m</i>/<i>z</i> 959.3090.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(Benzyloxycarbonyl)aminoethyl-2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranoside (<b>49</b>)</h4><div class="NLM_p last">Phenyl-2,3,4,6-tetra-<i>O</i>-acetyl-1-thio-α-<span class="smallcaps smallerCapital">d</span>-mannopyranoside (<b>47</b>, 1.1 g, 2.5 mmol) and <i>N</i>-Cbz-ethanolamine (<b>48</b>, 586 mg, 3.0 mmol) were dissolved in anhydrous dichloromethane (20 mL) at 0 °C, and activated 4Å molecular sieves (2 g) were added. The mixture was stirred at 0 °C for 15 min under nitrogen protection. Trifluoromethanesulfonic acid (80 μL, 0.9 mmol) was added, and the solution immediately turned to a red color and stirred at rt overnight. The reaction was quenched with Et<sub>3</sub>N and diluted with dichloromethane, and the liquid layer was separated by filtration through Celite. The residue was washed with saturated aqueous NaHCO<sub>3</sub> and brine successively. The organic phase was dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was isolated by column chromatography (EtOAc/petroleum ether 2:3 then 1:1) to give <b>49</b> as a colorless oil in 57% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.27 (m, 5H), 5.34–5.25 (m, 2H), 5.24–5.19 (m, 2H), 5.09 (s, 2H), 4.80 (s, 1H), 4.23 (dd, <i>J</i> = 12.1, 5.8 Hz, 1H), 4.07 (td, <i>J</i> = 12.4, 4.5 Hz, 1H), 3.94 (ddd, <i>J</i> = 8.8, 5.7, 2.4 Hz, 1H), 3.75 (p, <i>J</i> = 4.5 Hz, 1H), 3.55 (ddd, <i>J</i> = 10.5, 6.8, 3.6 Hz, 1H), 3.48–3.32 (m, 2H), 2.13 (s, 3H), 2.06 (s, 4H), 2.01 (d, <i>J</i> = 4.7 Hz, 4H).</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(Benzyloxycarbonyl)aminoethyl-2,3,4,6-tetra-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-glycoside (<b>51a</b>, <b>51b</b>)</h4><div class="NLM_p last">Peracetylated sugar <b>50a</b> or <b>50b</b> (1 g, 2.56 mmol) and <i>N</i>-Cbz-ethanolamine <b>48</b> (604 mg, 3.09 mmol) were dissolved in dry acetonitrile under a nitrogen atmosphere. The solution was cooled to 0 °C, and BF<sub>3</sub>·Et<sub>2</sub>O (1.6 mL, 13.0 mmol) was added dropwise. The reaction was stirred for 30 min at 0 °C and then overnight at rt. The reaction was quenched with Et<sub>3</sub>N and concentrated in vacuo; the residue was redissolved in dichloromethane and then washed successively with saturated NaHCO<sub>3</sub>, water, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>; the solvent was removed under reduced pressure, and the product was purified by column chromatography on silica. Column chromatography (EtOAc/petroleum ether 2:3) gave pyranoside <b>51a</b> or <b>51b</b> as a colorless oil in 30–50% yield.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-(Benzyloxycarbonyl)aminoethyl-2,3,4,6-tetra-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside (<b>51a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39–7.32 (m, 5H), 5.39 (dd, <i>J</i> = 3.4, 1.1 Hz, 1H), 5.21 (t, <i>J</i> = 3.3 Hz, 1H), 5.20–5.16 (m, 1H), 5.11 (s, 2H), 5.05–4.99 (m, 1H), 4.46 (d, <i>J</i> = 7.9 Hz, 1H), 4.18–4.11 (m, 2H), 3.94–3.87 (m, 2H), 3.70 (ddd, <i>J</i> = 10.7, 7.3, 3.7 Hz, 1H), 3.48–3.33 (m, 2H), 2.16 (s, 3H), 2.04 (s, 3H), 2.01 (s, 3H), 1.99 (s, 3H).</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(Benzyloxycarbonyl)aminoethyl-2,3,4,6-tetra-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-glucopyranoside (<b>51b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.28 (m, 5H), 5.19 (t, <i>J</i> = 9.5 Hz, 1H), 5.09 (s, 2H), 5.06 (t, <i>J</i> = 9.7 Hz, 1H), 4.97 (dd, <i>J</i> = 9.6, 8.0 Hz, 1H), 4.49 (d, <i>J</i> = 8.0 Hz, 1H), 4.23 (dd, <i>J</i> = 12.3, 4.9 Hz, 1H), 4.13 (dd, <i>J</i> = 12.0, 2.0 Hz, 1H), 3.86 (ddd, <i>J</i> = 10.0, 5.8, 3.9 Hz, 1H), 3.74–3.63 (m, 2H), 3.45–3.28 (m, 2H), 2.05 (s, 3H), 2.02 (s, 3H), 2.00 (s, 6H).</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(Benzyloxycarbonyl)aminoethyl-2-acetamido-3,4,6-tri-<i>O</i>-acetyl-2-deoxy-β-<span class="smallcaps smallerCapital">d</span>-glucopyranoside (<b>51c</b>)</h4><div class="NLM_p last">β-<span class="smallcaps smallerCapital">d</span>-Glucosamine pentacetate (<b>50c</b>, 1.0 g, 2.5 mmol) and <i>N</i>-Cbz-ethanolamine (<b>48</b>, 1.25 g, 6.4 mmol) were dissolved in dry acetonitrile (10 mL) under a nitrogen atmosphere. The reaction was cooled to 0 °C, and SnCl<sub>4</sub> (360 μL, 3.1 mmol) was added dropwise. The reaction was warmed to rt, heated to 75 °C, and stirred for 14 h. TLC indicated the completion of the reaction; then, the mixture was cooled to rt, quenched with 2 mL of Et<sub>3</sub>N, and concentrated in vacuum. The residue was dissolved in 50 mL of dichloromethane, washed with water, and with saturated brine successively. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated after filtration. Column chromatography (EtOAc/petroleum ether 1:1 to 4:1) gave a white solid in 30% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42–7.30 (m, 5H), 5.57 (d, <i>J</i> = 8.8 Hz, 1H), 5.31 (s, 1H), 5.20 (t, <i>J</i> = 10.0 Hz, 1H), 5.15–5.04 (m, 3H), 4.60 (d, <i>J</i> = 8.3 Hz, 1H), 4.25 (dd, <i>J</i> = 12.3, 4.8 Hz, 1H), 4.15 (dd, <i>J</i> = 12.4, 2.5 Hz, 1H), 3.89 (ddd, <i>J</i> = 10.1, 6.0, 3.4 Hz, 1H), 3.68 (ddd, <i>J</i> = 9.9, 4.8, 2.4 Hz, 2H), 2.08 (s, 3H), 2.05 (d, <i>J</i> = 2.3 Hz, 6H), 1.91 (s, 3H).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Kanamycin-Vancomycin and Amikacin-Vancomycin Conjugates (<b>54</b>–<b>56</b>, <b>58</b>–<b>63</b>)</h3><div class="NLM_p">Amidation reactions were performed in the synthesis of compounds <b>54</b>–<b>56</b>. Intermediate <b>3b</b> (50 mg, 30 μmol), HBTU (21 mg, 45 μmol), and DIPEA (25 μL, 151 μmol) were dissolved in DMF (3 mL), and the mixture was stirred for 15 min at rt. Then, <i>N</i>,<i>N</i>-dimethylaminopropylamine (18 μL, 143 μmol) was added, and the solution was stirred for 24 h until analytic RP-HPLC showed the starting material was totally consumed. Then, the crude product was precipitated by addition of diethyl ether (30 mL) and centrifuged. The supernatant was removed, and the solid cake was washed with diethyl ether (15 mL). The crude was dissolved in water and acetonitrile and subjected to preparative RP-HPLC purification. The fractions containing the product were combined and lyophilized to give <b>54</b> as a white fluffy solid. Then, the Mannich reaction was performed following the same procedure described above for the synthesis of <b>5</b>–<b>46</b> to introduce the Kanamycin and Amikacin fragments. Compounds <b>58</b>–<b>63</b> were synthesized directly by the Mannich reaction with compounds <b>1</b>, <b>3b</b>, and <b>3m</b>. All of the products were purified by preparative RP-HPLC to afford the final compounds (<b>55</b>, <b>56</b>, <b>58</b>–<b>63</b>) in 30–50% yield.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>,<i>N</i>-Dimethyl-<i>N</i>-(3-aminopropyl)-(<i>N</i>-4′-chlorobiphenylmethyl-vancomycin)carboxamide (<b>54</b>)</h4><div class="NLM_p last">Yield 30% (15.8 mg, 9.1 μmol). RT = 18.002 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, deuterium oxide) δ 8.71 (s, 1H), 8.54 (s, 1H), 7.84 (d, <i>J</i> = 1.9 Hz, 1H), 7.75–7.70 (m, 4H), 7.56 (d, <i>J</i> = 8.1 Hz, 2H), 7.53 (d, <i>J</i> = 8.3 Hz, 2H), 7.49–7.45 (m, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.26 (s, 1H), 7.22 (d, <i>J</i> = 8.3 Hz, 1H), 6.78 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 6.71 (d, <i>J</i> = 8.4 Hz, 1H), 6.39 (d, <i>J</i> = 2.3 Hz, 1H), 6.22 (d, <i>J</i> = 2.3 Hz, 1H), 5.78–5.73 (m, 1H), 5.62 (s, 1H), 5.36 (d, <i>J</i> = 7.7 Hz, 1H), 5.29 (d, <i>J</i> = 4.5 Hz, 1H), 5.28 (s, 1H), 5.19 (d, <i>J</i> = 3.9 Hz, 1H), 5.18 (s, 1H), 4.93 (s, 1H), 4.71–4.64 (m, 1H), 4.48 (d, <i>J</i> = 5.2 Hz, 1H), 4.32 (d, <i>J</i> = 5.2 Hz, 1H), 4.26 (s, 1H), 4.04 (q, <i>J</i> = 12.7 Hz, 2H), 3.97 (t, <i>J</i> = 7.2 Hz, 1H), 3.68 (d, <i>J</i> = 10.7 Hz, 1H), 3.58 (t, <i>J</i> = 8.5 Hz, 1H), 3.38–3.32 (m, 1H), 3.31–3.23 (m, 2H), 3.15–3.06 (m, 1H), 3.01–2.96 (m, 2H), 2.75 (s, 3H), 2.74 (s, 3H), 2.63 (s, 3H), 2.20–2.09 (m, 2H), 1.88–1.76 (m, 3H), 1.68 (dd, <i>J</i> = 13.2, 6.9 Hz, 1H), 1.65–1.60 (m, 1H), 1.56 (dd, <i>J</i> = 13.2, 6.5 Hz, 1H), 1.51 (s, 3H), 1.13 (d, <i>J</i> = 6.3 Hz, 3H), 0.90 (d, <i>J</i> = 6.2 Hz, 3H), 0.85 (d, <i>J</i> = 6.3 Hz, 3H). HRMS (ESI) calcd for C<sub>84</sub>H<sub>96</sub>Cl<sub>3</sub>N<sub>11</sub>O<sub>23</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 866.7951, found <i>m</i>/<i>z</i> 866.7988.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>,<i>N</i>-Dimethyl-<i>N</i>-(3-aminopropyl)-((α-<span class="smallcaps smallerCapital">d</span>-mannopyranosylethyl)aminomethyl-<i>N</i>-4′-chlorobiphenylmethyl-vancomycin)carboxamide (<b>55</b>)</h4><div class="NLM_p last">Yield 35% (13.8 mg, 7.0 μmol). RT = 16.854 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.67 (s, 1H), 7.83 (s, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.70 (d, <i>J</i> = 8.7 Hz, 2H), 7.57 (d, <i>J</i> = 8.0 Hz, 2H), 7.54–7.51 (m, 2H), 7.48–7.45 (m, 1H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.19 (s, 1H), 6.84 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.49 (s, 1H), 5.73 (d, <i>J</i> = 7.5 Hz, 1H), 5.71 (s, 1H), 5.39 (s, 1H), 5.35 (d, <i>J</i> = 7.6 Hz, 1H), 5.29 (s, 1H), 5.14 (s, 1H), 5.11 (s, 1H), 4.80 (s, 1H), 4.65 (d, <i>J</i> = 7.4 Hz, 1H), 4.64 (d, <i>J</i> = 1.7 Hz, 1H), 4.47 (s, 1H), 4.27 (d, <i>J</i> = 5.1 Hz, 1H), 4.20–3.97 (m, 7H), 3.88–3.80 (m, 1H), 3.69–3.59 (m, 4H), 3.56 (t, <i>J</i> = 8.5 Hz, 1H), 3.50 (dd, <i>J</i> = 9.0, 3.4 Hz, 1H), 3.38 (t, <i>J</i> = 9.4 Hz, 1H), 3.33 (dd, <i>J</i> = 6.5, 3.0 Hz, 1H), 3.29–3.22 (m, 2H), 3.12 (d, <i>J</i> = 19.2 Hz, 3H), 3.04–2.91 (m, 2H), 2.72 (d, <i>J</i> = 1.8 Hz, 6H), 2.57 (s, 3H), 2.15–2.06 (m, 2H), 1.89–1.78 (m, 3H), 1.69–1.59 (m, 2H), 1.50 (s, 3H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.0 Hz, 3H), 0.86 (d, <i>J</i> = 6.2 Hz, 3H). HRMS (ESI) calcd for C<sub>93</sub>H<sub>113</sub>Cl<sub>3</sub>N<sub>12</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 984.3479, found <i>m</i>/<i>z</i> 984.3486.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>N,N</i>-Dimethyl-<i>N</i>-(3-aminopropyl)-((acyclic-gluconic acid lactone)acylaminopropylaminomethyl-<i>N</i>-4′-chlorobiphenylmethyl-vancomycin)carboxamide (<b>56</b>)</h4><div class="NLM_p last">Yield 40% (15.9 mg, 8.0 μmol). RT = 16.233 min (analytical HPLC). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (s, 1H), 8.67 (s, 1H), 7.82 (m, 1H), 7.72 (d, <i>J</i> = 8.6 Hz, 2H), 7.70 (d, <i>J</i> = 8.6 Hz, 2H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.50 (d, <i>J</i> = 8.7 Hz, 1H), 7.48–7.44 (m, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (d, <i>J</i> = 8.4 Hz, 1H), 7.20 (s, 1H), 6.85 (d, <i>J</i> = 8.5 Hz, 1H), 6.77 (d, <i>J</i> = 8.5 Hz, 1H), 6.48 (s, 1H), 5.73 (s, 1H), 5.71 (s, 1H), 5.35 (d, <i>J</i> = 7.7 Hz, 1H), 5.30 (s, 2H), 5.13 (s, 1H), 5.10 (d, <i>J</i> = 1.9 Hz, 1H), 4.81 (s, 1H), 4.69–4.62 (m, 1H), 4.47 (s, 1H), 4.29 (d, <i>J</i> = 5.4 Hz, 1H), 4.17 (s, 1H), 4.05 (s, 2H), 4.02 (d, <i>J</i> = 11.3 Hz, 2H), 4.00 (d, <i>J</i> = 3.6 Hz, 2H), 3.88 (dd, <i>J</i> = 3.6, 2.3 Hz, 1H), 3.67 (d, <i>J</i> = 10.7 Hz, 1H), 3.59–3.53 (m, 2H), 3.53–3.49 (m, 1H), 3.36 (dd, <i>J</i> = 10.5, 4.9 Hz, 1H), 3.30–3.23 (m, 2H), 3.22–3.05 (m, 2H), 2.96 (t, <i>J</i> = 7.9 Hz, 2H), 2.90 (d, <i>J</i> = 7.2 Hz, 2H), 2.73 (s, 3H), 2.72 (s, 3H), 2.57 (s, 3H), 2.15–2.07 (m, 2H), 1.83–1.77 (m, 5H), 1.64 (d, <i>J</i> = 10.2 Hz, 2H), 1.50 (s, 3H), 1.11 (d, <i>J</i> = 6.3 Hz, 3H), 0.91 (d, <i>J</i> = 6.1 Hz, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). HRMS (ESI) calcd for C<sub>94</sub>H<sub>116</sub>Cl<sub>3</sub>N<sub>13</sub>O<sub>29</sub> [M + 2H]<sup>2+</sup><i>m</i>/<i>z</i> 998.8612, found <i>m</i>/<i>z</i> 998.8630.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Biological Assays</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> In Vitro Antibacterial Activity for Minimum Inhibitory Concentration (MIC) Determination<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></h4><div class="NLM_p last">The MIC values for all antimicrobial agents were measured by broth microdilution using Mueller-Hinton II broth (cation-adjusted, BD 212322). Generally, compounds were dissolved with DMSO to 5.12 mg/mL as stock solutions. All samples were diluted with culture broth to 128 μg/mL as the initial concentration. Further, 1:2 serial dilutions were performed by addition of culture broth to reach concentrations ranging from 128 to 0.0625 μg/mL or lower. Then, 150 μL of each dilution was distributed in 96-well plates as well as sterile controls, growth controls (containing culture broth plus DMSO, without compounds), and positive controls (containing culture broth plus control antibiotics such as vancomycin, Telavancin, etc.). Each test and growth control well was inoculated with 5 μL of an exponential phase bacterial suspension (∼10<sup>5</sup> CFU/well). The 96-well plates were incubated at 37 °C for 24 h. MIC values of these compounds were defined as the lowest concentration to completely inhibit the bacterial growth. All MIC values were interpreted according to recommendations of the Clinical and Laboratory Standards Institute (CLSI).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> In Vivo Antibacterial Assay</h4><div class="NLM_p">Mice used in this study were obtained from SIPPR-BK Lab Animal Ltd. (<a href="http://www.slarc.org.cn" class="extLink">http://www.slarc.org.cn</a>) and housed under specified pathogen-free conditions. Overnight cultured <i>S. aureus</i> USA300 LAC strain (CA-MRSA) or Mu50 strain (HA-MRSA/VISA) was transferred into fresh tryptic soy broth (TSB) medium (1:100, <i>v</i>/<i>v</i>) and continued cultivating for 3 h to reach the exponential growth phase. Strains were washed twice with sterile PBS buffer and suspended in the same buffer until use.</div><div class="NLM_p">Six-to-eight week old female BALB/c mice were anesthetized with pentobarbital sodium (80 mg/kg, intraperitoneally) and were infected by retro-orbital injection with a suspension of ∼2.35 × 10<sup>8</sup> colony-forming units (CFUs) of USA300 LAC (for lethal challenge) or ∼3.8 × 10<sup>8</sup> CFUs of Mu50 (for abscess formation). For these two animal models, the group used 15 and 12 mice, respectively, as indicated.</div><div class="NLM_p">For the efficacy of selected compounds (<b>18</b>, <b>32</b>, <b>40</b>, <b>44</b>, <b>46</b>) and control compounds (Vancomycin, Telavancin) to be evaluated on the outcome of <i>S. aureus</i> pathogenesis, mice received intraperitoneal injections with a signal dose of 7 mg/kg of compounds (<b>18</b>, <b>32</b>, <b>40</b>, <b>44</b>, <b>46</b>, Vancomycin, Telavancin) for USA300 LAC infection or two doses of 7 mg/kg of compounds (<b>18</b>, <b>46</b>, Vancomycin, Telavancin) dissolved in sterile ddH<sub>2</sub>O in a 24 h interval for Mu50 infection. The treatment began 1 h after infection.</div><div class="NLM_p last">For lethal challenge, the number of dead mice caused by infection was recorded every day and used for the creation of the survival curve. For abscess formation, animals were euthanized by CO<sub>2</sub> inhalation 5 d after infection. Liver was harvested and homogenized in 1 mL of sterile PBS buffer (containing 0.01% tritonX-100). Homogenates were serially diluted, and 10 μL dilutions were spotted onto TSA agar to determine the CFU counts. Bacterial burdens within liver were quantified by counting CFU obtained from serial dilutions of the organ homogenate. All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Public Health Clinical Center and were performed in accordance with the relevant guidelines and regulations.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> In Vivo Pharmacokinetic Assay</h3><div class="NLM_p">CD-1 mice used in this study were purchased from Shanghai Lingchang Biological Technology Co. LTD, and the animal room environment was controlled (target conditions: temperature 18–29 °C, relative humidity 30–70%). An electronic time-controlled lighting system was used to provide a 12 h light/12 h dark cycle.</div><div class="NLM_p last">Compounds <b>18</b>, <b>32</b>, <b>40</b>, <b>46</b>, Vancomycin, and Telavancin (5 mg/kg) were injected in the caudal vein of the tail of fasted CD-1 mice (male, 18–22 g, <i>n</i> = 18, group = 6), respectively. Blood samples were collected at 0.25, 0.75, 2, 4, 8, and 24 h after intravenous administration. Samples were analyzed by Xevo TQ-S triple quadrupole mass spectrometer (Waters, USA) coupled with ACQUITY I-Class UPLC System (Waters, USA). The ACQUITY UPLC BEH C<sub>18</sub> (1.7 μm, 2.0 mm × 50 mm, Waters, USA) was used for the analysis. After analyzing the concentrations of compounds, the values of <i>T</i><sub>1/2</sub>, AUC<sub>last</sub>, AUC<sub>INF_obs</sub>, CL<sub>_obs</sub>, MRT<sub>INF_obs</sub>, and <i>V</i><sub>SS_obs</sub> were calculated from time–concentration curves in each animal using Phoenix WinNonlin (CERTARA, USA).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Cytotoxicity Assays</h3><div class="NLM_p last">Cell viability kit CCK-8 (Cell Counting Kit-8)<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> was used to evaluate the cytotoxicity of newly synthesized vancomycin derivatives. Generally, 100 μL of HK-2 cell (human renal proximal tubule epithelial cells) and HL-7702 cell (human liver cells) suspensions (∼5000 cells/well) were distributed into 96-well plates. After overnight incubation, 10 μL of various concentrations of <b>16</b>, <b>46</b>, Vancomycin, and Telavancin were added to the plate well (final concentration: 10, 50, and 100 μM) and further incubated for 72 h. After that, 10 μL of CCK-8 solution was added to each well of the plate, and the whole plate was incubated at 37 °C for 1.5 h. Finally, the optical density at 450 nm (OD450) was recorded using a VERSMax microplate reader. To calculate the cell viability, growth controls (sterile PBS buffer without compounds) and blank controls (culture broth only, no cells) were also included. Each set was performed in triplicate. Cell viability was defined as OD<sub>C</sub>/OD<sub>C=0</sub> × 100, for which OD<sub>C</sub> represents the optical density of cells treated with different concentrations of compounds and OD<sub>C=0</sub> represents the optical density with no compounds added.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Interaction of Vancomycin Analogues with Bacterial Peptidoglycan Precursor Peptide</h3><div class="NLM_p last">The interaction of compound <b>46</b> with bacterial peptidoglycan precursor model peptide was determined by the constant-time [<sup>13</sup>C,<sup>1</sup>H]-HSQC. They were recorded on an AVANCE III HD BRUKER Ascend 600 MHz instrument. First, compound <b>46</b> (2 mM) dissolved in D<sub>2</sub>O was determined at 25 °C at pH 3.1; then, the corresponding model peptide ligand Ac<sub>2</sub>Lys-<i>d</i>Ala-<i>d</i>Ala was added to make the final concentration up to 10 mM while maintaining the same conditions as above. The solution was determined by the constant-time [<sup>13</sup>C,<sup>1</sup>H]-HSQC again.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01345">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01345" class="ext-link">10.1021/acs.jmedchem.7b01345</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">NMR detection, synthesis, and antibacterial assay of <b>58</b>–<b>63</b>, synthetic procedures of intermediates and Telavancin, and NMR, MS, and HPLC spectra of target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Binding model of <b>46</b> and ligand Ac<sub>2</sub>Lys-<i>d</i>Ala-<i>d</i>Ala (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings of all target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_001.pdf">jm7b01345_si_001.pdf (19.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_002.pdb">jm7b01345_si_002.pdb (23.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_003.csv">jm7b01345_si_003.csv (20.03 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01345" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lefu Lan</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5551-5496" title="Orcid link">http://orcid.org/0000-0002-5551-5496</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5f33333e311f2c363232713e3c713c31"><span class="__cf_email__" data-cfemail="244848454a64574d49490a45470a474a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Huang</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6432-1848" title="Orcid link">http://orcid.org/0000-0001-6432-1848</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a5cdd0c4cbc2d2c0cce5d6ccc8c88bc4c68bc6cb"><span class="__cf_email__" data-cfemail="deb6abbfb0b9a9bbb79eadb7b3b3f0bfbdf0bdb0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dongliang Guan</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feifei Chen</span> - <span class="hlFld-Affiliation affiliation">†CAS
Key Laboratory of Receptor Research, CAS Center for Excellence in
Molecular Cell Science, ∥State Key Laboratory of Drug Research, and ⊥Center for Bio-drug
Development, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong,
Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7251-1956" title="Orcid link">http://orcid.org/0000-0002-7251-1956</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lun Xiong</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Tang</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong"> Faridoon</span> - <span class="hlFld-Affiliation affiliation">†CAS
Key Laboratory of Receptor Research, CAS Center for Excellence in
Molecular Cell Science, ∥State Key Laboratory of Drug Research, and ⊥Center for Bio-drug
Development, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong,
Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunguang Qiu</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naixia Zhang</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Likun Gong</span> - <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>D.G. and F.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d136e8735-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (NNSFC, Nos. 21372238 and 21572244), the SIMM institute fund (CASIMM0120162014 and CASIMM0120164007), and the Youth Innovation Promotion Association of CAS (No. 2017328). We thank the NMR facility of SIMM for their kind help in compound characterization and NMR binding tests.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i89" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i89"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i90" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i90"> Abbreviations Used</h2><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)-uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">MSSA</td><td class="NLM_def"><p class="first last">methicillin-sensitive <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">VISA</td><td class="NLM_def"><p class="first last">vancomycin-intermediate resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">VRSA</td><td class="NLM_def"><p class="first last">vancomycin-resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">VRE</td><td class="NLM_def"><p class="first last">vancomycin-resistant <i>Enterococci</i></p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming units</p></td></tr><tr><td class="NLM_term">2D</td><td class="NLM_def"><p class="first last">two-dimensional</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">McCormick, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittenger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittenger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span> </span><span class="NLM_article-title">Vancomycin, a new antibiotic. I. Chemical and biologic properties</span> <span class="citation_source-journal">Antibiot. Annu.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1954&pages=606-611&author=M.+H.+McCormickauthor=J.+McGuireauthor=G.+Pittengerauthor=R.+Pittengerauthor=W.+Stark&title=Vancomycin%2C+a+new+antibiotic.+I.+Chemical+and+biologic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormick%26aufirst%3DM.%2BH.%26aulast%3DMcGuire%26aufirst%3DJ.%26aulast%3DPittenger%26aufirst%3DG.%26aulast%3DPittenger%26aufirst%3DR.%26aulast%3DStark%26aufirst%3DW.%26atitle%3DVancomycin%252C%2520a%2520new%2520antibiotic.%2520I.%2520Chemical%2520and%2520biologic%2520properties%26jtitle%3DAntibiot.%2520Annu.%26date%3D1954%26volume%3D3%26spage%3D606%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, T. M.</span><span> </span><span class="NLM_article-title">Vancomycin: structure and transformation to CDP-I</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6915</span><span class="NLM_x">–</span> <span class="NLM_lpage">6922</span><span class="refDoi"> DOI: 10.1021/ja00361a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00361a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaL3sXlvFGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1983&pages=6915-6922&author=C.+M.+Harrisauthor=H.+Kopeckaauthor=T.+M.+Harris&title=Vancomycin%3A+structure+and+transformation+to+CDP-I&doi=10.1021%2Fja00361a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin:  structure and transformation to CDP-I</span></div><div class="casAuthors">Harris, Constance M.; Kopecka, Hana; Harris, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6915-22</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The rearrangement of vancomycin (I) to CDP-I proceeds through a pathway involving succinimide II as an intermediate.  II was isolated and characterized by its FT-IR and FAB-MS.  CDP-I is an equil. mixt. of III and IV, which are atropisomers involving different orientations of the Cl-substituted arom. ring.  Treatment of II at pH 8 gave an immediate appearance of the minor form of CDP-I, which slowly gave an equil. mixt. with the major form (III:IV ∼64:36).  III and IV can interconvert by simple reorientation of the arom. ring rather than via a transient cleavage product.  The cyclophane ring in which the Cl-substituted arom. residue 2 is embedded is enlarged by one CH2 unit in the conversion of I to CDP-I; rotation of ring 2 can occur in CDP-I, but not in I.  The addnl. CH2 unit in the N-terminal cyclophane ring of CDP-I causes the ring to lie in a conformation that is significantly different from that of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVg2fE0oCmw7Vg90H21EOLACvtfcHk0liIhjg__Qh17A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlvFGnsr0%253D&md5=c9ff55a6261c2b76c537391ba4ac8a03</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fja00361a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00361a029%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DKopecka%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DT.%2BM.%26atitle%3DVancomycin%253A%2520structure%2520and%2520transformation%2520to%2520CDP-I%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1983%26volume%3D105%26spage%3D6915%26epage%3D6922%26doi%3D10.1021%2Fja00361a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Swartz, M. N.</span><span> </span><span class="NLM_article-title">Hospital-acquired infections: diseases with increasingly limited therapies</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">2420</span><span class="NLM_x">–</span> <span class="NLM_lpage">2427</span><span class="refDoi"> DOI: 10.1073/pnas.91.7.2420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1073%2Fpnas.91.7.2420" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=2420-2427&author=M.+N.+Swartz&title=Hospital-acquired+infections%3A+diseases+with+increasingly+limited+therapies&doi=10.1073%2Fpnas.91.7.2420"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.7.2420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.7.2420%26sid%3Dliteratum%253Aachs%26aulast%3DSwartz%26aufirst%3DM.%2BN.%26atitle%3DHospital-acquired%2520infections%253A%2520diseases%2520with%2520increasingly%2520limited%2520therapies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D2420%26epage%3D2427%26doi%3D10.1073%2Fpnas.91.7.2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Shallcross, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S. C.</span><span> </span><span class="NLM_article-title">Tackling the threat of antimicrobial resistance: from policy to sustainable action</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">20140082</span><span class="refDoi"> DOI: 10.1098/rstb.2014.0082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1098%2Frstb.2014.0082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=25918440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC2MbmtV2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2015&pages=20140082&author=L.+J.+Shallcrossauthor=S.+J.+Howardauthor=T.+Fowlerauthor=S.+C.+Davies&title=Tackling+the+threat+of+antimicrobial+resistance%3A+from+policy+to+sustainable+action&doi=10.1098%2Frstb.2014.0082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling the threat of antimicrobial resistance: from policy to sustainable action</span></div><div class="casAuthors">Shallcross Laura J; Howard Simon J; Fowler Tom; Davies Sally C</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">1670</span>),
    <span class="NLM_cas:pages">20140082</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Antibiotics underpin all of modern medicine, from routine major surgery through to caesarean sections and modern cancer therapies.  These drugs have revolutionized how we practice medicine, but we are in a constant evolutionary battle to evade microbial resistance and this has become a major global public health problem.  We have overused and misused these essential medicines both in the human and animal health sectors and this threatens the effectiveness of antimicrobials for future generations.  We can only address the threat of antimicrobial resistance (AMR) through international collaboration across human and animal health sectors integrating social, economic and behavioural factors.  Our global organizations are rising to the challenge with the recent World Health Assembly resolution on AMR and development of the Global Action plan but we must act now to avoid a return to a pre-antibiotic era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOKlg0cqm-HZw7prLlxLOzfW6udTcc2eazFqh2H3Hrurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbmtV2nsQ%253D%253D&md5=519d5a93a17771b05deb2d288cb6ba22</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1098%2Frstb.2014.0082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2014.0082%26sid%3Dliteratum%253Aachs%26aulast%3DShallcross%26aufirst%3DL.%2BJ.%26aulast%3DHoward%26aufirst%3DS.%2BJ.%26aulast%3DFowler%26aufirst%3DT.%26aulast%3DDavies%26aufirst%3DS.%2BC.%26atitle%3DTackling%2520the%2520threat%2520of%2520antimicrobial%2520resistance%253A%2520from%2520policy%2520to%2520sustainable%2520action%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2015%26volume%3D370%26spage%3D20140082%26doi%3D10.1098%2Frstb.2014.0082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Goff, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilchrist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathwani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escandón-Vargas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, A.</span><span> </span><span class="NLM_article-title">A global call from five countries to collaborate in antibiotic stewardship: United we succeed, divided we might fail</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56</span><span class="NLM_x">–</span> <span class="NLM_lpage">e63</span><span class="refDoi"> DOI: 10.1016/S1473-3099(16)30386-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1016%2FS1473-3099%2816%2930386-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=27866945" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=e56-e63&author=D.+A.+Goffauthor=R.+Kullarauthor=E.+J.+Goldsteinauthor=M.+Gilchristauthor=D.+Nathwaniauthor=A.+C.+Chengauthor=K.+A.+Cairnsauthor=K.+Escand%C3%B3n-Vargasauthor=M.+V.+Villegasauthor=A.+Brink&title=A+global+call+from+five+countries+to+collaborate+in+antibiotic+stewardship%3A+United+we+succeed%2C+divided+we+might+fail&doi=10.1016%2FS1473-3099%2816%2930386-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2930386-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252930386-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DKullar%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DE.%2BJ.%26aulast%3DGilchrist%26aufirst%3DM.%26aulast%3DNathwani%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCairns%26aufirst%3DK.%2BA.%26aulast%3DEscand%25C3%25B3n-Vargas%26aufirst%3DK.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DBrink%26aufirst%3DA.%26atitle%3DA%2520global%2520call%2520from%2520five%2520countries%2520to%2520collaborate%2520in%2520antibiotic%2520stewardship%253A%2520United%2520we%2520succeed%252C%2520divided%2520we%2520might%2520fail%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26spage%3De56%26epage%3De63%26doi%3D10.1016%2FS1473-3099%2816%2930386-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Leclercq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derlot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duval, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courvalin, P.</span><span> </span><span class="NLM_article-title">Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1056/NEJM198807213190307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1056%2FNEJM198807213190307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=2968517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADyaL1c3mtFCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1988&pages=157-161&author=R.+Leclercqauthor=E.+Derlotauthor=J.+Duvalauthor=P.+Courvalin&title=Plasmid-mediated+resistance+to+vancomycin+and+teicoplanin+in+Enterococcus+faecium&doi=10.1056%2FNEJM198807213190307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium</span></div><div class="casAuthors">Leclercq R; Derlot E; Duval J; Courvalin P</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-61</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpsC6iB5sB4dXdcedVHT5tfW6udTcc2eZYb7t-LlZfXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3mtFCmug%253D%253D&md5=8d80510086bb90e9fc13479cd08f4660</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJM198807213190307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198807213190307%26sid%3Dliteratum%253Aachs%26aulast%3DLeclercq%26aufirst%3DR.%26aulast%3DDerlot%26aufirst%3DE.%26aulast%3DDuval%26aufirst%3DJ.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DPlasmid-mediated%2520resistance%2520to%2520vancomycin%2520and%2520teicoplanin%2520in%2520Enterococcus%2520faecium%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1988%26volume%3D319%26spage%3D157%26epage%3D161%26doi%3D10.1056%2FNEJM198807213190307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Control, C. f. D.</span><span> </span><span class="NLM_article-title">Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996</span> <span class="citation_source-journal">MMWR. Morbidity and mortality weekly report</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1997&pages=493-501&author=C.+f.+D.+Control&title=Prevention.+Reduced+susceptibility+of+Staphylococcus+aureus+to+vancomycin%2D%2DJapan%2C+1996"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DControl%26aufirst%3DC.%2Bf.%2BD.%26atitle%3DPrevention.%2520Reduced%2520susceptibility%2520of%2520Staphylococcus%2520aureus%2520to%2520vancomycin--Japan%252C%25201996%26jtitle%3DMMWR.%2520Morbidity%2520and%2520mortality%2520weekly%2520report%26date%3D1997%26volume%3D340%26spage%3D493%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Smith, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson-Dunn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenover, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, W. R.</span><span> </span><span class="NLM_article-title">Emergence of vancomycin resistance in Staphylococcus aureus</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1056/NEJM199902183400701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1056%2FNEJM199902183400701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10021469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXhsV2mtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=493-501&author=T.+L.+Smithauthor=M.+L.+Pearsonauthor=K.+R.+Wilcoxauthor=C.+Cruzauthor=M.+V.+Lancasterauthor=B.+Robinson-Dunnauthor=F.+C.+Tenoverauthor=M.+J.+Zervosauthor=J.+D.+Bandauthor=E.+Whiteauthor=W.+R.+Jarvis&title=Emergence+of+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.1056%2FNEJM199902183400701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of vancomycin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Smith, Theresa L.; Pearson, Michele L.; Wilcox, Kenneth R.; Cruz, Cosme; Lancaster, Michael V.; Robinson-Dunn, Barbara; Tenover, Fred C.; Zervos, Marcus J.; Band, Jeffrey D.; White, Elizabeth; Jarvis, William R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-501</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Since the emergence of methicillin-resistant Staphylococcus aureus, the glycopeptide vancomycin has been the only uniformly effective treatment for staphylococcal infections.  In 1997, two infections due to S. aureus with reduced susceptibility to vancomycin were identified in the United States.  We investigated the two patients with infections due to S. aureus with intermediate resistance to glycopeptides, as defined by a minimal inhibitory concn. of vancomycin of 8 to 16 μg per mL.  To assess the carriage and transmission of these strains of S. aureus, we cultured samples from the patients and their contacts and evaluated the isolates.  The first patient was a 59-yr-old man in Michigan with diabetes mellitus and chronic renal failure.  Peritonitis due to S. aureus with intermediate resistance to glycopeptides developed after 18 wk of vancomycin treatment for recurrent methicillin-resistant S. aureus peritonitis assocd. with dialysis.  The removal of the peritoneal catheter plus treatment with rifampin and trimethoprim-sulfamethoxazole eradicated the infection.  The second patient was a 66-yr-old man with diabetes in New Jersey.  A bloodstream infection due to S. aureus with intermediate resistance to glycopeptides developed after 18 wk of vancomycin treatment for recurrent methicillin-resistant S. aureus bacteremia.  This infection was eradicated with vancomycin, gentamicin, and rifampin.  Both patients died.  The glycopeptide-intermediate S. aureus isolates differed by two bands on pulse-field gel electrophoresis.  On electron microscopy, the isolates from the infected patients had thicker extracellular matrixes than control methicillin-resistant S. aureus isolates.  No carriage was documented among 177 contacts of the two patients.  The emergence of S. aureus with intermediate resistance to glycopeptides emphasizes the importance of the prudent use of antibiotics, the lab. capacity to identify resistant strains, and the use of infection-control precautions to prevent transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUpvGDq63H7Vg90H21EOLACvtfcHk0liGzrrjlMmbJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsV2mtLo%253D&md5=b07b824bb3e5f0463923103cb489561c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJM199902183400701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199902183400701%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DT.%2BL.%26aulast%3DPearson%26aufirst%3DM.%2BL.%26aulast%3DWilcox%26aufirst%3DK.%2BR.%26aulast%3DCruz%26aufirst%3DC.%26aulast%3DLancaster%26aufirst%3DM.%2BV.%26aulast%3DRobinson-Dunn%26aufirst%3DB.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26aulast%3DBand%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DE.%26aulast%3DJarvis%26aufirst%3DW.%2BR.%26atitle%3DEmergence%2520of%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D340%26spage%3D493%26epage%3D501%26doi%3D10.1056%2FNEJM199902183400701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rotun, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonmaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maupin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenover, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackman, D. M.</span><span> </span><span class="NLM_article-title">Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.3201/eid0501.990118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.3201%2Feid0501.990118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10081683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVSjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=147-149&author=S.+S.+Rotunauthor=V.+McMathauthor=D.+J.+Schoonmakerauthor=P.+S.+Maupinauthor=F.+C.+Tenoverauthor=B.+C.+Hillauthor=D.+M.+Ackman&title=Staphylococcus+aureus+with+reduced+susceptibility+to+vancomycin+isolated+from+a+patient+with+fatal+bacteremia&doi=10.3201%2Feid0501.990118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia</span></div><div class="casAuthors">Rotun, Sharon S.; McMath, Virginia; Schoonmaker, Dianna J.; Maupin, Peggy S.; Tenover, Fred C.; Hill, Bertha C.; Ackman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Infectious Diseases</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-149</span>CODEN:
                <span class="NLM_cas:coden">EIDIFA</span>;
        ISSN:<span class="NLM_cas:issn">1080-6040</span>.
    
            (<span class="NLM_cas:orgname">National Center for Infectious Diseases, Centers for Disease Control and Prevention</span>)
        </div><div class="casAbstract">A Staphylococcus aureus isolate with reduced susceptibility to vancomycin was obtained from a dialysis patient with a fatal case of bacteremia.  Comparison of the isolate with two methicillin-resistant S. aureus (MRSA) isolates obtained from the same patient 4 mo earlier suggests that the S. aureus with reduced susceptibility to vancomycin emerged from the MRSA strain with which the patient was infected.  Atypical phenotypic characteristics, including weak or neg. latex-agglutination test results, weak or neg.-slide coagulase test results, heterogeneous morphol. features, slow rate of growth, and vancomycin susceptibility (by disk diffusion test) were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSj4r3d2xXwrVg90H21EOLACvtfcHk0ljjTH56E0gHxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVSjtrk%253D&md5=202a7b715fa0b0978ed572e8d8cd0bf2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3201%2Feid0501.990118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid0501.990118%26sid%3Dliteratum%253Aachs%26aulast%3DRotun%26aufirst%3DS.%2BS.%26aulast%3DMcMath%26aufirst%3DV.%26aulast%3DSchoonmaker%26aufirst%3DD.%2BJ.%26aulast%3DMaupin%26aufirst%3DP.%2BS.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DHill%26aufirst%3DB.%2BC.%26aulast%3DAckman%26aufirst%3DD.%2BM.%26atitle%3DStaphylococcus%2520aureus%2520with%2520reduced%2520susceptibility%2520to%2520vancomycin%2520isolated%2520from%2520a%2520patient%2520with%2520fatal%2520bacteremia%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D1999%26volume%3D5%26spage%3D147%26epage%3D149%26doi%3D10.3201%2Feid0501.990118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Weinstein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, S. K.</span><span> </span><span class="NLM_article-title">Vancomycin-intermediate and-resistant Staphylococcus aureus: what the infectious disease specialist needs to know</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1086/317542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1086%2F317542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=11118389" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=108-115&author=R.+A.+Weinsteinauthor=S.+K.+Fridkin&title=Vancomycin-intermediate+and-resistant+Staphylococcus+aureus%3A+what+the+infectious+disease+specialist+needs+to+know&doi=10.1086%2F317542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1086%2F317542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F317542%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DR.%2BA.%26aulast%3DFridkin%26aufirst%3DS.%2BK.%26atitle%3DVancomycin-intermediate%2520and-resistant%2520Staphylococcus%2520aureus%253A%2520what%2520the%2520infectious%2520disease%2520specialist%2520needs%2520to%2520know%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2001%26volume%3D32%26spage%3D108%26epage%3D115%26doi%3D10.1086%2F317542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ward, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabsch, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayall, B. C.</span><span> </span><span class="NLM_article-title">Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin</span> <span class="citation_source-journal">Med. J. Aust.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=11758077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FjtleqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2001&pages=480-483&author=P.+B.+Wardauthor=E.+A.+Grabschauthor=B.+C.+Mayall&title=Treatment+failure+due+to+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29+with+reduced+susceptibility+to+vancomycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin</span></div><div class="casAuthors">Ward P B; Johnson P D; Grabsch E A; Mayall B C; Grayson M L</div><div class="citationInfo"><span class="NLM_cas:title">The Medical journal of Australia</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">480-3</span>
        ISSN:<span class="NLM_cas:issn">0025-729X</span>.
    </div><div class="casAbstract">We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin--heteroresistant vancomycin-intermediate S. aureus (hVISA).  The infection occurred in a 41-year-old man with multiple risk factors.  No transmission of the organism to other patients or the environment was detected.  This case may herald the beginning of a new phase of staphylococcal resistance in Australia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwaNgPrGaImR0LsK7uFuY7fW6udTcc2eaYvmxWpdMYsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FjtleqtQ%253D%253D&md5=ff78aabb57a79ec0cdeeb7e84a47305b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BB.%26aulast%3DGrabsch%26aufirst%3DE.%2BA.%26aulast%3DMayall%26aufirst%3DB.%2BC.%26atitle%3DTreatment%2520failure%2520due%2520to%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520with%2520reduced%2520susceptibility%2520to%2520vancomycin%26jtitle%3DMed.%2520J.%2520Aust.%26date%3D2001%26volume%3D175%26spage%3D480%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hageman, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegues, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jepson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenover, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, S. K.</span><span> </span><span class="NLM_article-title">Vancomycin-intermediate Staphylococcus aureus in a home health-care patient</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span><span class="refDoi"> DOI: 10.3201/eid0706.010618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.3201%2Feid0706.010618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=11747733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BD3MnpvFWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1023-1025&author=J.+C.+Hagemanauthor=D.+A.+Peguesauthor=C.+Jepsonauthor=R.+L.+Bellauthor=M.+Guinanauthor=K.+W.+Wardauthor=M.+D.+Cohenauthor=J.+A.+Hindlerauthor=F.+C.+Tenoverauthor=S.+K.+McAllister&title=Vancomycin-intermediate+Staphylococcus+aureus+in+a+home+health-care+patient&doi=10.3201%2Feid0706.010618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin-intermediate Staphylococcus aureus in a home health-care patient</span></div><div class="casAuthors">Hageman J C; Pegues D A; Jepson C; Bell R L; Guinan M; Ward K W; Cohen M D; Hindler J A; Tenover F C; McAllister S K; Kellum M E; Fridkin S K</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1023-5</span>
        ISSN:<span class="NLM_cas:issn">1080-6040</span>.
    </div><div class="casAbstract">In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy.  Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types.  The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction.  Standard precautions in the home health setting appear successful in preventing transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_veJpIoI07MzK395ZObgVfW6udTcc2eaYvmxWpdMYsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnpvFWjtA%253D%253D&md5=4e14d8c57070b115279b9d1ea7133664</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3201%2Feid0706.010618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid0706.010618%26sid%3Dliteratum%253Aachs%26aulast%3DHageman%26aufirst%3DJ.%2BC.%26aulast%3DPegues%26aufirst%3DD.%2BA.%26aulast%3DJepson%26aufirst%3DC.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DGuinan%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DCohen%26aufirst%3DM.%2BD.%26aulast%3DHindler%26aufirst%3DJ.%2BA.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DMcAllister%26aufirst%3DS.%2BK.%26atitle%3DVancomycin-intermediate%2520Staphylococcus%2520aureus%2520in%2520a%2520home%2520health-care%2520patient%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2001%26volume%3D7%26spage%3D1023%26epage%3D1025%26doi%3D10.3201%2Feid0706.010618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zhanel, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenitsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé-Wiens, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlowsky, J. A.</span><span> </span><span class="NLM_article-title">New lipoglycopeptides</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span><span class="refDoi"> DOI: 10.2165/11534440-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.2165%2F11534440-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=20426497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=859-886&author=G.+G.+Zhanelauthor=D.+Calicauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=H.+Adamauthor=P.+R.+Lagac%C3%A9-Wiensauthor=E.+Rubinsteinauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+A.+Karlowsky&title=New+lipoglycopeptides&doi=10.2165%2F11534440-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin</span></div><div class="casAuthors">Zhanel, George G.; Calic, Divna; Schweizer, Frank; Zelenitsky, Sheryl; Adam, Heather; Lagace-Wiens, Philippe R. S.; Rubinstein, Ethan; Gin, Alfred S.; Hoban, Daryl J.; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">859-886</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by multi-drug-resistant Gram-pos. pathogens.  Each of these agents contains a heptapeptide core, common to all glycopeptides, which enables them to inhibit transglycosylation and transpeptidation (cell wall synthesis).  Modifications to the heptapeptide core result in different in vitro activities for the three semisynthetic lipoglycopeptides.  All three lipoglycopeptides contain lipophilic side chains, which prolong their half-life, help to anchor the agents to the cell membrane and increase their activity against Gram-pos. cocci.  In addn. to inhibiting cell wall synthesis, telavancin and oritavancin are also able to disrupt bacterial membrane integrity and increase membrane permeability; oritavancin also inhibits RNA synthesis.  Enterococci exhibiting the VanA phenotype (resistance to both vancomycin and teicoplanin) are resistant to both dalbavancin and telavancin, while oritavancin retains activity.  Dalbavancin, oritavancin and telavancin exhibit activity against VanB vancomycin-resistant enterococci.  All three lipoglycopeptides demonstrate potent in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis regardless of their susceptibility to meticillin, as well as Streptococcus spp.  Both dalbavancin and telavancin are active against vancomycin-intermediate S. aureus (VISA), but display poor activity vs. vancomycin-resistant S. aureus (VRSA).  Oritavancin is active against both VISA and VRSA.  Telavancin displays greater activity against Clostridium spp. than dalbavancin, oritavancin or vancomycin.  The half-life of dalbavancin ranges from 147 to 258 h, which allows for once-weekly dosing, the half-life of oritavancin of 393 h may allow for one dose per treatment course, while telavancin requires daily administration.  Dalbavancin and telavancin exhibit concn.-dependent activity and AUC/MIC (area under the concn.-time curve to min. inhibitory concn. ratio) is the pharmacodynamic parameter that best describes their activities.  Oritavancin's activity is also considered concn.-dependent in vitro, while in vivo its activity has been described by both concn. and time-dependent models; however, AUC/MIC is the pharmacodynamic parameter that best describes its activity.  Clin. trials involving patients with complicated skin and skin structure infections (cSSSIs) have demonstrated that all three agents are as efficacious as comparators.  The most common adverse effects reported with dalbavancin use included nausea, diarrhoea and constipation, while injection site reactions, fever and diarrhoea were commonly obsd. with oritavancin therapy.  Patients administered telavancin frequently reported nausea, taste disturbance and insomnia.  To date, no drug-drug interactions have been identified for dalbavancin, oritavancin or telavancin.  All three of these agents are promising alternatives for the treatment of cSSSIs in cases where more economical options such as vancomycin have been ineffective, in cases of reduced vancomycin susceptibility or resistance, or where vancomycin use has been assocd. with adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kTvXBDIDUrVg90H21EOLACvtfcHk0lif7f9D9vw0Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D&md5=0409400bb17ec3b413752b85443aaf0f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2165%2F11534440-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11534440-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DCalic%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DLagac%25C3%25A9-Wiens%26aufirst%3DP.%2BR.%26aulast%3DRubinstein%26aufirst%3DE.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DNew%2520lipoglycopeptides%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D859%26epage%3D886%26doi%3D10.2165%2F11534440-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Okano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schammel, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Total synthesis of [Ψ[C (═NH)NH] Tpg4] vancomycin and its (4-Chlorobiphenyl) methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual d-Ala-d-Ala and d-Ala-d-Lac binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">13522</span><span class="NLM_x">–</span> <span class="NLM_lpage">13525</span><span class="refDoi"> DOI: 10.1021/ja507009a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja507009a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13522-13525&author=A.+Okanoauthor=A.+Nakayamaauthor=A.+W.+Schammelauthor=D.+L.+Boger&title=Total+synthesis+of+%5B%CE%A8%5BC+%28%E2%95%90NH%29NH%5D+Tpg4%5D+vancomycin+and+its+%284-Chlorobiphenyl%29+methyl+derivative%3A+impact+of+peripheral+modifications+on+vancomycin+analogues+redesigned+for+dual+d-Ala-d-Ala+and+d-Ala-d-Lac+binding&doi=10.1021%2Fja507009a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja507009a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja507009a%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DSchammel%26aufirst%3DA.%2BW.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520synthesis%2520of%2520%255B%25CE%25A8%255BC%2520%2528%25E2%2595%2590NH%2529NH%255D%2520Tpg4%255D%2520vancomycin%2520and%2520its%2520%25284-Chlorobiphenyl%2529%2520methyl%2520derivative%253A%2520impact%2520of%2520peripheral%2520modifications%2520on%2520vancomycin%2520analogues%2520redesigned%2520for%2520dual%2520d-Ala-d-Ala%2520and%2520d-Ala-d-Lac%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13522%26epage%3D13525%26doi%3D10.1021%2Fja507009a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Okano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isley, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Peripheral modifications of [Ψ [CH2NH] Tpg4] vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">5052</span><span class="NLM_x">–</span> <span class="NLM_lpage">5061</span><span class="refDoi"> DOI: 10.1073/pnas.1704125114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1073%2Fpnas.1704125114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=5052-5061&author=A.+Okanoauthor=N.+A.+Isleyauthor=D.+L.+Boger&title=Peripheral+modifications+of+%5B%CE%A8+%5BCH2NH%5D+Tpg4%5D+vancomycin+with+added+synergistic+mechanisms+of+action+provide+durable+and+potent+antibiotics&doi=10.1073%2Fpnas.1704125114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1704125114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1704125114%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DIsley%26aufirst%3DN.%2BA.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPeripheral%2520modifications%2520of%2520%255B%25CE%25A8%2520%255BCH2NH%255D%2520Tpg4%255D%2520vancomycin%2520with%2520added%2520synergistic%2520mechanisms%2520of%2520action%2520provide%2520durable%2520and%2520potent%2520antibiotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D5052%26epage%3D5061%26doi%3D10.1073%2Fpnas.1704125114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yarlagadda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konai, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunath, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span> </span><span class="NLM_article-title">Tackling vancomycin-resistant bacteria with’lipophilic-vancomycin-carbohydrate conjugates’</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/ja.2014.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fja.2014.144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=302-312&author=V.+Yarlagaddaauthor=M.+M.+Konaiauthor=G.+B.+Manjunathauthor=C.+Ghoshauthor=J.+Haldar&title=Tackling+vancomycin-resistant+bacteria+with%E2%80%99lipophilic-vancomycin-carbohydrate+conjugates%E2%80%99&doi=10.1038%2Fja.2014.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.144%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DTackling%2520vancomycin-resistant%2520bacteria%2520with%25E2%2580%2599lipophilic-vancomycin-carbohydrate%2520conjugates%25E2%2580%2599%26jtitle%3DJ.%2520Antibiot.%26date%3D2015%26volume%3D68%26spage%3D302%26epage%3D312%26doi%3D10.1038%2Fja.2014.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yarlagadda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaddar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paramanandham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shome, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span> </span><span class="NLM_article-title">Membrane disruption and enhanced inhibition of cell-wall biosynthesis: a synergistic approach to tackle vancomycin-resistant bacteria</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">13644</span><span class="NLM_x">–</span> <span class="NLM_lpage">13649</span><span class="refDoi"> DOI: 10.1002/anie.201507567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2Fanie.201507567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26473305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=13644-13649&author=V.+Yarlagaddaauthor=S.+Samaddarauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=J.+Haldar&title=Membrane+disruption+and+enhanced+inhibition+of+cell-wall+biosynthesis%3A+a+synergistic+approach+to+tackle+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201507567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Samaddar, Sandip; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">13644-13649</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Resistance to glycopeptide antibiotics, the drugs of choice for life-threatening bacterial infections, is on the rise.  To counter the threat of glycopeptide-resistant bacteria, the authors report development of a new class of semi-synthetic glycopeptide antibiotics, which not only target the bacterial membrane but also display enhanced inhibition of cell-wall biosynthesis through increased binding affinity to their target peptides.  The combined effect of these two mechanisms resulted in improved in vitro activity of two to three orders of magnitude over vancomycin and no propensity to trigger drug resistance in bacteria.  In murine model of kidney infection, the optimized compd. was able to bring bacterial burden down by about 6 logs at 12 mg kg-1 with no obsd. toxicity.  The results furnished emphasize the potential of this class of compds. as future antibiotics for drug-resistant Gram-pos. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdntAtQFj3MrVg90H21EOLACvtfcHk0lganXcMK54n9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI&md5=6612d63cd53b251565cddd6727df5e9c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507567%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520disruption%2520and%2520enhanced%2520inhibition%2520of%2520cell-wall%2520biosynthesis%253A%2520a%2520synergistic%2520approach%2520to%2520tackle%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D13644%26epage%3D13649%26doi%3D10.1002%2Fanie.201507567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yarlagadda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaddar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span> </span><span class="NLM_article-title">A vancomycin derivative with a pyrophosphate-binding group: a strategy to combat vancomycin-resistant bacteria</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7836</span><span class="NLM_x">–</span> <span class="NLM_lpage">7840</span><span class="refDoi"> DOI: 10.1002/anie.201601621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2Fanie.201601621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVChsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=7836-7840&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=S.+Samaddarauthor=J.+Haldar&title=A+vancomycin+derivative+with+a+pyrophosphate-binding+group%3A+a+strategy+to+combat+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201601621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Sarkar, Paramita; Samaddar, Sandip; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">7836-7840</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Vancomycin, the drug of last resort for Gram-pos. bacterial infections, has also been rendered ineffective by the emergence of resistance in such bacteria.  To combat the threat of vancomycin-resistant bacteria (VRB), the authors report the development of a dipicolyl-vancomycin conjugate (Dipi-van), which leads to enhanced inhibition of cell-wall biosynthesis in VRB and displays in vitro activity that is more than two orders of magnitude higher than that of vancomycin.  Conjugation of the dipicolyl moiety, which is a zinc-binding ligand, endowed the parent drug with the ability to bind to pyrophosphate groups of cell-wall lipids while maintaining the inherent binding affinity for pentapeptide termini of cell-wall precursors.  Furthermore, no detectable resistance was obsd. after several serial passages, and the compd. reduced the bacterial burden by a factor of 5 logs at 12 mg kg-1 in a murine model of VRB kidney infection.  The findings presented stress the potential of the authors' strategy to combat VRB infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsJJjdJGAiGbVg90H21EOLACvtfcHk0lganXcMK54n9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVChsbo%253D&md5=b954f612802d363f8f1a82ffef27162c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601621%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DA%2520vancomycin%2520derivative%2520with%2520a%2520pyrophosphate-binding%2520group%253A%2520a%2520strategy%2520to%2520combat%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D7836%26epage%3D7840%26doi%3D10.1002%2Fanie.201601621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Leonard, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections</span> <span class="citation_source-journal">Pharmacother. J. Hum. Pharmacol. Drug Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1592/phco.28.4.458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1592%2Fphco.28.4.458" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=458-468&author=S.+N.+Leonardauthor=M.+J.+Rybak&title=Telavancin%3A+an+antimicrobial+with+a+multifunctional+mechanism+of+action+for+the+treatment+of+serious+gram-positive+infections&doi=10.1592%2Fphco.28.4.458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1592%2Fphco.28.4.458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1592%252Fphco.28.4.458%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DS.%2BN.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DTelavancin%253A%2520an%2520antimicrobial%2520with%2520a%2520multifunctional%2520mechanism%2520of%2520action%2520for%2520the%2520treatment%2520of%2520serious%2520gram-positive%2520infections%26jtitle%3DPharmacother.%2520J.%2520Hum.%2520Pharmacol.%2520Drug%2520Ther.%26date%3D2008%26volume%3D28%26spage%3D458%26epage%3D468%26doi%3D10.1592%2Fphco.28.4.458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Smith, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Dalbavancin: a novel lipoglycopeptide antibiotic with extended activity against Gram-positive infections</span> <span class="citation_source-journal">Infect. Dis. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1007/s40121-015-0077-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1007%2Fs40121-015-0077-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26341488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC287psFCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=245-258&author=J.+R.+Smithauthor=K.+D.+Robertsauthor=M.+J.+Rybak&title=Dalbavancin%3A+a+novel+lipoglycopeptide+antibiotic+with+extended+activity+against+Gram-positive+infections&doi=10.1007%2Fs40121-015-0077-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections</span></div><div class="casAuthors">Smith Jordan R; Roberts Karrine D; Rybak Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-58</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Dalbavancin is a lipoglycopeptide antibiotic recently approved by the United States Food and Drug Administration (FDA) for acute bacterial skin and skin structure infections (ABSSSIs).  It is active against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), and minimum inhibitory concentrations (MICs) are consistently <0.125 μg/ml, much lower than most other anti-MRSA agents.  Dalbavancin possesses an extended half-life of over 1 week, allowing an initial dose of 1000 mg followed by 500 mg 1 week later to complete a course of therapy for ABSSSI.  It is approximately 95% protein bound and is widely distributed throughout the body, achieving concentrations similar to plasma levels in numerous tissues.  Against MRSA, dalbavancin is 4-8 times more potent than vancomycin in vitro, and limited data suggest it possesses activity against MRSA with reduced susceptibility to vancomycin such as hVISA and VISA.  Dalbavancin also possesses in vitro activity against streptococci and enterococci, although activity against vancomycin-resistant enterococci is lacking.  In phase 3 ABSSSI studies, dalbavancin demonstrated similar activity to vancomycin and provides a more convenient dosing regimen.  Limited phase 2 data suggest dalbavancin also possesses activity in catheter-related bloodstream infections.  Potential further therapeutic uses include conditions that require long-term treatment such as osteomyelitis and infective endocarditis, although data are currently lacking.  The extended half-life of dalbavancin, along with its in vitro activity against gram-positive organisms with reduced susceptibility to other anti-MRSA antibiotics, suggest it could have an exciting clinical role going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUQHmegw0cIe2qxNLjzXe8fW6udTcc2eYl49zCPCmVPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287psFCntw%253D%253D&md5=47ac79a61c38ea0b6fceac1febc57ff2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs40121-015-0077-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-015-0077-7%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BR.%26aulast%3DRoberts%26aufirst%3DK.%2BD.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DDalbavancin%253A%2520a%2520novel%2520lipoglycopeptide%2520antibiotic%2520with%2520extended%2520activity%2520against%2520Gram-positive%2520infections%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2015%26volume%3D4%26spage%3D245%26epage%3D258%26doi%3D10.1007%2Fs40121-015-0077-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Brade, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Oritavancin: a new lipoglycopeptide antibiotic in the treatment of gram-positive infections</span> <span class="citation_source-journal">Infect. Dis. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1007/s40121-016-0103-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1007%2Fs40121-016-0103-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26831328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC28nmt1aqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=1-15&author=K.+D.+Bradeauthor=J.+M.+Rybakauthor=M.+J.+Rybak&title=Oritavancin%3A+a+new+lipoglycopeptide+antibiotic+in+the+treatment+of+gram-positive+infections&doi=10.1007%2Fs40121-016-0103-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections</span></div><div class="casAuthors">Brade Karrine D; Rybak Jeffrey M; Rybak Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Resistance among Gram-positive organisms has been steadily increasing over the last several years; however, the development of new antibiotics to treat infections caused from these organisms has fallen short of the emergent need.  Specifically, resistance among Staphylococcus aureus and Enterococcus spp. to essential antibiotics is considered a major problem.  Oritavancin is a semisynthetic lipoglycopeptide antibiotic that was recently approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI).  While structurally related to vancomycin, oritavancin also possesses unique mechanisms of action that greatly enhance its antimicrobial potency against multi-drug resistant pathogens including both VanA- and VanB-mediated vancomycin-resistant enterococci.  Owing to the addition of the highly hydrophobic tail group, oritavancin possesses a prolonged half-life ranging from 200-300 h.  Although oritavancin is only currently Food and Drug Administration approved for ABSSSI, this agent may eventually play a role in additional indications where new innovative therapy is needed including bacteremia and deep-seeded, Gram-positive infections such as infective endocarditis or osteomyelitis.  This review will focus on oritavancin's spectrum of activity, mechanisms of action and resistance, pharmacokinetic and pharmacodynamic properties, and the completed and ongoing clinical studies evaluating its use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs2cCxBc27dtTiMd2aNQVUfW6udTcc2ebyecaK9r36X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmt1aqsQ%253D%253D&md5=6d23932cdf873427ca88650b56508b8a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs40121-016-0103-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-016-0103-4%26sid%3Dliteratum%253Aachs%26aulast%3DBrade%26aufirst%3DK.%2BD.%26aulast%3DRybak%26aufirst%3DJ.%2BM.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DOritavancin%253A%2520a%2520new%2520lipoglycopeptide%2520antibiotic%2520in%2520the%2520treatment%2520of%2520gram-positive%2520infections%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2016%26volume%3D5%26spage%3D1%26epage%3D15%26doi%3D10.1007%2Fs40121-016-0103-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Butler, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. A.</span><span> </span><span class="NLM_article-title">Glycopeptide antibiotics: back to the future</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span><span class="refDoi"> DOI: 10.1038/ja.2014.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fja.2014.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=25118105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=631-644&author=M.+S.+Butlerauthor=K.+A.+Hansfordauthor=M.+A.+Blaskovichauthor=R.+Halaiauthor=M.+A.+Cooper&title=Glycopeptide+antibiotics%3A+back+to+the+future&doi=10.1038%2Fja.2014.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide antibiotics: Back to the future</span></div><div class="casAuthors">Butler, Mark S.; Hansford, Karl A.; Blaskovich, Mark A. T.; Halai, Reena; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">631-644</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glycopeptide antibiotics have been a key weapon in the fight against bacterial infections for over half a century, with the progenitors, vancomycin (1) and teicoplanin (2), still used extensively.  The increased occurrence of resistance and the effectiveness of these 'last resort' treatments for Gram-pos. infections has led to the discovery and clin. development of second generation, semisynthetic lipoglycopeptide derivs. such as telavancin (3), dalbavancin (4) and oritavancin (5), which all possess broader spectra of activity and improved pharmacokinetic properties.  Two of these new antibiotics, telavancin (3) and dalbavancin (4), were approved in the past 5 years and the third, oritavancin (5), is awaiting regulatory approval.  In this review, the discovery, development and assocd. resistance of vancomycin (1) and teicoplanin (2), and semi-synthetic glycopeptides, telavancin (3), dalbavancin (4) and oritavancin (5), are detailed.  The clin. implications of glycopeptide resistance, esp. vancomycin (1), as well as the future prospects for current glycopeptide drugs and the development of new glycopeptides are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBXjY3YHnypbVg90H21EOLACvtfcHk0lgiVtIFffmpOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK&md5=04a3089be94990f1f3891cd6958ae79a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.111%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DHalai%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DGlycopeptide%2520antibiotics%253A%2520back%2520to%2520the%2520future%26jtitle%3DJ.%2520Antibiot.%26date%3D2014%26volume%3D67%26spage%3D631%26epage%3D644%26doi%3D10.1038%2Fja.2014.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kahne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C.</span><span> </span><span class="NLM_article-title">Glycopeptide and lipoglycopeptide antibiotics</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span><span class="refDoi"> DOI: 10.1021/cr030103a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030103a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=425-448&author=D.+Kahneauthor=C.+Leimkuhlerauthor=W.+Luauthor=C.+Walsh&title=Glycopeptide+and+lipoglycopeptide+antibiotics&doi=10.1021%2Fcr030103a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide and Lipoglycopeptide Antibiotics</span></div><div class="casAuthors">Kahne, Dan; Leimkuhler, Catherine; Lu, Wei; Walsh, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">425-448</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on glycopeptide and lipoglycopeptide antibiotics.  Structural features, chem. synthesis, mechanism of action, resistance mechanisms and new directions for treating drug resistance are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBnRcMTFq_cbVg90H21EOLACvtfcHk0lgiVtIFffmpOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D&md5=ef3f1a5f07faeacd22c0444d42637fd1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr030103a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030103a%26sid%3Dliteratum%253Aachs%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DLeimkuhler%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DWalsh%26aufirst%3DC.%26atitle%3DGlycopeptide%2520and%2520lipoglycopeptide%2520antibiotics%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D425%26epage%3D448%26doi%3D10.1021%2Fcr030103a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafai Far, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, J.</span><span> </span><span class="NLM_article-title">Locations of the hydrophobic side chains of lipoglycopeptides bound to the peptidoglycan of Staphylococcus aureus</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3405</span><span class="NLM_x">–</span> <span class="NLM_lpage">3014</span><span class="refDoi"> DOI: 10.1021/bi400054p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400054p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1yls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=3405-3014&author=S.+J.+Kimauthor=K.+S.+Tanakaauthor=E.+Dietrichauthor=A.+Rafai+Farauthor=J.+Schaefer&title=Locations+of+the+hydrophobic+side+chains+of+lipoglycopeptides+bound+to+the+peptidoglycan+of+Staphylococcus+aureus&doi=10.1021%2Fbi400054p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Locations of the Hydrophobic Side Chains of Lipoglycopeptides Bound to the Peptidoglycan of Staphylococcus aureus</span></div><div class="casAuthors">Kim, Sung Joon; Tanaka, Kelly S. E.; Dietrich, Evelyne; Rafai Far, Adel; Schaefer, Jacob</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3405-3414</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycopeptides whose aminosugars have been modified by attachment of hydrophobic side chains are frequently active against vancomycin-resistant microorganisms.  The authors have compared the conformations of six such fluorinated glycopeptides (with side chains of varying length) complexed to cell walls labeled with D-[1-13C]alanine, [1-13C]glycine, and L-[ε-15N]lysine in whole cells of Staphylococcus aureus.  The internuclear distances from 19F of the bound drug to the 13C and 15N labels of the peptidoglycan, and to the natural abundance 31P of lipid membranes and teichoic acids, were detd. by rotational-echo double resonance NMR.  The drugs did not dimerize, and their side chains did not form membrane anchors but instead became essential parts of secondary binding to pentaglycyl bridge segments of the cell-wall peptidoglycan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpXJ9V5BKWPbVg90H21EOLACvtfcHk0lgiVtIFffmpOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1yls70%253D&md5=a12a172367252e11c4c5166025108ac5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi400054p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400054p%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DTanaka%26aufirst%3DK.%2BS.%26aulast%3DDietrich%26aufirst%3DE.%26aulast%3DRafai%2BFar%26aufirst%3DA.%26aulast%3DSchaefer%26aufirst%3DJ.%26atitle%3DLocations%2520of%2520the%2520hydrophobic%2520side%2520chains%2520of%2520lipoglycopeptides%2520bound%2520to%2520the%2520peptidoglycan%2520of%2520Staphylococcus%2520aureus%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D3405%26epage%3D3014%26doi%3D10.1021%2Fbi400054p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nagarajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schabel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Occolowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Counter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felty-Duckworth, A.</span><span> </span><span class="NLM_article-title">Synthesis and antibacterial evaluation of N-alkyl vancomycins</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.7164/antibiotics.42.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.42.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=2540369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaL1MXmtlemt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1989&pages=63-72&author=R.+Nagarajanauthor=A.+Schabelauthor=J.+Occolowitzauthor=F.+Counterauthor=J.+Ottauthor=A.+Felty-Duckworth&title=Synthesis+and+antibacterial+evaluation+of+N-alkyl+vancomycins&doi=10.7164%2Fantibiotics.42.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antibacterial evaluation of N-alkyl vancomycins</span></div><div class="casAuthors">Nagarajan, R.; Schabel, A. A.; Occolowitz, J. L.; Counter, F. T.; Ott, J. L.; Felty-Duckworth, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">Eighty-one N-alkyl vancomycins I (R = R1 = alkyl; R = alkyl, R1 = H; R = H, R1 = alkyl) were synthesized by reductive alkylation of vancomycin with the appropriate aldehydes.  The N-alkyl vancomycins exhibit greater antibacterial activity than the corresponding N-acyl vancomycins.  I [R = 4-R2C6H4CH2, R1 = H; R2 = H, Bu, BuO, Me(CH2)7, Me(CH2)7O] were the most active compds., with activities up to 5 times that of vancomycin.  The N-alkyl vancomycins also show longer elimination half-lives in rats than vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxcAlYu4y_jLVg90H21EOLACvtfcHk0lgx3AgCldV9qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtlemt7g%253D&md5=79ef633e1c0c0eaf01fc080663f234ee</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.42.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.42.63%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DSchabel%26aufirst%3DA.%26aulast%3DOccolowitz%26aufirst%3DJ.%26aulast%3DCounter%26aufirst%3DF.%26aulast%3DOtt%26aufirst%3DJ.%26aulast%3DFelty-Duckworth%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520antibacterial%2520evaluation%2520of%2520N-alkyl%2520vancomycins%26jtitle%3DJ.%2520Antibiot.%26date%3D1989%26volume%3D42%26spage%3D63%26epage%3D72%26doi%3D10.7164%2Fantibiotics.42.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Leadbetter, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fatheree, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karr, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsell, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodwell, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, J. L.</span><span> </span><span class="NLM_article-title">Hydrophobic vancomycin derivatives with improved ADME properties</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.7164/antibiotics.57.326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.57.326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=15303493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2004&pages=326-336&author=M.+R.+Leadbetterauthor=S.+M.+Adamsauthor=B.+Bazziniauthor=P.+R.+Fathereeauthor=D.+E.+Karrauthor=K.+M.+Krauseauthor=B.+M.+Lamauthor=M.+S.+Linsellauthor=M.+B.+Nodwellauthor=J.+L.+Pace&title=Hydrophobic+vancomycin+derivatives+with+improved+ADME+properties&doi=10.7164%2Fantibiotics.57.326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)</span></div><div class="casAuthors">Leadbetter, Michael R.; Adams, Stacy M.; Bazzini, Bettina; Fatheree, Paul R.; Karr, Dane E.; Krause, Kevin M.; Lam, Bernice M. T.; Linsell, Martin S.; Nodwell, Matthew B.; Pace, John L.; Quast, Kelly; Shaw, Jeng-Pyng; Soriano, Elizabeth; Trapp, Sean G.; Villena, Jenny D.; Wu, Terry X.; Christensen, Burton G.; Judice, J. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">326-336</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Novel derivs. of N-decylaminoethylvancomycin (2), contg. appended hydrophilic groups were synthesized and their antibacterial activity and ADME properties were evaluated.  The compds. were prepd. by reacting amines with the C-terminus (C-) of 2 using PyBOP mediated amide formation, or with the resorcinol-like (R-) position of 2 using a Mannich aminomethylation reaction.  These analogs retained the antibacterial activity of 2 against methicillin-resistant staphylococci and vancomycin-resistant enterococci.  Compds. with a neg. charged auxiliary group also exhibited improved ADME properties relative to 2.  In particular, R-phosphonomethylaminomethyl deriv. 21 displayed good in vitro antibacterial activity, high urinary recovery and low distribution to liver and kidney tissues.  Based on these results, 21 was advanced into development as TD-6424, and is currently in human clin. trials.  The generic name telavancin has recently been approved for compd. 21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobrfFAGGvnOLVg90H21EOLACvtfcHk0lgx3AgCldV9qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D&md5=7a24e7cda0ffe2f03280f9c7a36fe028</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.57.326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.57.326%26sid%3Dliteratum%253Aachs%26aulast%3DLeadbetter%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%2BM.%26aulast%3DBazzini%26aufirst%3DB.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DKrause%26aufirst%3DK.%2BM.%26aulast%3DLam%26aufirst%3DB.%2BM.%26aulast%3DLinsell%26aufirst%3DM.%2BS.%26aulast%3DNodwell%26aufirst%3DM.%2BB.%26aulast%3DPace%26aufirst%3DJ.%2BL.%26atitle%3DHydrophobic%2520vancomycin%2520derivatives%2520with%2520improved%2520ADME%2520properties%26jtitle%3DJ.%2520Antibiot.%26date%3D2004%26volume%3D57%26spage%3D326%26epage%3D336%26doi%3D10.7164%2Fantibiotics.57.326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Arhin, F. F.; Belley, A.; Far, A. R.; Lehoux, D.; Moeck, G.; Parr, T. R.</span><span> </span><span class="NLM_article-title">Glycopeptides and Lipoglycopeptides</span>. In  <span class="citation_source-book">Antibiot. Discov. Dev.</span>; <span class="NLM_contrib-group">Dougherty, T. J.; Pucci, M. J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1007%2F978-1-4614-1400-1_9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=301-346&author=F.+F.+Arhin&author=A.+Belley&author=A.+R.+Far&author=D.+Lehoux&author=G.+Moeck&author=T.+R.+Parrauthor=T.+J.+Dougherty&author=M.+J.+Pucci&title=Antibiot.+Discov.+Dev."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-1400-1_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-1400-1_9%26sid%3Dliteratum%253Aachs%26aulast%3DArhin%26aufirst%3DF.%2BF.%26atitle%3DGlycopeptides%2520and%2520Lipoglycopeptides%26btitle%3DAntibiot.%2520Discov.%2520Dev.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26pub%3DSpringer%26date%3D2012%26spage%3D301%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Parenti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beretta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arioli, V.</span><span> </span><span class="NLM_article-title">Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.7164/antibiotics.31.276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.31.276" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1978&pages=276-283&author=F.+Parentiauthor=G.+Berettaauthor=M.+Bertiauthor=V.+Arioli&title=Teichomycins%2C+new+antibiotics+from+Actinoplanes+teichomyceticus+nov.+sp&doi=10.7164%2Fantibiotics.31.276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.31.276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.31.276%26sid%3Dliteratum%253Aachs%26aulast%3DParenti%26aufirst%3DF.%26aulast%3DBeretta%26aufirst%3DG.%26aulast%3DBerti%26aufirst%3DM.%26aulast%3DArioli%26aufirst%3DV.%26atitle%3DTeichomycins%252C%2520new%2520antibiotics%2520from%2520Actinoplanes%2520teichomyceticus%2520nov.%2520sp%26jtitle%3DJ.%2520Antibiot.%26date%3D1978%26volume%3D31%26spage%3D276%26epage%3D283%26doi%3D10.7164%2Fantibiotics.31.276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Barna, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddrell, D. M.</span><span> </span><span class="NLM_article-title">Structure elucidation of the teicoplanin antibiotics</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">4895</span><span class="NLM_x">–</span> <span class="NLM_lpage">4902</span><span class="refDoi"> DOI: 10.1021/ja00329a044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00329a044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1984&pages=4895-4902&author=J.+C.+Barnaauthor=D.+H.+Williamsauthor=D.+J.+Stoneauthor=T.+C.+Leungauthor=D.+M.+Doddrell&title=Structure+elucidation+of+the+teicoplanin+antibiotics&doi=10.1021%2Fja00329a044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja00329a044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00329a044%26sid%3Dliteratum%253Aachs%26aulast%3DBarna%26aufirst%3DJ.%2BC.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DStone%26aufirst%3DD.%2BJ.%26aulast%3DLeung%26aufirst%3DT.%2BC.%26aulast%3DDoddrell%26aufirst%3DD.%2BM.%26atitle%3DStructure%2520elucidation%2520of%2520the%2520teicoplanin%2520antibiotics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1984%26volume%3D106%26spage%3D4895%26epage%3D4902%26doi%3D10.1021%2Fja00329a044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Nicas, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flokowitsch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, R.</span><span> </span><span class="NLM_article-title">Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2194</span><span class="NLM_x">–</span> <span class="NLM_lpage">2199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=2194-2199&author=T.+I.+Nicasauthor=D.+L.+Mullenauthor=J.+E.+Flokowitschauthor=D.+A.+Prestonauthor=N.+J.+Snyderauthor=M.+J.+Zweifelauthor=S.+C.+Wilkieauthor=M.+J.+Rodriguezauthor=R.+C.+Thompsonauthor=R.+Cooper&title=Semisynthetic+glycopeptide+antibiotics+derived+from+LY264826+active+against+vancomycin-resistant+enterococci"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicas%26aufirst%3DT.%2BI.%26aulast%3DMullen%26aufirst%3DD.%2BL.%26aulast%3DFlokowitsch%26aufirst%3DJ.%2BE.%26aulast%3DPreston%26aufirst%3DD.%2BA.%26aulast%3DSnyder%26aufirst%3DN.%2BJ.%26aulast%3DZweifel%26aufirst%3DM.%2BJ.%26aulast%3DWilkie%26aufirst%3DS.%2BC.%26aulast%3DRodriguez%26aufirst%3DM.%2BJ.%26aulast%3DThompson%26aufirst%3DR.%2BC.%26aulast%3DCooper%26aufirst%3DR.%26atitle%3DSemisynthetic%2520glycopeptide%2520antibiotics%2520derived%2520from%2520LY264826%2520active%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D2194%26epage%3D2199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Nagarajan, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of vancomycin-type glycopeptide antibiotics</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.7164/antibiotics.46.1181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.46.1181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=8407579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVSrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=1181-1195&author=R.+Nagarajan&title=Structure-activity+relationships+of+vancomycin-type+glycopeptide+antibiotics&doi=10.7164%2Fantibiotics.46.1181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of vancomycin-type glycopeptide antibiotics</span></div><div class="casAuthors">Nagarajan, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1181-95</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">A review, with 44 refs., on the scope of the structure-activity relations of glycopeptides; on the structure-activity relations of core hexapeptide's amino acids; on the structure-activity relations of semisynthetic glycopeptide antibiotics; and on activity against resistant enterococci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIVM15M_zCRrVg90H21EOLACvtfcHk0li1neX9JsTBPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVSrsrk%253D&md5=e094c1b84dea61fe55c8ac9da108bd0a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.46.1181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.46.1181%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationships%2520of%2520vancomycin-type%2520glycopeptide%2520antibiotics%26jtitle%3DJ.%2520Antibiot.%26date%3D1993%26volume%3D46%26spage%3D1181%26epage%3D1195%26doi%3D10.7164%2Fantibiotics.46.1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Pavlov, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazhko, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preobrazhenskaya, M. N.</span><span> </span><span class="NLM_article-title">A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span><span class="refDoi"> DOI: 10.7164/antibiotics.50.509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.50.509" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1997&pages=509-513&author=A.+Y.+Pavlovauthor=E.+I.+Lazhkoauthor=M.+N.+Preobrazhenskaya&title=A+new+type+of+chemical+modification+of+glycopeptides+antibiotics%3A+aminomethylated+derivatives+of+eremomycin+and+their+antibacterial+activity&doi=10.7164%2Fantibiotics.50.509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.50.509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.50.509%26sid%3Dliteratum%253Aachs%26aulast%3DPavlov%26aufirst%3DA.%2BY.%26aulast%3DLazhko%26aufirst%3DE.%2BI.%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%2BN.%26atitle%3DA%2520new%2520type%2520of%2520chemical%2520modification%2520of%2520glycopeptides%2520antibiotics%253A%2520aminomethylated%2520derivatives%2520of%2520eremomycin%2520and%2520their%2520antibacterial%2520activity%26jtitle%3DJ.%2520Antibiot.%26date%3D1997%26volume%3D50%26spage%3D509%26epage%3D513%26doi%3D10.7164%2Fantibiotics.50.509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pathak, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span> </span><span class="NLM_article-title">Site-selective bromination of vancomycin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">6120</span><span class="NLM_x">–</span> <span class="NLM_lpage">6123</span><span class="refDoi"> DOI: 10.1021/ja301566t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja301566t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVWmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=6120-6123&author=T.+P.+Pathakauthor=S.+J.+Miller&title=Site-selective+bromination+of+vancomycin&doi=10.1021%2Fja301566t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Selective Bromination of Vancomycin</span></div><div class="casAuthors">Pathak, Tejas P.; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6120-6123</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the site-selective bromination of vancomycin to produce, with substantial efficiency, previously unknown monobromovancomycins, a dibromovancomycin, and a tribromovancomycin.  The authors document the inherent reactivity of native vancomycin toward N-bromophthalimide.  The authors, then, demonstrate significant rate acceleration and perturbation of the inherent product distribution in the presence of a rationally designed peptide-based promoter.  Alternative site selectivity is obsd. as a function of solvent and replacement of the peptide with guanidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosVbHWpfmmqbVg90H21EOLACvtfcHk0li1neX9JsTBPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVWmurc%253D&md5=138dc20f506d36493e1dd6f5e186b0d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja301566t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja301566t%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DT.%2BP.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DSite-selective%2520bromination%2520of%2520vancomycin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D6120%26epage%3D6123%26doi%3D10.1021%2Fja301566t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalman, J. R.</span><span> </span><span class="NLM_article-title">Structural and mode of action studies on the antibiotic vancomycin. Evidence from 270-MHz proton magnetic resonance</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2768</span><span class="NLM_x">–</span> <span class="NLM_lpage">2774</span><span class="refDoi"> DOI: 10.1021/ja00450a058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00450a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1977&pages=2768-2774&author=D.+H.+Williamsauthor=J.+R.+Kalman&title=Structural+and+mode+of+action+studies+on+the+antibiotic+vancomycin.+Evidence+from+270-MHz+proton+magnetic+resonance&doi=10.1021%2Fja00450a058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja00450a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00450a058%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DKalman%26aufirst%3DJ.%2BR.%26atitle%3DStructural%2520and%2520mode%2520of%2520action%2520studies%2520on%2520the%2520antibiotic%2520vancomycin.%2520Evidence%2520from%2520270-MHz%2520proton%2520magnetic%2520resonance%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1977%26volume%3D99%26spage%3D2768%26epage%3D2774%26doi%3D10.1021%2Fja00450a058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Novel inhibitors of staphyloxanthin virulence factor in comparison with linezolid and vancomycin versus methicilin-resistant, linezolid-resistant, and vancomycin-intermediate staphylococcus aureus infections in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">8145</span><span class="NLM_x">–</span> <span class="NLM_lpage">8159</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8145-8159&author=S.+Niauthor=H.+Weiauthor=B.+Liauthor=F.+Chenauthor=Y.+Liuauthor=W.+Chenauthor=Y.+Xuauthor=X.+Qiuauthor=X.+Liauthor=Y.+Luauthor=W.+Liuauthor=L.+Huauthor=D.+Linauthor=M.+Wangauthor=X.+Zhengauthor=F.+Maoauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+inhibitors+of+staphyloxanthin+virulence+factor+in+comparison+with+linezolid+and+vancomycin+versus+methicilin-resistant%2C+linezolid-resistant%2C+and+vancomycin-intermediate+staphylococcus+aureus+infections+in+vivo&doi=10.1021%2Facs.jmedchem.7b00949"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00949%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520inhibitors%2520of%2520staphyloxanthin%2520virulence%2520factor%2520in%2520comparison%2520with%2520linezolid%2520and%2520vancomycin%2520versus%2520methicilin-resistant%252C%2520linezolid-resistant%252C%2520and%2520vancomycin-intermediate%2520staphylococcus%2520aureus%2520infections%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8145%26epage%3D8159%26doi%3D10.1021%2Facs.jmedchem.7b00949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Duthie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, L. L.</span><span> </span><span class="NLM_article-title">Staphylococcal coagulase: mode of action and antigenicity</span> <span class="citation_source-journal">Microbiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1099/00221287-6-1-2-95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1099%2F00221287-6-1-2-95" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1952&pages=95-107&author=E.+Duthieauthor=L.+L.+Lorenz&title=Staphylococcal+coagulase%3A+mode+of+action+and+antigenicity&doi=10.1099%2F00221287-6-1-2-95"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1099%2F00221287-6-1-2-95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F00221287-6-1-2-95%26sid%3Dliteratum%253Aachs%26aulast%3DDuthie%26aufirst%3DE.%26aulast%3DLorenz%26aufirst%3DL.%2BL.%26atitle%3DStaphylococcal%2520coagulase%253A%2520mode%2520of%2520action%2520and%2520antigenicity%26jtitle%3DMicrobiology%26date%3D1952%26volume%3D6%26spage%3D95%26epage%3D107%26doi%3D10.1099%2F00221287-6-1-2-95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1038/nchembio.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fnchembio.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26780405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=174-179&author=F.+Chenauthor=H.+Diauthor=Y.+Wangauthor=Q.+Caoauthor=B.+Xuauthor=X.+Zhangauthor=N.+Yangauthor=G.+Liuauthor=C.-G.+Yangauthor=Y.+Xu&title=Small-molecule+targeting+of+a+diapophytoene+desaturase+inhibits+S.+aureus+virulence&doi=10.1038%2Fnchembio.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span></div><div class="casAuthors">Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-179</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance.  In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing.  Here we show that naftifine, a US Food and Drug Administration (FDA)-approved antifungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concns.  This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis.  We found that naftifine attenuated the virulence of a variety of clin. S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models.  Specifically, we detd. that naftifine is a lead compd. for potent CrtN inhibitors.  In sum, these findings reveal that naftifine could serve as a chem. probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3544UnQ977LVg90H21EOLACvtfcHk0lhdS_S4iaH0-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D&md5=77be3d6b1b252ea24f011b711f348130</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.-G.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DSmall-molecule%2520targeting%2520of%2520a%2520diapophytoene%2520desaturase%2520inhibits%2520S.%2520aureus%2520virulence%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D174%26epage%3D179%26doi%3D10.1038%2Fnchembio.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuzawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span> </span><span class="NLM_article-title">Whole genome sequencing of methicillin-resistant Staphylococcus aureus</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1225-1240&author=M.+Kurodaauthor=T.+Ohtaauthor=I.+Uchiyamaauthor=T.+Babaauthor=H.+Yuzawaauthor=I.+Kobayashiauthor=L.+Cuiauthor=A.+Oguchiauthor=K.-i.+Aokiauthor=Y.+Nagai&title=Whole+genome+sequencing+of+methicillin-resistant+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DI.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DYuzawa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DI.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DOguchi%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DK.-i.%26aulast%3DNagai%26aufirst%3DY.%26atitle%3DWhole%2520genome%2520sequencing%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1225%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span> </span><span class="NLM_article-title">vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4643</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span><span class="refDoi"> DOI: 10.1128/AAC.01710-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1128%2FAAC.01710-09" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4643-4647&author=X.+Xuauthor=D.+Linauthor=G.+Yanauthor=X.+Yeauthor=S.+Wuauthor=Y.+Guoauthor=D.+Zhuauthor=F.+Huauthor=Y.+Zhangauthor=F.+Wang&title=vanM%2C+a+new+glycopeptide+resistance+gene+cluster+found+in+Enterococcus+faecium&doi=10.1128%2FAAC.01710-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FAAC.01710-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01710-09%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DvanM%252C%2520a%2520new%2520glycopeptide%2520resistance%2520gene%2520cluster%2520found%2520in%2520Enterococcus%2520faecium%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4643%26epage%3D4647%26doi%3D10.1128%2FAAC.01710-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wardenburg, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span> </span><span class="NLM_article-title">Vaccine protection against Staphylococcus aureus pneumonia</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1084/jem.20072208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1084%2Fjem.20072208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2008&pages=287-294&author=J.+B.+Wardenburgauthor=O.+Schneewind&title=Vaccine+protection+against+Staphylococcus+aureus+pneumonia&doi=10.1084%2Fjem.20072208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1084%2Fjem.20072208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20072208%26sid%3Dliteratum%253Aachs%26aulast%3DWardenburg%26aufirst%3DJ.%2BB.%26aulast%3DSchneewind%26aufirst%3DO.%26atitle%3DVaccine%2520protection%2520against%2520Staphylococcus%2520aureus%2520pneumonia%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2008%26volume%3D205%26spage%3D287%26epage%3D294%26doi%3D10.1084%2Fjem.20072208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Perkins, H.</span><span> </span><span class="NLM_article-title">Specificity of combination between mucopeptide precursors and vancomycin or ristocetin</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1042/bj1110195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1042%2Fbj1110195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=5763787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaF1MXls1anug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1969&pages=195-205&author=H.+Perkins&title=Specificity+of+combination+between+mucopeptide+precursors+and+vancomycin+or+ristocetin&doi=10.1042%2Fbj1110195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of combination between mucopeptide precursors and Vancomycin or ristocetin</span></div><div class="casAuthors">Perkins, Harold R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-205</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Vancomycin and ristocetin formed complexes on being mixed with mucopeptide precursors from various bacteria, as shown by chromatog., electrophoresis, and differential uv spectra.  Equimolar proportions of antibiotic and peptide were present.  The specificity of the reaction was studied and the smallest mol. found to react with acetyl-D-alanyl-D-alanine.  This C-terminal dipeptide sequence must be present for complex formation; change of configuration or esterification prevented it.  Modified vancomycins that retained antibiotic activity also combined with appropriate peptides.  The dissocn. consts. of the more stable complexes were estd. from the differential-absorption results.  The relation of complex formation to antibiotic action was discussed.  Penicillin, supposed to be an analog of acetyl-D-alanyl-D-alanine, also modified the spectrum of vancomycin; so, too, did Na benzylpenicilloate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeA5bQWXPS7Vg90H21EOLACvtfcHk0lhdS_S4iaH0-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXls1anug%253D%253D&md5=02c4bc1f850196e20f1acebe06dbb56a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1042%2Fbj1110195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1110195%26sid%3Dliteratum%253Aachs%26aulast%3DPerkins%26aufirst%3DH.%26atitle%3DSpecificity%2520of%2520combination%2520between%2520mucopeptide%2520precursors%2520and%2520vancomycin%2520or%2520ristocetin%26jtitle%3DBiochem.%2520J.%26date%3D1969%26volume%3D111%26spage%3D195%26epage%3D205%26doi%3D10.1042%2Fbj1110195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hash, J. H.</span><span> </span><span class="NLM_article-title">Antibiotic mechanisms</span> <span class="citation_source-journal">Annu. Rev. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1146/annurev.pa.12.040172.000343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1146%2Fannurev.pa.12.040172.000343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1972&pages=35-56&author=J.+H.+Hash&title=Antibiotic+mechanisms&doi=10.1146%2Fannurev.pa.12.040172.000343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pa.12.040172.000343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pa.12.040172.000343%26sid%3Dliteratum%253Aachs%26aulast%3DHash%26aufirst%3DJ.%2BH.%26atitle%3DAntibiotic%2520mechanisms%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%26date%3D1972%26volume%3D12%26spage%3D35%26epage%3D56%26doi%3D10.1146%2Fannurev.pa.12.040172.000343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Nitanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanamaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span> </span><span class="NLM_article-title">Crystal structures of the complexes between vancomycin and cell-wall precursor analogs</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">1422</span><span class="NLM_x">–</span> <span class="NLM_lpage">1432</span><span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1016%2Fj.jmb.2008.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=18976660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=1422-1432&author=Y.+Nitanaiauthor=T.+Kikuchiauthor=K.+Kakoiauthor=S.+Hanamakiauthor=I.+Fujisawaauthor=K.+Aoki&title=Crystal+structures+of+the+complexes+between+vancomycin+and+cell-wall+precursor+analogs&doi=10.1016%2Fj.jmb.2008.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs</span></div><div class="casAuthors">Nitanai, Yasushi; Kikuchi, Takanori; Kakoi, Kouji; Hanamaki, Shinji; Fujisawa, Ikuhide; Aoki, Katsuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1422-1432</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The crystal structures of three vancomycin complexes with two vancomycin-sensitive cell-wall precursor analogs (diacetyl-Lys-D-Ala-D-Ala and acetyl-D-Ala-D-Ala) and a vancomycin-resistant cell-wall precursor analog (diacetyl-Lys-D-Ala-D-lactate) were detd. at at. resolns. of 1.80 Å, 1.07 Å, and 0.93 Å, resp.  These structures not only reconfirm the "back-to-back" dimerization of vancomycin monomers and the ligand-binding scheme proposed by previous expts. but also show important structural features of strategies for the generation of new glycopeptide antibiotics.  These structural features involve a water-mediated antibiotic-ligand interaction and supramol. structures such as "side-by-side" arranged dimer-to-dimer structures, in addn. to ligand-mediated and "face-to-face" arranged dimer-to-dimer structures.  In the diacetyl-Lys-D-Ala-D-lactate complex, the interat. O···O distance between the carbonyl oxygen of the fourth residue of the antibiotic backbone and the ester oxygen of the D-lactate moiety of the ligand is clearly longer than the corresponding N-H···O hydrogen-bonding distance obsd. in the two other complexes due to electrostatic repulsion.  In addn., two neighboring hydrogen bonds are concomitantly lengthened.  These observations provide, at least in part, a mol. basis for the reduced antibacterial activity of vancomycin toward vancomycin-resistant bacteria with cell-wall precursors terminating in -D-Ala-D-lactate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFyNh5WabH1rVg90H21EOLACvtfcHk0ljdrtXz9mm3Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D&md5=bb8666ff0899c33055430364c559905a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DNitanai%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DKakoi%26aufirst%3DK.%26aulast%3DHanamaki%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DK.%26atitle%3DCrystal%2520structures%2520of%2520the%2520complexes%2520between%2520vancomycin%2520and%2520cell-wall%2520precursor%2520analogs%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D1422%26epage%3D1432%26doi%3D10.1016%2Fj.jmb.2008.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N-and C-terminus substituent effects of the aglycon substrate</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3572</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span><span class="refDoi"> DOI: 10.1021/ol501568t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol501568t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3572-3575&author=A.+Nakayamaauthor=A.+Okanoauthor=Y.+Fengauthor=J.+C.+Collinsauthor=K.+C.+Collinsauthor=C.+T.+Walshauthor=D.+L.+Boger&title=Enzymatic+glycosylation+of+vancomycin+aglycon%3A+completion+of+a+total+synthesis+of+vancomycin+and+N-and+C-terminus+substituent+effects+of+the+aglycon+substrate&doi=10.1021%2Fol501568t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic Glycosylation of Vancomycin Aglycon: Completion of a Total Synthesis of Vancomycin and N- and C-Terminus Substituent Effects of the Aglycon Substrate</span></div><div class="casAuthors">Nakayama, Atsushi; Okano, Akinori; Feng, Yiqing; Collins, James C.; Collins, Karen C.; Walsh, Christopher T.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3572-3575</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Studies on the further development of the sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and the observation of unusual, perhaps unexpected, aglycon substrate substituent effects on the rate and efficiency of the initial glycosylation reaction are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgw_oFOesV7Vg90H21EOLACvtfcHk0ljdrtXz9mm3Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentL%252FF&md5=78079c4fabe751b8ec43a719545c9229</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fol501568t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol501568t%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DCollins%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DK.%2BC.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DEnzymatic%2520glycosylation%2520of%2520vancomycin%2520aglycon%253A%2520completion%2520of%2520a%2520total%2520synthesis%2520of%2520vancomycin%2520and%2520N-and%2520C-terminus%2520substituent%2520effects%2520of%2520the%2520aglycon%2520substrate%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D3572%26epage%3D3575%26doi%3D10.1021%2Fol501568t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castle, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseleur, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Q.</span><span> </span><span class="NLM_article-title">Total synthesis of the vancomycin aglycon</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">10004</span><span class="NLM_x">–</span> <span class="NLM_lpage">10011</span><span class="refDoi"> DOI: 10.1021/ja992577q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja992577q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXms1ejsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=10004-10011&author=D.+L.+Bogerauthor=S.+Miyazakiauthor=S.+H.+Kimauthor=J.+H.+Wuauthor=S.+L.+Castleauthor=O.+Loiseleurauthor=Q.+Jin&title=Total+synthesis+of+the+vancomycin+aglycon&doi=10.1021%2Fja992577q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of the Vancomycin Aglycon</span></div><div class="casAuthors">Boger, Dale L.; Miyazaki, Susumu; Kim, Seong Heon; Wu, Jason H.; Castle, Steven L.; Loiseleur, Olivier; Jin, Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10004-10011</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Full details of a diastereoselective total synthesis of the vancomycin aglycon are described.  Two key arom. nucleophilic substitution macrocyclizations with formation of the 16-membered diaryl ethers were enlisted for sequential CD and DE ring formations, an effective macrolactamization was developed for closure of the 12-membered biaryl AB ring system, and the defined order of CD, AB, and DE ring closures permitted selective thermal atropisomerism of the newly formed ring systems or their immediate precursors.  This indirect control of the atropisomer stereochem. allowed all synthetic material to be funneled into the one of eight atropdiastereomers characterizing the natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouXVlO_mY9LrVg90H21EOLACvtfcHk0ljdrtXz9mm3Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXms1ejsbY%253D&md5=2fea24bc82eab355f5a0fef63bd8ef76</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja992577q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja992577q%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DWu%26aufirst%3DJ.%2BH.%26aulast%3DCastle%26aufirst%3DS.%2BL.%26aulast%3DLoiseleur%26aufirst%3DO.%26aulast%3DJin%26aufirst%3DQ.%26atitle%3DTotal%2520synthesis%2520of%2520the%2520vancomycin%2520aglycon%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D10004%26epage%3D10011%26doi%3D10.1021%2Fja992577q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorson, J. S.</span><span> </span><span class="NLM_article-title">Antibiotic optimization via in vitro glycorandomization</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span><span class="refDoi"> DOI: 10.1038/nbt909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fnbt909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=14608364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1GltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=1467-1469&author=X.+Fuauthor=C.+Albermannauthor=J.+Jiangauthor=J.+Liaoauthor=C.+Zhangauthor=J.+S.+Thorson&title=Antibiotic+optimization+via+in+vitro+glycorandomization&doi=10.1038%2Fnbt909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic optimization via in vitro glycorandomization</span></div><div class="casAuthors">Fu, Xun; Albermann, Christoph; Jiang, Jiqing; Liao, Jianchun; Zhang, Changsheng; Thorson, Jon S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1467-1469</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In nature, the attachment of sugars to small mols. is often used to mediate targeting, mechanism of action and/or pharmacol.  As an alternative to pathway engineering or total synthesis, we report a useful method, in vitro glycorandomization (IVG), to diversify the glycosylation patterns of complex natural products.  We have used flexible glycosyltransferases on nucleotide diphospho-sugar (NDP-sugar) libraries to generate glyco-randomized natural products and then applied chemoselective ligation to produce mono-glycosylated vancomycins that rival vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoudm6jphj2DrVg90H21EOLACvtfcHk0lj9SDjzwHs4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1GltLg%253D&md5=9f0bdf5299ecd81eeac723dd08be3415</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnbt909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt909%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DAlbermann%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DThorson%26aufirst%3DJ.%2BS.%26atitle%3DAntibiotic%2520optimization%2520via%2520in%2520vitro%2520glycorandomization%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26spage%3D1467%26epage%3D1469%26doi%3D10.1038%2Fnbt909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ritter, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mong, K. K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. H.</span><span> </span><span class="NLM_article-title">A Programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: a case study of vancomycin</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4660</span><span class="refDoi"> DOI: 10.1002/anie.200351534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2Fanie.200351534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=4657-4660&author=T.+K.+Ritterauthor=K.+K.+T.+Mongauthor=H.+Liuauthor=T.+Nakataniauthor=C.+H.+Wong&title=A+Programmable+one-pot+oligosaccharide+synthesis+for+diversifying+the+sugar+domains+of+natural+products%3A+a+case+study+of+vancomycin&doi=10.1002%2Fanie.200351534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: A case study of vancomycin</span></div><div class="casAuthors">Ritter, Thomas K.; Mong, Kwok-Kong T.; Liu, Haitian; Nakatani, Takuji; Wong, Chi-Huey</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">4657-4660</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The present communication establishes an efficient glycosylation technique for attaching oligosaccharides to a protected vancomycin aglycon.  The deprotected vancomycin oligosaccharide derivs. were tested for growth inhibition of the Van A strain, however, none of the compds. had antibacterial activity up to 100 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtCJWCgPNIY7Vg90H21EOLACvtfcHk0lj9SDjzwHs4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12ksr4%253D&md5=f808afc9fe07b957e4833a540a6a9e1b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351534%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DT.%2BK.%26aulast%3DMong%26aufirst%3DK.%2BK.%2BT.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DNakatani%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DA%2520Programmable%2520one-pot%2520oligosaccharide%2520synthesis%2520for%2520diversifying%2520the%2520sugar%2520domains%2520of%2520natural%2520products%253A%2520a%2520case%2520study%2520of%2520vancomycin%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D4657%26epage%3D4660%26doi%3D10.1002%2Fanie.200351534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Nicolaou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winssinger, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koumbis, A. E.</span><span> </span><span class="NLM_article-title">Total synthesis of vancomycin—Part 4: Attachment of the sugar moieties and completion of the synthesis</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2648</span><span class="NLM_x">–</span> <span class="NLM_lpage">2667</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3765(19990903)5:9<2648::AID-CHEM2648>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVKltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=2648-2667&author=K.+Nicolaouauthor=H.+J.+Mitchellauthor=N.+F.+Jainauthor=T.+Bandoauthor=R.+Hughesauthor=N.+Winssingerauthor=S.+Natarajanauthor=A.+E.+Koumbis&title=Total+synthesis+of+vancomycin%E2%80%94Part+4%3A+Attachment+of+the+sugar+moieties+and+completion+of+the+synthesis&doi=10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Total synthesis of vancomycin-part 4: attachment of the sugar moieties and completion of the synthesis</span></div><div class="casAuthors">Nicolaou, K. C.; Mitchell, Helen J.; Jain, Nareshkumar F.; Bando, Toshikazu; Hughes, Robert; Winssinger, Nicolas; Natarajan, Swaminathan; Koumbis, Alexandros E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2648-2667</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The total synthesis of vancomycin is described.  The successful plan for this synthesis involves sequential and stereoselective coupling of vancomycin aglycon acceptor I (TBS = Me3CSiMe2, Cbz = PhCH2O2C) and glycosyl donors, trichloroacetimidate II (Alloc = allyloxycarbonyl) and glycosyl fluoride III.  Acceptor I was synthesized from vancomycin aglycon, which was derived both by total synthesis and by semisynthesis from vancomycin itself.  The vancosamine deriv. III was obtained by total synthesis while the glycosyl deriv. II was prepd. from glucal.  A no. of glycosidation model studies, carried out in order to establish the final route to vancomycin, are also described and so are a no. of failed attempts to secure the target mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroJ_Pl47gGobVg90H21EOLACvtfcHk0lj9SDjzwHs4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVKltrc%253D&md5=9a72a07019ab4f85459799f79e8cfd39</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252819990903%25295%253A9%253C2648%253A%253AAID-CHEM2648%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%26aulast%3DMitchell%26aufirst%3DH.%2BJ.%26aulast%3DJain%26aufirst%3DN.%2BF.%26aulast%3DBando%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DWinssinger%26aufirst%3DN.%26aulast%3DNatarajan%26aufirst%3DS.%26aulast%3DKoumbis%26aufirst%3DA.%2BE.%26atitle%3DTotal%2520synthesis%2520of%2520vancomycin%25E2%2580%2594Part%25204%253A%2520Attachment%2520of%2520the%2520sugar%2520moieties%2520and%2520completion%2520of%2520the%2520synthesis%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D1999%26volume%3D5%26spage%3D2648%26epage%3D2667%26doi%3D10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Yoganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span> </span><span class="NLM_article-title">Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2367</span><span class="NLM_x">–</span> <span class="NLM_lpage">2377</span><span class="refDoi"> DOI: 10.1021/jm501872s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501872s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2367-2377&author=S.+Yoganathanauthor=S.+J.+Miller&title=Structure+diversification+of+vancomycin+through+peptide-catalyzed%2C+site-selective+lipidation%3A+a+catalysis-based+approach+to+combat+glycopeptide-resistant+pathogens&doi=10.1021%2Fjm501872s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens</span></div><div class="casAuthors">Yoganathan, Sabesan; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2367-2377</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of antibiotic-resistant infections highlights the need for novel antibiotic leads, perhaps with a broader spectrum of activity.  Herein, the authors disclose a semisynthetic, catalytic approach for structure diversification of vancomycin.  The authors have identified three unique peptide catalysts that exhibit site-selectivity for the lipidation of the aliph. hydroxyls on vancomycin, generating three new derivs.  Incorporation of lipid chains into the vancomycin scaffold provides promising improvement of its bioactivity against vancomycin-resistant enterococci (Van A and Van B phenotypes of VRE).  The MICs for the new derivs. against MRSA and VRE (Van B phenotype) range from 0.12 to 0.25 μg/mL.  The authors have also performed a structure-activity relationship (SAR) study to investigate the effect of lipid chain length at the newly accessible G4-OH derivatization site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBqmVrTjYNT7Vg90H21EOLACvtfcHk0ljgDrv1MfPN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D&md5=9aafed77399f231be3dbd0d9d878eafb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm501872s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501872s%26sid%3Dliteratum%253Aachs%26aulast%3DYoganathan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DStructure%2520diversification%2520of%2520vancomycin%2520through%2520peptide-catalyzed%252C%2520site-selective%2520lipidation%253A%2520a%2520catalysis-based%2520approach%2520to%2520combat%2520glycopeptide-resistant%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2367%26epage%3D2377%26doi%3D10.1021%2Fjm501872s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Skaar, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humayun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBord, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span> </span><span class="NLM_article-title">Iron-source preference of Staphylococcus aureus infections</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1626</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span><span class="refDoi"> DOI: 10.1126/science.1099930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1126%2Fscience.1099930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=15361626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlGrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1626-1628&author=E.+P.+Skaarauthor=M.+Humayunauthor=T.+Baeauthor=K.+L.+DeBordauthor=O.+Schneewind&title=Iron-source+preference+of+Staphylococcus+aureus+infections&doi=10.1126%2Fscience.1099930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-Source Preference of Staphylococcus aureus Infections</span></div><div class="casAuthors">Skaar, Eric P.; Humayun, Munir; Bae, Taeok; DeBord, Kristin L.; Schneewind, Olaf</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5690</span>),
    <span class="NLM_cas:pages">1626-1629</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Although bacteria use different iron compds. in vitro, the possibility that microbes distinguish between these iron sources during infection has hitherto not been examd.  We applied stable isotope labeling to detect source-specific iron by mass spectrometry and show that Staphylococcus aureus preferentially imports heme iron over transferrin iron.  By combining this approach with computational genome anal., we identified hts (heme transport system), a gene cluster that promotes preferred heme iron import by S. aureus.  Heme iron scavenging by means of hts is required for staphylococcal pathogenesis in animal hosts, indicating that heme iron is the preferred iron source during the initiation of infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb8l4raVy9v7Vg90H21EOLACvtfcHk0ljgDrv1MfPN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlGrsrs%253D&md5=39cfa45f85b78d39b0c0162e65d5ed79</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099930%26sid%3Dliteratum%253Aachs%26aulast%3DSkaar%26aufirst%3DE.%2BP.%26aulast%3DHumayun%26aufirst%3DM.%26aulast%3DBae%26aufirst%3DT.%26aulast%3DDeBord%26aufirst%3DK.%2BL.%26aulast%3DSchneewind%26aufirst%3DO.%26atitle%3DIron-source%2520preference%2520of%2520Staphylococcus%2520aureus%2520infections%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1626%26epage%3D1628%26doi%3D10.1126%2Fscience.1099930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Corbin, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dattilo, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerads, R.</span><span> </span><span class="NLM_article-title">Metal chelation and inhibition of bacterial growth in tissue abscesses</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span><span class="refDoi"> DOI: 10.1126/science.1152449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1126%2Fscience.1152449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=18276893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslOmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=962-965&author=B.+D.+Corbinauthor=E.+H.+Seeleyauthor=A.+Raabauthor=J.+Feldmannauthor=M.+R.+Millerauthor=V.+J.+Torresauthor=K.+L.+Andersonauthor=B.+M.+Dattiloauthor=P.+M.+Dunmanauthor=R.+Gerads&title=Metal+chelation+and+inhibition+of+bacterial+growth+in+tissue+abscesses&doi=10.1126%2Fscience.1152449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses</span></div><div class="casAuthors">Corbin, Brian D.; Seeley, Erin H.; Raab, Andrea; Feldmann, Joerg; Miller, Michael R.; Torres, Victor J.; Anderson, Kelsi L.; Dattilo, Brian M.; Dunman, Paul M.; Gerads, Russell; Caprioli, Richard M.; Nacken, Wolfgang; Chazin, Walter J.; Skaar, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5865</span>),
    <span class="NLM_cas:pages">962-965</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Bacterial infection often results in the formation of tissue abscesses, which represent the primary site of interaction between invading bacteria and the innate immune system.  The authors identify the host protein calprotectin as a neutrophil-dependent factor expressed inside Staphylococcus aureus abscesses.  Neutrophil-derived calprotectin inhibited S. aureus growth through chelation of nutrient Mn2+ and Zn2+: an activity that results in reprogramming of the bacterial transcriptome.  The abscesses of mice lacking calprotectin were enriched in metal, and staphylococcal proliferation was enhanced in these metal-rich abscesses.  These results demonstrate that calprotectin is a crit. factor in the innate immune response to infection and define metal chelation as a strategy for inhibiting microbial growth inside abscessed tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrho6DiscZvXrVg90H21EOLACvtfcHk0ljgDrv1MfPN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslOmt7g%253D&md5=8803ab1a0e6b6444d38945d02bd170db</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1126%2Fscience.1152449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1152449%26sid%3Dliteratum%253Aachs%26aulast%3DCorbin%26aufirst%3DB.%2BD.%26aulast%3DSeeley%26aufirst%3DE.%2BH.%26aulast%3DRaab%26aufirst%3DA.%26aulast%3DFeldmann%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BR.%26aulast%3DTorres%26aufirst%3DV.%2BJ.%26aulast%3DAnderson%26aufirst%3DK.%2BL.%26aulast%3DDattilo%26aufirst%3DB.%2BM.%26aulast%3DDunman%26aufirst%3DP.%2BM.%26aulast%3DGerads%26aufirst%3DR.%26atitle%3DMetal%2520chelation%2520and%2520inhibition%2520of%2520bacterial%2520growth%2520in%2520tissue%2520abscesses%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D962%26epage%3D965%26doi%3D10.1126%2Fscience.1152449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Thammavongsa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missiakas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span> </span><span class="NLM_article-title">Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span><span class="refDoi"> DOI: 10.1126/science.1242255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1126%2Fscience.1242255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=863-866&author=V.+Thammavongsaauthor=D.+M.+Missiakasauthor=O.+Schneewind&title=Staphylococcus+aureus+degrades+neutrophil+extracellular+traps+to+promote+immune+cell+death&doi=10.1126%2Fscience.1242255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1126%2Fscience.1242255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1242255%26sid%3Dliteratum%253Aachs%26aulast%3DThammavongsa%26aufirst%3DV.%26aulast%3DMissiakas%26aufirst%3DD.%2BM.%26aulast%3DSchneewind%26aufirst%3DO.%26atitle%3DStaphylococcus%2520aureus%2520degrades%2520neutrophil%2520extracellular%2520traps%2520to%2520promote%2520immune%2520cell%2520death%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D863%26epage%3D866%26doi%3D10.1126%2Fscience.1242255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Thomer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missiakas, D.</span><span> </span><span class="NLM_article-title">Pathogenesis of Staphylococcus aureus bloodstream infections</span> <span class="citation_source-journal">Annu. Rev. Pathol.: Mech. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1146/annurev-pathol-012615-044351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1146%2Fannurev-pathol-012615-044351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26925499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsVGls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=343-364&author=L.+Thomerauthor=O.+Schneewindauthor=D.+Missiakas&title=Pathogenesis+of+Staphylococcus+aureus+bloodstream+infections&doi=10.1146%2Fannurev-pathol-012615-044351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of Staphylococcus aureus Bloodstream Infections</span></div><div class="casAuthors">Thomer, Lena; Schneewind, Olaf; Missiakas, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">343-364</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Staphylococcus aureus, a Gram-pos. bacterium colonizing nares, skin, and the gastrointestinal tract, frequently invades the skin, soft tissues, and bloodstreams of humans.  Even with surgical and antibiotic therapy, bloodstream infections are assocd. with significant mortality.  The secretion of coagulases, proteins that assoc. with and activate the host hemostatic factor prothrombin, and the bacterial surface display of agglutinins, proteins that bind polymd. fibrin, are key virulence strategies for the pathogenesis of S. aureus bloodstream infections, which culminate in the establishment of abscess lesions.  Pathogen-controlled processes, involving a wide spectrum of secreted factors, are responsible for the recruitment and destruction of immune cells, transforming abscess lesions into purulent exudate, with which staphylococci disseminate to produce new infectious lesions or to infect new hosts.  Research on S. aureus bloodstream infections is a frontier for the characterization of protective vaccine antigens and the development of immune therapeutics aiming to prevent disease or improve outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGhH0dC352ErVg90H21EOLACvtfcHk0lg5g98HIwoMEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsVGls7Y%253D&md5=ad76dd0cd2eb55de0e8cc24cc1b0fd44</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-012615-044351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-012615-044351%26sid%3Dliteratum%253Aachs%26aulast%3DThomer%26aufirst%3DL.%26aulast%3DSchneewind%26aufirst%3DO.%26aulast%3DMissiakas%26aufirst%3DD.%26atitle%3DPathogenesis%2520of%2520Staphylococcus%2520aureus%2520bloodstream%2520infections%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2016%26volume%3D11%26spage%3D343%26epage%3D364%26doi%3D10.1146%2Fannurev-pathol-012615-044351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Fowler, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laemmerhold, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span> </span><span class="NLM_article-title">Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9755</span><span class="NLM_x">–</span> <span class="NLM_lpage">9761</span><span class="refDoi"> DOI: 10.1021/ja302692j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302692j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVertLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9755-9761&author=B.+S.+Fowlerauthor=K.+M.+Laemmerholdauthor=S.+J.+Miller&title=Catalytic+site-selective+thiocarbonylations+and+deoxygenations+of+vancomycin+reveal+hydroxyl-dependent+conformational+effects&doi=10.1021%2Fja302692j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Site-Selective Thiocarbonylation and Deoxygenation of Vancomycin Reveal Hydroxyl-Dependent Conformational Effects</span></div><div class="casAuthors">Fowler, Brandon S.; Laemmerhold, Kai M.; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9755-9761</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have examd. peptide-based catalysts for the site-selective thiocarbonylation of a protected form of vancomycin.  Several catalysts were identified that either enhanced or altered the inherent selectivity profile exhibited by the substrate.  Two catalysts, one identified through screening and another through rational design, were demonstrated to be effective on 0.50-g scale.  Deoxygenations led ultimately to two new deoxy-vancomycin derivs., and surprising conformational consequences of deoxygenation were revealed for one of the new compds.  These effects were mirrored in the biol. activities of the new analogs and support a structural role for certain hydroxyls in the native structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV5d_OHFytr7Vg90H21EOLACvtfcHk0lg5g98HIwoMEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVertLY%253D&md5=3512a3128c79aa4478738e8135da80ca</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja302692j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302692j%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DB.%2BS.%26aulast%3DLaemmerhold%26aufirst%3DK.%2BM.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DCatalytic%2520site-selective%2520thiocarbonylations%2520and%2520deoxygenations%2520of%2520vancomycin%2520reveal%2520hydroxyl-dependent%2520conformational%2520effects%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9755%26epage%3D9761%26doi%3D10.1021%2Fja302692j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sardzik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissenborn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitsch, S. L.</span><span> </span><span class="NLM_article-title">Preparation of aminoethyl glycosides for glycoconjugation</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.3762/bjoc.6.81</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.3762%2Fbjoc.6.81" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=20978609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC3cbisFWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=699-703&author=R.+Sardzikauthor=G.+T.+Nobleauthor=M.+J.+Weissenbornauthor=A.+Martinauthor=S.+J.+Webbauthor=S.+L.+Flitsch&title=Preparation+of+aminoethyl+glycosides+for+glycoconjugation&doi=10.3762%2Fbjoc.6.81"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of aminoethyl glycosides for glycoconjugation</span></div><div class="casAuthors">Sardzik Robert; Noble Gavin T; Weissenborn Martin J; Martin Andrew; Webb Simon J; Flitsch Sabine L</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein journal of organic chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The synthesis of a number of aminoethyl glycosides of cell-surface carbohydrates, which are important intermediates for glycoarray synthesis, is described.  A set of protocols was developed which provide these intermediates, in a short number of steps, from commercially available starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmChyM5fOTzt-cVm4E2RlLfW6udTcc2ebArGrJbEnpbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbisFWmsA%253D%253D&md5=e8187f6e705c8dbef6fa02d7440cf5ce</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.6.81&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.6.81%26sid%3Dliteratum%253Aachs%26aulast%3DSardzik%26aufirst%3DR.%26aulast%3DNoble%26aufirst%3DG.%2BT.%26aulast%3DWeissenborn%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DS.%2BJ.%26aulast%3DFlitsch%26aufirst%3DS.%2BL.%26atitle%3DPreparation%2520of%2520aminoethyl%2520glycosides%2520for%2520glycoconjugation%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2010%26volume%3D6%26spage%3D699%26epage%3D703%26doi%3D10.3762%2Fbjoc.6.81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wikler, M. A.</span> <span class="citation_source-book">Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement</span>. <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute (CLSI)</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1&author=M.+A.+Wikler&title=Performance+standards+for+antimicrobial+susceptibility+testing%3A+eighteenth+informational+supplement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWikler%26aufirst%3DM.%2BA.%26btitle%3DPerformance%2520standards%2520for%2520antimicrobial%2520susceptibility%2520testing%253A%2520eighteenth%2520informational%2520supplement%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%2520%2528CLSI%2529%26date%3D2008%26volume%3D28%26spage%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Ishiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, K.</span><span> </span><span class="NLM_article-title">A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability</span> <span class="citation_source-journal">Talanta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span><span class="refDoi"> DOI: 10.1016/S0039-9140(97)00017-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1016%2FS0039-9140%2897%2900017-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=18966866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK2sXktVWgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1997&pages=1299-1305&author=M.+Ishiyamaauthor=Y.+Miyazonoauthor=K.+Sasamotoauthor=Y.+Ohkuraauthor=K.+Ueno&title=A+highly+water-soluble+disulfonated+tetrazolium+salt+as+a+chromogenic+indicator+for+NADH+as+well+as+cell+viability&doi=10.1016%2FS0039-9140%2897%2900017-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability</span></div><div class="casAuthors">Ishiyama, Munetaka; Miyazono, Yoko; Sasamoto, Kazumi; Ohkura, Yosuke; Ueno, Keiyu</div><div class="citationInfo"><span class="NLM_cas:title">Talanta</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1299-1305</span>CODEN:
                <span class="NLM_cas:coden">TLNTA2</span>;
        ISSN:<span class="NLM_cas:issn">0039-9140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A highly water sol. disulfonated tetrazolium salt, 4-[3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt, was synthesized.  The compd. is reduced by NADH in good yields at neutral pHs in the presence of 1-methoxy PMS to produce the corresponding formazan dye that absorbs at 460 nm.  The formation is sol. to water at concn. higher than 0.1 M.  The tetrazolium salt thus proved to be useful as a sensitive chromogenic indicator for NADH.  It is also applicable to cell proliferation assays as a cell viability indicator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI2x91OFXFt7Vg90H21EOLACvtfcHk0lgH84xfSVN1wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktVWgsL0%253D&md5=2437761bdc9555b821a07b698240bf5c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0039-9140%2897%2900017-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-9140%252897%252900017-9%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DM.%26aulast%3DMiyazono%26aufirst%3DY.%26aulast%3DSasamoto%26aufirst%3DK.%26aulast%3DOhkura%26aufirst%3DY.%26aulast%3DUeno%26aufirst%3DK.%26atitle%3DA%2520highly%2520water-soluble%2520disulfonated%2520tetrazolium%2520salt%2520as%2520a%2520chromogenic%2520indicator%2520for%2520NADH%2520as%2520well%2520as%2520cell%2520viability%26jtitle%3DTalanta%26date%3D1997%26volume%3D44%26spage%3D1299%26epage%3D1305%26doi%3D10.1016%2FS0039-9140%2897%2900017-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Tominaga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohseto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span> </span><span class="NLM_article-title">A water-soluble tetrazolium salt useful for colorimetric cell viability assay</span> <span class="citation_source-journal">Anal. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1039/a809656b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1039%2Fa809656b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXotVynsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=47-50&author=H.+Tominagaauthor=M.+Ishiyamaauthor=F.+Ohsetoauthor=K.+Sasamotoauthor=T.+Hamamotoauthor=K.+Suzukiauthor=M.+Watanabe&title=A+water-soluble+tetrazolium+salt+useful+for+colorimetric+cell+viability+assay&doi=10.1039%2Fa809656b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A water-soluble tetrazolium salt useful for colorimetric cell viability assay</span></div><div class="casAuthors">Tominaga, Hideyuki; Ishiyama, Munetaka; Ohseto, Fumio; Sasamoto, Kazumi; Hamamoto, Tomoyuki; Suzuki, Keiji; Watanabe, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">ANCOFE</span>;
        ISSN:<span class="NLM_cas:issn">1359-7337</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The application of a tetrazolium salt, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium, monosodium salt (WST-8), to cell viability assays and in vitro drug sensitivity tests is described.  With a higher sensitivity as a chromogenic indicator for cell viability compared with conventional tetrazolium salts, WST-8 produced results of cell viability and IC50 values that were in good agreement, resp., with the MTT method and [3H]thymidine uptake method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLbzO9lH4ArVg90H21EOLACvtfcHk0lgH84xfSVN1wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVynsw%253D%253D&md5=6a9501b64f5f9678040f6a14f056c2c6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2Fa809656b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa809656b%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DH.%26aulast%3DIshiyama%26aufirst%3DM.%26aulast%3DOhseto%26aufirst%3DF.%26aulast%3DSasamoto%26aufirst%3DK.%26aulast%3DHamamoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DM.%26atitle%3DA%2520water-soluble%2520tetrazolium%2520salt%2520useful%2520for%2520colorimetric%2520cell%2520viability%2520assay%26jtitle%3DAnal.%2520Commun.%26date%3D1999%26volume%3D36%26spage%3D47%26epage%3D50%26doi%3D10.1039%2Fa809656b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Peng-Peng Niu, Peng-Yu Liu, Yue-Ning Meng, Fang Yu, <span class="NLM_string-name hlFld-ContribAuthor">Yu-Peng He</span>. </span><span class="cited-content_cbyCitation_article-title">MIA-Directed 2-Pyridione-Enabled Selective Ortho-C–H Arylation of Phenylalanine: A Mechanistic Study. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (3)
                                     , 3096-3106. <a href="https://doi.org/10.1021/acs.joc.0c02872" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02872%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMIA-Directed%252B2-Pyridione-Enabled%252BSelective%252BOrtho-C%2525E2%252580%252593H%252BArylation%252Bof%252BPhenylalanine%25253A%252BA%252BMechanistic%252BStudy%26aulast%3DNiu%26aufirst%3DPeng-Peng%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03122020%26date%3D14012021%26volume%3D86%26issue%3D3%26spage%3D3096%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhi-Chen Wu, <span class="NLM_string-name hlFld-ContribAuthor">Dale L. Boger</span>. </span><span class="cited-content_cbyCitation_article-title">Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2020,</strong> <em>53 </em>
                                    (11)
                                     , 2587-2599. <a href="https://doi.org/10.1021/acs.accounts.0c00569" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00569%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DMaxamycins%25253A%252BDurable%252BAntibiotics%252BDerived%252Bby%252BRational%252BRedesign%252Bof%252BVancomycin%26aulast%3DWu%26aufirst%3DZhi-Chen%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08092020%26date%3D02112020%26volume%3D53%26issue%3D11%26spage%3D2587%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhi-Chen Wu, Michael D. Cameron, <span class="NLM_string-name hlFld-ContribAuthor">Dale L. Boger</span>. </span><span class="cited-content_cbyCitation_article-title">Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (8)
                                     , 2169-2180. <a href="https://doi.org/10.1021/acsinfecdis.0c00258" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00258%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DVancomycin%252BC-Terminus%252BGuanidine%252BModifications%252Band%252BFurther%252BInsights%252Binto%252Ban%252BAdded%252BMechanism%252Bof%252BAction%252BImparted%252Bby%252Ba%252BPeripheral%252BStructural%252BModification%26aulast%3DWu%26aufirst%3DZhi-Chen%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D14072020%26date%3D29062020%26volume%3D6%26issue%3D8%26spage%3D2169%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ping Zeng, Chen Xu, Chenyu Liu, Jun Liu, Qipeng Cheng, Wei Gao, Xuemei Yang, Sheng Chen, Kin-Fai Chan, <span class="NLM_string-name hlFld-ContribAuthor">Kwok-Yin Wong</span>. </span><span class="cited-content_cbyCitation_article-title">De Novo Designed Hexadecapeptides Synergize Glycopeptide Antibiotics Vancomycin and Teicoplanin against Pathogenic Klebsiella pneumoniae via Disruption of Cell Permeability and Potential. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (3)
                                     , 1738-1752. <a href="https://doi.org/10.1021/acsabm.0c00044" title="DOI URL">https://doi.org/10.1021/acsabm.0c00044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.0c00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.0c00044%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DDe%252BNovo%252BDesigned%252BHexadecapeptides%252BSynergize%252BGlycopeptide%252BAntibiotics%252BVancomycin%252Band%252BTeicoplanin%252Bagainst%252BPathogenic%252BKlebsiella%252Bpneumoniae%252Bvia%252BDisruption%252Bof%252BCell%252BPermeability%252Band%252BPotential%26aulast%3DZeng%26aufirst%3DPing%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11012020%26date%3D14022020%26date%3D28022020%26date%3D14022020%26volume%3D3%26issue%3D3%26spage%3D1738%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Geetika Dhanda, Paramita Sarkar, Sandip Samaddar, <span class="NLM_string-name hlFld-ContribAuthor">Jayanta Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3184-3205. <a href="https://doi.org/10.1021/acs.jmedchem.8b01093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBattle%252Bagainst%252BVancomycin-Resistant%252BBacteria%25253A%252BRecent%252BDevelopments%252Bin%252BChemical%252BStrategies%26aulast%3DDhanda%26aufirst%3DGeetika%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D21112018%26date%3D07112018%26volume%3D62%26issue%3D7%26spage%3D3184%26epage%3D3205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chun-Man Huang, Syue-Yi Lyu, Kuan-Hung Lin, Chun-Liang Chen, Mei-Hua Chen, Hao-Wei Shih, Ning-Shian Hsu, I-Wen Lo, Yung-Lin Wang, Yi-Shan Li, Chang-Jer Wu, <span class="NLM_string-name hlFld-ContribAuthor">Tsung-Lin Li</span>. </span><span class="cited-content_cbyCitation_article-title">Teicoplanin Reprogrammed with the N-Acyl-Glucosamine Pharmacophore at the Penultimate Residue of Aglycone Acquires Broad-Spectrum Antimicrobial Activities Effectively Killing Gram-Positive and -Negative Pathogens. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (3)
                                     , 430-442. <a href="https://doi.org/10.1021/acsinfecdis.8b00317" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00317%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DTeicoplanin%252BReprogrammed%252Bwith%252Bthe%252BN-Acyl-Glucosamine%252BPharmacophore%252Bat%252Bthe%252BPenultimate%252BResidue%252Bof%252BAglycone%252BAcquires%252BBroad-Spectrum%252BAntimicrobial%252BActivities%252BEffectively%252BKilling%252BGram-Positive%252Band%252B-Negative%252BPathogens%26aulast%3DHuang%26aufirst%3DChun-Man%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D18112018%26date%3D11012019%26date%3D01012019%26volume%3D5%26issue%3D3%26spage%3D430%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mark A. T. Blaskovich, Karl A. Hansford, Mark S. Butler, ZhiGuang Jia, Alan E. Mark, <span class="NLM_string-name hlFld-ContribAuthor">Matthew A. Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">Developments in Glycopeptide Antibiotics. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2018,</strong> <em>4 </em>
                                    (5)
                                     , 715-735. <a href="https://doi.org/10.1021/acsinfecdis.7b00258" title="DOI URL">https://doi.org/10.1021/acsinfecdis.7b00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.7b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.7b00258%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDevelopments%252Bin%252BGlycopeptide%252BAntibiotics%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04122017%26date%3D19022018%26date%3D24012018%26volume%3D4%26issue%3D5%26spage%3D715%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Shi</span>, <span class="hlFld-ContribAuthor ">Feifei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiangman  Zou</span>, <span class="hlFld-ContribAuthor ">Shang  Jiao</span>, <span class="hlFld-ContribAuthor ">Siqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Hu</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Feng  Tang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>45 </em>, 128122. <a href="https://doi.org/10.1016/j.bmcl.2021.128122" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128122%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantibacterial%252Bevaluation%252Bof%252Bvancomycin-LPS%252Bbinding%252Bpeptide%252Bconjugates%26aulast%3DShi%26aufirst%3DWeiwei%26date%3D2021%26volume%3D45%26spage%3D128122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiangman  Zou</span>, <span class="hlFld-ContribAuthor ">Weiwei  Shi</span>, <span class="hlFld-ContribAuthor ">Chenhui  Ma</span>, <span class="hlFld-ContribAuthor ">Feifei  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Shang  Jiao</span>, <span class="hlFld-ContribAuthor ">Guoyu  Pan</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Feng  Tang</span>, <span class="hlFld-ContribAuthor ">Fan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A facile method for vancomycin C-terminus functionalization and derivatization through hydrazide. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 128027. <a href="https://doi.org/10.1016/j.bmcl.2021.128027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bfacile%252Bmethod%252Bfor%252Bvancomycin%252BC-terminus%252Bfunctionalization%252Band%252Bderivatization%252Bthrough%252Bhydrazide%26aulast%3DHu%26aufirst%3DYu%26date%3D2021%26volume%3D42%26spage%3D128027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Tao</span>, <span class="hlFld-ContribAuthor ">Ya-Nan  Li</span>, <span class="hlFld-ContribAuthor ">Wen-Jun  Tang</span>, <span class="hlFld-ContribAuthor ">Peng-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Yu</span>, <span class="hlFld-ContribAuthor ">Yu-Peng  He</span>. </span><span class="cited-content_cbyCitation_article-title">Di-ortho-C H arylation of phenylalanine: A bimetallic interaction between Pd(IV)-Ag(I). </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>74 </em>, 153158. <a href="https://doi.org/10.1016/j.tetlet.2021.153158" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153158%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDi-ortho-C%252BH%252Barylation%252Bof%252Bphenylalanine%25253A%252BA%252Bbimetallic%252Binteraction%252Bbetween%252BPd%252528IV%252529-Ag%252528I%252529%26aulast%3DTao%26aufirst%3DQian%26date%3D2021%26volume%3D74%26spage%3D153158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bethany  Mills</span>, <span class="hlFld-ContribAuthor ">Alicia  Megia-Fernandez</span>, <span class="hlFld-ContribAuthor ">Dominic  Norberg</span>, <span class="hlFld-ContribAuthor ">Sheelagh  Duncan</span>, <span class="hlFld-ContribAuthor ">Adam  Marshall</span>, <span class="hlFld-ContribAuthor ">Ahsan R.  Akram</span>, <span class="hlFld-ContribAuthor ">Thomas  Quinn</span>, <span class="hlFld-ContribAuthor ">Irene  Young</span>, <span class="hlFld-ContribAuthor ">Annya M.  Bruce</span>, <span class="hlFld-ContribAuthor ">Emma  Scholefield</span>, <span class="hlFld-ContribAuthor ">Gareth O. S.  Williams</span>, <span class="hlFld-ContribAuthor ">Nikola  Krstajić</span>, <span class="hlFld-ContribAuthor ">Tushar R.  Choudhary</span>, <span class="hlFld-ContribAuthor ">Helen E.  Parker</span>, <span class="hlFld-ContribAuthor ">Michael G.  Tanner</span>, <span class="hlFld-ContribAuthor ">Kerrianne  Harrington</span>, <span class="hlFld-ContribAuthor ">Harry A. C.  Wood</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Birks</span>, <span class="hlFld-ContribAuthor ">Jonathan C.  Knight</span>, <span class="hlFld-ContribAuthor ">Christopher  Haslett</span>, <span class="hlFld-ContribAuthor ">Kevin  Dhaliwal</span>, <span class="hlFld-ContribAuthor ">Mark  Bradley</span>, <span class="hlFld-ContribAuthor ">Muhammed  Ucuncu</span>, <span class="hlFld-ContribAuthor ">James M.  Stone</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular detection of Gram-positive bacteria in the human lung through an optical fiber–based endoscope. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>48 </em>
                                    (3)
                                     , 800-807. <a href="https://doi.org/10.1007/s00259-020-05021-4" title="DOI URL">https://doi.org/10.1007/s00259-020-05021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-05021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-05021-4%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DMolecular%252Bdetection%252Bof%252BGram-positive%252Bbacteria%252Bin%252Bthe%252Bhuman%252Blung%252Bthrough%252Ban%252Boptical%252Bfiber%2525E2%252580%252593based%252Bendoscope%26aulast%3DMills%26aufirst%3DBethany%26date%3D2021%26date%3D2020%26volume%3D48%26issue%3D3%26spage%3D800%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112686. <a href="https://doi.org/10.1016/j.ejmech.2020.112686" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112686%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C3-Triazole-containing%252Bhybrids%252Bwith%252Bpotential%252Bantibacterial%252Bactivity%252Bagainst%252Bmethicillin-resistant%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%26aulast%3DXu%26aufirst%3DZhi%26date%3D2020%26volume%3D206%26spage%3D112686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gwendolyn M.  Pais</span>, <span class="hlFld-ContribAuthor ">Jiajun  Liu</span>, <span class="hlFld-ContribAuthor ">Sanja  Zepcan</span>, <span class="hlFld-ContribAuthor ">Sean N.  Avedissian</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Rhodes</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Downes</span>, <span class="hlFld-ContribAuthor ">Ganesh S.  Moorthy</span>, <span class="hlFld-ContribAuthor ">Marc H.  Scheetz</span>. </span><span class="cited-content_cbyCitation_article-title">Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention. </span><span class="cited-content_cbyCitation_journal-name">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</span><span> <strong>2020,</strong> <em>40 </em>
                                    (5)
                                     , 438-454. <a href="https://doi.org/10.1002/phar.2388" title="DOI URL">https://doi.org/10.1002/phar.2388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/phar.2388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fphar.2388%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacotherapy%253A%2520The%2520Journal%2520of%2520Human%2520Pharmacology%2520and%2520Drug%2520Therapy%26atitle%3DVancomycin%2525E2%252580%252590Induced%252BKidney%252BInjury%25253A%252BAnimal%252BModels%252Bof%252BToxicodynamics%25252C%252BMechanisms%252Bof%252BInjury%25252C%252BHuman%252BTranslation%25252C%252Band%252BPotential%252BStrategies%252Bfor%252BPrevention%26aulast%3DPais%26aufirst%3DGwendolyn%2BM.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D5%26spage%3D438%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Quan</span>, <span class="hlFld-ContribAuthor ">Zuantao  Lin</span>, <span class="hlFld-ContribAuthor ">Yuebin  Lin</span>, <span class="hlFld-ContribAuthor ">Yanchun  Wei</span>, <span class="hlFld-ContribAuthor ">Liu  Lei</span>, <span class="hlFld-ContribAuthor ">Yaxi  Li</span>, <span class="hlFld-ContribAuthor ">Gongjun  Tan</span>, <span class="hlFld-ContribAuthor ">Min  Xiao</span>, <span class="hlFld-ContribAuthor ">Tianfu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glucose-modification of cisplatin to facilitate cellular uptake, mitigate toxicity to normal cells, and improve anti-cancer effect in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1203 </em>, 127361. <a href="https://doi.org/10.1016/j.molstruc.2019.127361" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.127361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.127361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.127361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DGlucose-modification%252Bof%252Bcisplatin%252Bto%252Bfacilitate%252Bcellular%252Buptake%25252C%252Bmitigate%252Btoxicity%252Bto%252Bnormal%252Bcells%25252C%252Band%252Bimprove%252Banti-cancer%252Beffect%252Bin%252Bcancer%252Bcells%26aulast%3DQuan%26aufirst%3DLi%26date%3D2020%26volume%3D1203%26spage%3D127361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anja  Greule</span>, <span class="hlFld-ContribAuthor ">Max J.  Cryle</span>. </span><span class="cited-content_cbyCitation_article-title">The Glycopeptide Antibiotics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 247-283. <a href="https://doi.org/10.1016/B978-0-12-409547-2.14691-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14691-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14691-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14691-8%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BGlycopeptide%252BAntibiotics%26aulast%3DGreule%26aufirst%3DAnja%26date%3D2020%26spage%3D247%26epage%3D283%26pub%3DElsevier%26atitle%3DComprehensive%252BNatural%252BProducts%252BIII%26date%3D2020%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Girija S.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Carbohydrate-based antibiotics: Opportunities and challenges. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 523-559. <a href="https://doi.org/10.1016/B978-0-12-816675-8.00013-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816675-8.00013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816675-8.00013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816675-8.00013-0%26sid%3Dliteratum%253Aachs%26atitle%3DCarbohydrate-based%252Bantibiotics%25253A%252BOpportunities%252Band%252Bchallenges%26aulast%3DSingh%26aufirst%3DGirija%2BS.%26date%3D2020%26spage%3D523%26epage%3D559%26pub%3DElsevier%26atitle%3DCarbohydrates%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2020%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Xiao</span>, <span class="hlFld-ContribAuthor ">Gang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Current scenario of tetrazole hybrids for antibacterial activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>184 </em>, 111744. <a href="https://doi.org/10.1016/j.ejmech.2019.111744" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111744%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Bscenario%252Bof%252Btetrazole%252Bhybrids%252Bfor%252Bantibacterial%252Bactivity%26aulast%3DGao%26aufirst%3DFeng%26date%3D2019%26volume%3D184%26spage%3D111744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongliang  Guan</span>, <span class="hlFld-ContribAuthor ">Feifei  Chen</span>, <span class="hlFld-ContribAuthor ">Yunguang  Qiu</span>, <span class="hlFld-ContribAuthor ">Bofeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Likun  Gong</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug‐Resistant Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (20)
                                     , 6750-6754. <a href="https://doi.org/10.1002/ange.201902210" title="DOI URL">https://doi.org/10.1002/ange.201902210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201902210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201902210%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSulfonium%25252C%252Ban%252BUnderestimated%252BMoiety%252Bfor%252BStructural%252BModification%25252C%252BAlters%252Bthe%252BAntibacterial%252BProfile%252Bof%252BVancomycin%252BAgainst%252BMultidrug%2525E2%252580%252590Resistant%252BBacteria%26aulast%3DGuan%26aufirst%3DDongliang%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D20%26spage%3D6750%26epage%3D6754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongliang  Guan</span>, <span class="hlFld-ContribAuthor ">Feifei  Chen</span>, <span class="hlFld-ContribAuthor ">Yunguang  Qiu</span>, <span class="hlFld-ContribAuthor ">Bofeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Likun  Gong</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug‐Resistant Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (20)
                                     , 6678-6682. <a href="https://doi.org/10.1002/anie.201902210" title="DOI URL">https://doi.org/10.1002/anie.201902210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201902210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201902210%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSulfonium%25252C%252Ban%252BUnderestimated%252BMoiety%252Bfor%252BStructural%252BModification%25252C%252BAlters%252Bthe%252BAntibacterial%252BProfile%252Bof%252BVancomycin%252BAgainst%252BMultidrug%2525E2%252580%252590Resistant%252BBacteria%26aulast%3DGuan%26aufirst%3DDongliang%26date%3D2019%26volume%3D58%26issue%3D20%26spage%3D6678%26epage%3D6682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 357-372. <a href="https://doi.org/10.1016/j.ejmech.2019.02.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252Breview%252Bon%252Bthe%252Banti-bacterial%252Bactivity%252Bof%252B1%25252C2%25252C3-triazole%252Bhybrids%26aulast%3DZhang%26aufirst%3DBo%26date%3D2019%26volume%3D168%26spage%3D357%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongliang  Guan</span>, <span class="hlFld-ContribAuthor ">Feifei  Chen</span>, <span class="hlFld-ContribAuthor ">Faridoon</span>, <span class="hlFld-ContribAuthor ">Junjie  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Pyrophosphate-Targeting Vancomycin Derivatives for Combating Vancomycin-Resistant
              Enterococci. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (16)
                                     , 1644-1657. <a href="https://doi.org/10.1002/cmdc.201800252" title="DOI URL">https://doi.org/10.1002/cmdc.201800252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800252%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPyrophosphate-Targeting%252BVancomycin%252BDerivatives%252Bfor%252BCombating%252BVancomycin-Resistant%252BEnterococci%26aulast%3DGuan%26aufirst%3DDongliang%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D16%26spage%3D1644%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigam M.  Mishra</span>, <span class="hlFld-ContribAuthor ">Izabela  Stolarzewicz</span>, <span class="hlFld-ContribAuthor ">David  Cannaerts</span>, <span class="hlFld-ContribAuthor ">Joris  Schuermans</span>, <span class="hlFld-ContribAuthor ">Rob  Lavigne</span>, <span class="hlFld-ContribAuthor ">Yannick  Looz</span>, <span class="hlFld-ContribAuthor ">Bart  Landuyt</span>, <span class="hlFld-ContribAuthor ">Liliane  Schoofs</span>, <span class="hlFld-ContribAuthor ">Dominique  Schols</span>, <span class="hlFld-ContribAuthor ">Jan  Paeshuyse</span>, <span class="hlFld-ContribAuthor ">Peter  Hickenbotham</span>, <span class="hlFld-ContribAuthor ">Martha  Clokie</span>, <span class="hlFld-ContribAuthor ">Walter  Luyten</span>, <span class="hlFld-ContribAuthor ">Erik V.  Van der Eycken</span>, <span class="hlFld-ContribAuthor ">Yves  Briers</span>. </span><span class="cited-content_cbyCitation_article-title">Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High in Vitro Therapeutic Index. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fmicb.2018.01175" title="DOI URL">https://doi.org/10.3389/fmicb.2018.01175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2018.01175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2018.01175%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DIterative%252BChemical%252BEngineering%252Bof%252BVancomycin%252BLeads%252Bto%252BNovel%252BVancomycin%252BAnalogs%252BWith%252Ba%252BHigh%252Bin%252BVitro%252BTherapeutic%252BIndex%26aulast%3DMishra%26aufirst%3DNigam%2BM.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of vancomycin and its lipo-analogues. Extra sugar moieties or hydrophilic groups are displayed in red color.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of New Vancomycin Derivatives <b>5</b>–<b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for synthesis of <b>3a</b>–<b>3n</b>, (a) <b>2a</b>–<b>n</b>, DIPEA, DMF, room temperature or 55 °C, 2–4 h; (b) NaCNBH<sub>3</sub>, TFA, MeOH, room temperature, 1 h (for <b>3a</b>, additional treatment of 20% piperidine in DMF for 20 min); for synthesis of <b>3o</b>–<b>3p</b>, (c) <b>2o</b>–<b>p</b>, DIPEA, DMF, 0 °C, 2 h; (ii) HCHO, <b>4a</b>–<b>k</b>, DIPEA, H<sub>2</sub>O:MeCN = 1:1, −10 °C, 12 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Saccharide Intermediates <b>4a</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NIS, TfOH, MS4A, dry DCM, 0 °C to room temperature, 12 h; (ii) MeOH, NaOMe, room temperature, 4 h; (iii) H<sub>2</sub>, Pd–C, MeOH, 2 h; (iv) BF<sub>3</sub>Et<sub>2</sub>O (for <b>51a</b>, <b>51b</b>) or SnCl<sub>4</sub> (for <b>51c</b>), dry MeCN, 0 °C to room temperature, 12 h; (v) CH<sub>3</sub>OH, reflux, 4 h; (vi) 2 N HCl, MeOH, room temperature, 2 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Vancomycin Analogues <b>54</b>–<b>56</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIPEA, HBTU, DMF, room temperature, 24 h; (ii) HCHO, <b>4a</b> or <b>4j</b>, DIPEA, H<sub>2</sub>O:MeCN = 1:1, −10 °C, 12 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NMR characterization and signal assignment of vancomycin analogues. (Panel A) <sup>1</sup>H NMR spectra of compounds <b>3m</b> (upper) and <b>46</b> (bottom); (Panel B) <sup>1</sup>H–<sup>13</sup>C HMBC spectra of compounds <b>3m</b> (left) and <b>46</b> (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Survival chart of USA300 LAC (MRSA)-infected mice after treatment with vancomycin derivatives in an in vivo lethal challenge assay. All compounds and positive controls were administrated with a single dose of 7 mg/kg via ip injection at the first day of infection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Liver CFU counts of Mu50 (VISA and MRSA)-infected mice after treatment with vancomycin derivatives in an in vivo abscess formation assay. All compounds and positive controls were administrated via ip injection twice at 7 mg/kg. Statistical significance determined by the Mann–Whitney test (two-tailed): *<i>p</i> < 0.05, **<i>p</i> < 0.01, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxicity assays of selected compounds. (Panel A) Cell viability test on HL-7702 cells (human liver cells); (Panel B) cell viability test on HK-2 cells (human renal proximal tubule epithelial cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/medium/jm-2017-01345s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Interaction of compound <b>46</b> with bacterial peptidoglycan precursor peptide ligand Ac<sub>2</sub>Lys-<i>d</i>Ala-<i>d</i>Ala via <sup>1</sup>H–<sup>13</sup>C HSQC NMR measurement. The spectral signals in red represent solo compound <b>46</b> and the signals in green represent the mixture of <b>46</b> and peptide ligand. The significantly changed signals of <b>46</b> after adding the peptide ligand were displayed in the selected spectral regions and assigned with their position information (x1, x2, x3, x5, V1, V5, Gal C<sub>2–5</sub>/H<sub>2–5</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01345/20180110/images/large/jm-2017-01345s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01345&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">McCormick, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittenger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittenger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span> </span><span class="NLM_article-title">Vancomycin, a new antibiotic. I. Chemical and biologic properties</span> <span class="citation_source-journal">Antibiot. Annu.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1954&pages=606-611&author=M.+H.+McCormickauthor=J.+McGuireauthor=G.+Pittengerauthor=R.+Pittengerauthor=W.+Stark&title=Vancomycin%2C+a+new+antibiotic.+I.+Chemical+and+biologic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormick%26aufirst%3DM.%2BH.%26aulast%3DMcGuire%26aufirst%3DJ.%26aulast%3DPittenger%26aufirst%3DG.%26aulast%3DPittenger%26aufirst%3DR.%26aulast%3DStark%26aufirst%3DW.%26atitle%3DVancomycin%252C%2520a%2520new%2520antibiotic.%2520I.%2520Chemical%2520and%2520biologic%2520properties%26jtitle%3DAntibiot.%2520Annu.%26date%3D1954%26volume%3D3%26spage%3D606%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, T. M.</span><span> </span><span class="NLM_article-title">Vancomycin: structure and transformation to CDP-I</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6915</span><span class="NLM_x">–</span> <span class="NLM_lpage">6922</span><span class="refDoi"> DOI: 10.1021/ja00361a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00361a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaL3sXlvFGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1983&pages=6915-6922&author=C.+M.+Harrisauthor=H.+Kopeckaauthor=T.+M.+Harris&title=Vancomycin%3A+structure+and+transformation+to+CDP-I&doi=10.1021%2Fja00361a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin:  structure and transformation to CDP-I</span></div><div class="casAuthors">Harris, Constance M.; Kopecka, Hana; Harris, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6915-22</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The rearrangement of vancomycin (I) to CDP-I proceeds through a pathway involving succinimide II as an intermediate.  II was isolated and characterized by its FT-IR and FAB-MS.  CDP-I is an equil. mixt. of III and IV, which are atropisomers involving different orientations of the Cl-substituted arom. ring.  Treatment of II at pH 8 gave an immediate appearance of the minor form of CDP-I, which slowly gave an equil. mixt. with the major form (III:IV ∼64:36).  III and IV can interconvert by simple reorientation of the arom. ring rather than via a transient cleavage product.  The cyclophane ring in which the Cl-substituted arom. residue 2 is embedded is enlarged by one CH2 unit in the conversion of I to CDP-I; rotation of ring 2 can occur in CDP-I, but not in I.  The addnl. CH2 unit in the N-terminal cyclophane ring of CDP-I causes the ring to lie in a conformation that is significantly different from that of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVg2fE0oCmw7Vg90H21EOLACvtfcHk0liI2N83Ven4fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlvFGnsr0%253D&md5=c9ff55a6261c2b76c537391ba4ac8a03</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fja00361a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00361a029%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DKopecka%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DT.%2BM.%26atitle%3DVancomycin%253A%2520structure%2520and%2520transformation%2520to%2520CDP-I%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1983%26volume%3D105%26spage%3D6915%26epage%3D6922%26doi%3D10.1021%2Fja00361a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Swartz, M. N.</span><span> </span><span class="NLM_article-title">Hospital-acquired infections: diseases with increasingly limited therapies</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">2420</span><span class="NLM_x">–</span> <span class="NLM_lpage">2427</span><span class="refDoi"> DOI: 10.1073/pnas.91.7.2420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1073%2Fpnas.91.7.2420" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=2420-2427&author=M.+N.+Swartz&title=Hospital-acquired+infections%3A+diseases+with+increasingly+limited+therapies&doi=10.1073%2Fpnas.91.7.2420"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.7.2420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.7.2420%26sid%3Dliteratum%253Aachs%26aulast%3DSwartz%26aufirst%3DM.%2BN.%26atitle%3DHospital-acquired%2520infections%253A%2520diseases%2520with%2520increasingly%2520limited%2520therapies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D2420%26epage%3D2427%26doi%3D10.1073%2Fpnas.91.7.2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Shallcross, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S. C.</span><span> </span><span class="NLM_article-title">Tackling the threat of antimicrobial resistance: from policy to sustainable action</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">20140082</span><span class="refDoi"> DOI: 10.1098/rstb.2014.0082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1098%2Frstb.2014.0082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=25918440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC2MbmtV2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2015&pages=20140082&author=L.+J.+Shallcrossauthor=S.+J.+Howardauthor=T.+Fowlerauthor=S.+C.+Davies&title=Tackling+the+threat+of+antimicrobial+resistance%3A+from+policy+to+sustainable+action&doi=10.1098%2Frstb.2014.0082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling the threat of antimicrobial resistance: from policy to sustainable action</span></div><div class="casAuthors">Shallcross Laura J; Howard Simon J; Fowler Tom; Davies Sally C</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">1670</span>),
    <span class="NLM_cas:pages">20140082</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Antibiotics underpin all of modern medicine, from routine major surgery through to caesarean sections and modern cancer therapies.  These drugs have revolutionized how we practice medicine, but we are in a constant evolutionary battle to evade microbial resistance and this has become a major global public health problem.  We have overused and misused these essential medicines both in the human and animal health sectors and this threatens the effectiveness of antimicrobials for future generations.  We can only address the threat of antimicrobial resistance (AMR) through international collaboration across human and animal health sectors integrating social, economic and behavioural factors.  Our global organizations are rising to the challenge with the recent World Health Assembly resolution on AMR and development of the Global Action plan but we must act now to avoid a return to a pre-antibiotic era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOKlg0cqm-HZw7prLlxLOzfW6udTcc2eaoPE99Xmjgarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbmtV2nsQ%253D%253D&md5=519d5a93a17771b05deb2d288cb6ba22</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1098%2Frstb.2014.0082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2014.0082%26sid%3Dliteratum%253Aachs%26aulast%3DShallcross%26aufirst%3DL.%2BJ.%26aulast%3DHoward%26aufirst%3DS.%2BJ.%26aulast%3DFowler%26aufirst%3DT.%26aulast%3DDavies%26aufirst%3DS.%2BC.%26atitle%3DTackling%2520the%2520threat%2520of%2520antimicrobial%2520resistance%253A%2520from%2520policy%2520to%2520sustainable%2520action%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2015%26volume%3D370%26spage%3D20140082%26doi%3D10.1098%2Frstb.2014.0082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Goff, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilchrist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathwani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escandón-Vargas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, A.</span><span> </span><span class="NLM_article-title">A global call from five countries to collaborate in antibiotic stewardship: United we succeed, divided we might fail</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56</span><span class="NLM_x">–</span> <span class="NLM_lpage">e63</span><span class="refDoi"> DOI: 10.1016/S1473-3099(16)30386-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1016%2FS1473-3099%2816%2930386-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=27866945" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=e56-e63&author=D.+A.+Goffauthor=R.+Kullarauthor=E.+J.+Goldsteinauthor=M.+Gilchristauthor=D.+Nathwaniauthor=A.+C.+Chengauthor=K.+A.+Cairnsauthor=K.+Escand%C3%B3n-Vargasauthor=M.+V.+Villegasauthor=A.+Brink&title=A+global+call+from+five+countries+to+collaborate+in+antibiotic+stewardship%3A+United+we+succeed%2C+divided+we+might+fail&doi=10.1016%2FS1473-3099%2816%2930386-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2930386-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252930386-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DKullar%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DE.%2BJ.%26aulast%3DGilchrist%26aufirst%3DM.%26aulast%3DNathwani%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCairns%26aufirst%3DK.%2BA.%26aulast%3DEscand%25C3%25B3n-Vargas%26aufirst%3DK.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DBrink%26aufirst%3DA.%26atitle%3DA%2520global%2520call%2520from%2520five%2520countries%2520to%2520collaborate%2520in%2520antibiotic%2520stewardship%253A%2520United%2520we%2520succeed%252C%2520divided%2520we%2520might%2520fail%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26spage%3De56%26epage%3De63%26doi%3D10.1016%2FS1473-3099%2816%2930386-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Leclercq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derlot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duval, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courvalin, P.</span><span> </span><span class="NLM_article-title">Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1056/NEJM198807213190307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1056%2FNEJM198807213190307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=2968517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADyaL1c3mtFCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1988&pages=157-161&author=R.+Leclercqauthor=E.+Derlotauthor=J.+Duvalauthor=P.+Courvalin&title=Plasmid-mediated+resistance+to+vancomycin+and+teicoplanin+in+Enterococcus+faecium&doi=10.1056%2FNEJM198807213190307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium</span></div><div class="casAuthors">Leclercq R; Derlot E; Duval J; Courvalin P</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-61</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpsC6iB5sB4dXdcedVHT5tfW6udTcc2eakT-IjB2LRArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3mtFCmug%253D%253D&md5=8d80510086bb90e9fc13479cd08f4660</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJM198807213190307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198807213190307%26sid%3Dliteratum%253Aachs%26aulast%3DLeclercq%26aufirst%3DR.%26aulast%3DDerlot%26aufirst%3DE.%26aulast%3DDuval%26aufirst%3DJ.%26aulast%3DCourvalin%26aufirst%3DP.%26atitle%3DPlasmid-mediated%2520resistance%2520to%2520vancomycin%2520and%2520teicoplanin%2520in%2520Enterococcus%2520faecium%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1988%26volume%3D319%26spage%3D157%26epage%3D161%26doi%3D10.1056%2FNEJM198807213190307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Control, C. f. D.</span><span> </span><span class="NLM_article-title">Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996</span> <span class="citation_source-journal">MMWR. Morbidity and mortality weekly report</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1997&pages=493-501&author=C.+f.+D.+Control&title=Prevention.+Reduced+susceptibility+of+Staphylococcus+aureus+to+vancomycin%2D%2DJapan%2C+1996"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DControl%26aufirst%3DC.%2Bf.%2BD.%26atitle%3DPrevention.%2520Reduced%2520susceptibility%2520of%2520Staphylococcus%2520aureus%2520to%2520vancomycin--Japan%252C%25201996%26jtitle%3DMMWR.%2520Morbidity%2520and%2520mortality%2520weekly%2520report%26date%3D1997%26volume%3D340%26spage%3D493%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Smith, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson-Dunn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenover, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, W. R.</span><span> </span><span class="NLM_article-title">Emergence of vancomycin resistance in Staphylococcus aureus</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1056/NEJM199902183400701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1056%2FNEJM199902183400701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10021469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXhsV2mtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=493-501&author=T.+L.+Smithauthor=M.+L.+Pearsonauthor=K.+R.+Wilcoxauthor=C.+Cruzauthor=M.+V.+Lancasterauthor=B.+Robinson-Dunnauthor=F.+C.+Tenoverauthor=M.+J.+Zervosauthor=J.+D.+Bandauthor=E.+Whiteauthor=W.+R.+Jarvis&title=Emergence+of+vancomycin+resistance+in+Staphylococcus+aureus&doi=10.1056%2FNEJM199902183400701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of vancomycin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Smith, Theresa L.; Pearson, Michele L.; Wilcox, Kenneth R.; Cruz, Cosme; Lancaster, Michael V.; Robinson-Dunn, Barbara; Tenover, Fred C.; Zervos, Marcus J.; Band, Jeffrey D.; White, Elizabeth; Jarvis, William R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-501</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Since the emergence of methicillin-resistant Staphylococcus aureus, the glycopeptide vancomycin has been the only uniformly effective treatment for staphylococcal infections.  In 1997, two infections due to S. aureus with reduced susceptibility to vancomycin were identified in the United States.  We investigated the two patients with infections due to S. aureus with intermediate resistance to glycopeptides, as defined by a minimal inhibitory concn. of vancomycin of 8 to 16 μg per mL.  To assess the carriage and transmission of these strains of S. aureus, we cultured samples from the patients and their contacts and evaluated the isolates.  The first patient was a 59-yr-old man in Michigan with diabetes mellitus and chronic renal failure.  Peritonitis due to S. aureus with intermediate resistance to glycopeptides developed after 18 wk of vancomycin treatment for recurrent methicillin-resistant S. aureus peritonitis assocd. with dialysis.  The removal of the peritoneal catheter plus treatment with rifampin and trimethoprim-sulfamethoxazole eradicated the infection.  The second patient was a 66-yr-old man with diabetes in New Jersey.  A bloodstream infection due to S. aureus with intermediate resistance to glycopeptides developed after 18 wk of vancomycin treatment for recurrent methicillin-resistant S. aureus bacteremia.  This infection was eradicated with vancomycin, gentamicin, and rifampin.  Both patients died.  The glycopeptide-intermediate S. aureus isolates differed by two bands on pulse-field gel electrophoresis.  On electron microscopy, the isolates from the infected patients had thicker extracellular matrixes than control methicillin-resistant S. aureus isolates.  No carriage was documented among 177 contacts of the two patients.  The emergence of S. aureus with intermediate resistance to glycopeptides emphasizes the importance of the prudent use of antibiotics, the lab. capacity to identify resistant strains, and the use of infection-control precautions to prevent transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUpvGDq63H7Vg90H21EOLACvtfcHk0lhPfyr3qnCIpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsV2mtLo%253D&md5=b07b824bb3e5f0463923103cb489561c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJM199902183400701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199902183400701%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DT.%2BL.%26aulast%3DPearson%26aufirst%3DM.%2BL.%26aulast%3DWilcox%26aufirst%3DK.%2BR.%26aulast%3DCruz%26aufirst%3DC.%26aulast%3DLancaster%26aufirst%3DM.%2BV.%26aulast%3DRobinson-Dunn%26aufirst%3DB.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26aulast%3DBand%26aufirst%3DJ.%2BD.%26aulast%3DWhite%26aufirst%3DE.%26aulast%3DJarvis%26aufirst%3DW.%2BR.%26atitle%3DEmergence%2520of%2520vancomycin%2520resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D340%26spage%3D493%26epage%3D501%26doi%3D10.1056%2FNEJM199902183400701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rotun, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonmaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maupin, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenover, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackman, D. M.</span><span> </span><span class="NLM_article-title">Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.3201/eid0501.990118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.3201%2Feid0501.990118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10081683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVSjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=147-149&author=S.+S.+Rotunauthor=V.+McMathauthor=D.+J.+Schoonmakerauthor=P.+S.+Maupinauthor=F.+C.+Tenoverauthor=B.+C.+Hillauthor=D.+M.+Ackman&title=Staphylococcus+aureus+with+reduced+susceptibility+to+vancomycin+isolated+from+a+patient+with+fatal+bacteremia&doi=10.3201%2Feid0501.990118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia</span></div><div class="casAuthors">Rotun, Sharon S.; McMath, Virginia; Schoonmaker, Dianna J.; Maupin, Peggy S.; Tenover, Fred C.; Hill, Bertha C.; Ackman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Infectious Diseases</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-149</span>CODEN:
                <span class="NLM_cas:coden">EIDIFA</span>;
        ISSN:<span class="NLM_cas:issn">1080-6040</span>.
    
            (<span class="NLM_cas:orgname">National Center for Infectious Diseases, Centers for Disease Control and Prevention</span>)
        </div><div class="casAbstract">A Staphylococcus aureus isolate with reduced susceptibility to vancomycin was obtained from a dialysis patient with a fatal case of bacteremia.  Comparison of the isolate with two methicillin-resistant S. aureus (MRSA) isolates obtained from the same patient 4 mo earlier suggests that the S. aureus with reduced susceptibility to vancomycin emerged from the MRSA strain with which the patient was infected.  Atypical phenotypic characteristics, including weak or neg. latex-agglutination test results, weak or neg.-slide coagulase test results, heterogeneous morphol. features, slow rate of growth, and vancomycin susceptibility (by disk diffusion test) were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSj4r3d2xXwrVg90H21EOLACvtfcHk0lhPfyr3qnCIpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVSjtrk%253D&md5=202a7b715fa0b0978ed572e8d8cd0bf2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3201%2Feid0501.990118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid0501.990118%26sid%3Dliteratum%253Aachs%26aulast%3DRotun%26aufirst%3DS.%2BS.%26aulast%3DMcMath%26aufirst%3DV.%26aulast%3DSchoonmaker%26aufirst%3DD.%2BJ.%26aulast%3DMaupin%26aufirst%3DP.%2BS.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DHill%26aufirst%3DB.%2BC.%26aulast%3DAckman%26aufirst%3DD.%2BM.%26atitle%3DStaphylococcus%2520aureus%2520with%2520reduced%2520susceptibility%2520to%2520vancomycin%2520isolated%2520from%2520a%2520patient%2520with%2520fatal%2520bacteremia%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D1999%26volume%3D5%26spage%3D147%26epage%3D149%26doi%3D10.3201%2Feid0501.990118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Weinstein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, S. K.</span><span> </span><span class="NLM_article-title">Vancomycin-intermediate and-resistant Staphylococcus aureus: what the infectious disease specialist needs to know</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1086/317542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1086%2F317542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=11118389" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=108-115&author=R.+A.+Weinsteinauthor=S.+K.+Fridkin&title=Vancomycin-intermediate+and-resistant+Staphylococcus+aureus%3A+what+the+infectious+disease+specialist+needs+to+know&doi=10.1086%2F317542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1086%2F317542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F317542%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DR.%2BA.%26aulast%3DFridkin%26aufirst%3DS.%2BK.%26atitle%3DVancomycin-intermediate%2520and-resistant%2520Staphylococcus%2520aureus%253A%2520what%2520the%2520infectious%2520disease%2520specialist%2520needs%2520to%2520know%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2001%26volume%3D32%26spage%3D108%26epage%3D115%26doi%3D10.1086%2F317542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ward, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabsch, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayall, B. C.</span><span> </span><span class="NLM_article-title">Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin</span> <span class="citation_source-journal">Med. J. Aust.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=11758077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FjtleqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2001&pages=480-483&author=P.+B.+Wardauthor=E.+A.+Grabschauthor=B.+C.+Mayall&title=Treatment+failure+due+to+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29+with+reduced+susceptibility+to+vancomycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin</span></div><div class="casAuthors">Ward P B; Johnson P D; Grabsch E A; Mayall B C; Grayson M L</div><div class="citationInfo"><span class="NLM_cas:title">The Medical journal of Australia</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">480-3</span>
        ISSN:<span class="NLM_cas:issn">0025-729X</span>.
    </div><div class="casAbstract">We report the first instance in Australia of treatment failure due to a strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin--heteroresistant vancomycin-intermediate S. aureus (hVISA).  The infection occurred in a 41-year-old man with multiple risk factors.  No transmission of the organism to other patients or the environment was detected.  This case may herald the beginning of a new phase of staphylococcal resistance in Australia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwaNgPrGaImR0LsK7uFuY7fW6udTcc2eYp71bgvn19yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FjtleqtQ%253D%253D&md5=ff78aabb57a79ec0cdeeb7e84a47305b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BB.%26aulast%3DGrabsch%26aufirst%3DE.%2BA.%26aulast%3DMayall%26aufirst%3DB.%2BC.%26atitle%3DTreatment%2520failure%2520due%2520to%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520with%2520reduced%2520susceptibility%2520to%2520vancomycin%26jtitle%3DMed.%2520J.%2520Aust.%26date%3D2001%26volume%3D175%26spage%3D480%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hageman, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegues, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jepson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenover, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, S. K.</span><span> </span><span class="NLM_article-title">Vancomycin-intermediate Staphylococcus aureus in a home health-care patient</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span><span class="refDoi"> DOI: 10.3201/eid0706.010618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.3201%2Feid0706.010618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=11747733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BD3MnpvFWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1023-1025&author=J.+C.+Hagemanauthor=D.+A.+Peguesauthor=C.+Jepsonauthor=R.+L.+Bellauthor=M.+Guinanauthor=K.+W.+Wardauthor=M.+D.+Cohenauthor=J.+A.+Hindlerauthor=F.+C.+Tenoverauthor=S.+K.+McAllister&title=Vancomycin-intermediate+Staphylococcus+aureus+in+a+home+health-care+patient&doi=10.3201%2Feid0706.010618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin-intermediate Staphylococcus aureus in a home health-care patient</span></div><div class="casAuthors">Hageman J C; Pegues D A; Jepson C; Bell R L; Guinan M; Ward K W; Cohen M D; Hindler J A; Tenover F C; McAllister S K; Kellum M E; Fridkin S K</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1023-5</span>
        ISSN:<span class="NLM_cas:issn">1080-6040</span>.
    </div><div class="casAbstract">In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy.  Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types.  The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction.  Standard precautions in the home health setting appear successful in preventing transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_veJpIoI07MzK395ZObgVfW6udTcc2eab7WlX8KOLwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnpvFWjtA%253D%253D&md5=4e14d8c57070b115279b9d1ea7133664</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3201%2Feid0706.010618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid0706.010618%26sid%3Dliteratum%253Aachs%26aulast%3DHageman%26aufirst%3DJ.%2BC.%26aulast%3DPegues%26aufirst%3DD.%2BA.%26aulast%3DJepson%26aufirst%3DC.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DGuinan%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DCohen%26aufirst%3DM.%2BD.%26aulast%3DHindler%26aufirst%3DJ.%2BA.%26aulast%3DTenover%26aufirst%3DF.%2BC.%26aulast%3DMcAllister%26aufirst%3DS.%2BK.%26atitle%3DVancomycin-intermediate%2520Staphylococcus%2520aureus%2520in%2520a%2520home%2520health-care%2520patient%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2001%26volume%3D7%26spage%3D1023%26epage%3D1025%26doi%3D10.3201%2Feid0706.010618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zhanel, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenitsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé-Wiens, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlowsky, J. A.</span><span> </span><span class="NLM_article-title">New lipoglycopeptides</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span><span class="refDoi"> DOI: 10.2165/11534440-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.2165%2F11534440-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=20426497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=859-886&author=G.+G.+Zhanelauthor=D.+Calicauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=H.+Adamauthor=P.+R.+Lagac%C3%A9-Wiensauthor=E.+Rubinsteinauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+A.+Karlowsky&title=New+lipoglycopeptides&doi=10.2165%2F11534440-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin</span></div><div class="casAuthors">Zhanel, George G.; Calic, Divna; Schweizer, Frank; Zelenitsky, Sheryl; Adam, Heather; Lagace-Wiens, Philippe R. S.; Rubinstein, Ethan; Gin, Alfred S.; Hoban, Daryl J.; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">859-886</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by multi-drug-resistant Gram-pos. pathogens.  Each of these agents contains a heptapeptide core, common to all glycopeptides, which enables them to inhibit transglycosylation and transpeptidation (cell wall synthesis).  Modifications to the heptapeptide core result in different in vitro activities for the three semisynthetic lipoglycopeptides.  All three lipoglycopeptides contain lipophilic side chains, which prolong their half-life, help to anchor the agents to the cell membrane and increase their activity against Gram-pos. cocci.  In addn. to inhibiting cell wall synthesis, telavancin and oritavancin are also able to disrupt bacterial membrane integrity and increase membrane permeability; oritavancin also inhibits RNA synthesis.  Enterococci exhibiting the VanA phenotype (resistance to both vancomycin and teicoplanin) are resistant to both dalbavancin and telavancin, while oritavancin retains activity.  Dalbavancin, oritavancin and telavancin exhibit activity against VanB vancomycin-resistant enterococci.  All three lipoglycopeptides demonstrate potent in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis regardless of their susceptibility to meticillin, as well as Streptococcus spp.  Both dalbavancin and telavancin are active against vancomycin-intermediate S. aureus (VISA), but display poor activity vs. vancomycin-resistant S. aureus (VRSA).  Oritavancin is active against both VISA and VRSA.  Telavancin displays greater activity against Clostridium spp. than dalbavancin, oritavancin or vancomycin.  The half-life of dalbavancin ranges from 147 to 258 h, which allows for once-weekly dosing, the half-life of oritavancin of 393 h may allow for one dose per treatment course, while telavancin requires daily administration.  Dalbavancin and telavancin exhibit concn.-dependent activity and AUC/MIC (area under the concn.-time curve to min. inhibitory concn. ratio) is the pharmacodynamic parameter that best describes their activities.  Oritavancin's activity is also considered concn.-dependent in vitro, while in vivo its activity has been described by both concn. and time-dependent models; however, AUC/MIC is the pharmacodynamic parameter that best describes its activity.  Clin. trials involving patients with complicated skin and skin structure infections (cSSSIs) have demonstrated that all three agents are as efficacious as comparators.  The most common adverse effects reported with dalbavancin use included nausea, diarrhoea and constipation, while injection site reactions, fever and diarrhoea were commonly obsd. with oritavancin therapy.  Patients administered telavancin frequently reported nausea, taste disturbance and insomnia.  To date, no drug-drug interactions have been identified for dalbavancin, oritavancin or telavancin.  All three of these agents are promising alternatives for the treatment of cSSSIs in cases where more economical options such as vancomycin have been ineffective, in cases of reduced vancomycin susceptibility or resistance, or where vancomycin use has been assocd. with adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kTvXBDIDUrVg90H21EOLACvtfcHk0libWE5YUne9DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1aqsLY%253D&md5=0409400bb17ec3b413752b85443aaf0f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2165%2F11534440-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11534440-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DCalic%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DLagac%25C3%25A9-Wiens%26aufirst%3DP.%2BR.%26aulast%3DRubinstein%26aufirst%3DE.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DNew%2520lipoglycopeptides%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D859%26epage%3D886%26doi%3D10.2165%2F11534440-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Okano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schammel, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Total synthesis of [Ψ[C (═NH)NH] Tpg4] vancomycin and its (4-Chlorobiphenyl) methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual d-Ala-d-Ala and d-Ala-d-Lac binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">13522</span><span class="NLM_x">–</span> <span class="NLM_lpage">13525</span><span class="refDoi"> DOI: 10.1021/ja507009a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja507009a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13522-13525&author=A.+Okanoauthor=A.+Nakayamaauthor=A.+W.+Schammelauthor=D.+L.+Boger&title=Total+synthesis+of+%5B%CE%A8%5BC+%28%E2%95%90NH%29NH%5D+Tpg4%5D+vancomycin+and+its+%284-Chlorobiphenyl%29+methyl+derivative%3A+impact+of+peripheral+modifications+on+vancomycin+analogues+redesigned+for+dual+d-Ala-d-Ala+and+d-Ala-d-Lac+binding&doi=10.1021%2Fja507009a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja507009a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja507009a%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DSchammel%26aufirst%3DA.%2BW.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DTotal%2520synthesis%2520of%2520%255B%25CE%25A8%255BC%2520%2528%25E2%2595%2590NH%2529NH%255D%2520Tpg4%255D%2520vancomycin%2520and%2520its%2520%25284-Chlorobiphenyl%2529%2520methyl%2520derivative%253A%2520impact%2520of%2520peripheral%2520modifications%2520on%2520vancomycin%2520analogues%2520redesigned%2520for%2520dual%2520d-Ala-d-Ala%2520and%2520d-Ala-d-Lac%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13522%26epage%3D13525%26doi%3D10.1021%2Fja507009a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Okano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isley, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Peripheral modifications of [Ψ [CH2NH] Tpg4] vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">5052</span><span class="NLM_x">–</span> <span class="NLM_lpage">5061</span><span class="refDoi"> DOI: 10.1073/pnas.1704125114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1073%2Fpnas.1704125114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=5052-5061&author=A.+Okanoauthor=N.+A.+Isleyauthor=D.+L.+Boger&title=Peripheral+modifications+of+%5B%CE%A8+%5BCH2NH%5D+Tpg4%5D+vancomycin+with+added+synergistic+mechanisms+of+action+provide+durable+and+potent+antibiotics&doi=10.1073%2Fpnas.1704125114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1704125114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1704125114%26sid%3Dliteratum%253Aachs%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DIsley%26aufirst%3DN.%2BA.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPeripheral%2520modifications%2520of%2520%255B%25CE%25A8%2520%255BCH2NH%255D%2520Tpg4%255D%2520vancomycin%2520with%2520added%2520synergistic%2520mechanisms%2520of%2520action%2520provide%2520durable%2520and%2520potent%2520antibiotics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D5052%26epage%3D5061%26doi%3D10.1073%2Fpnas.1704125114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yarlagadda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konai, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunath, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span> </span><span class="NLM_article-title">Tackling vancomycin-resistant bacteria with’lipophilic-vancomycin-carbohydrate conjugates’</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/ja.2014.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fja.2014.144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=302-312&author=V.+Yarlagaddaauthor=M.+M.+Konaiauthor=G.+B.+Manjunathauthor=C.+Ghoshauthor=J.+Haldar&title=Tackling+vancomycin-resistant+bacteria+with%E2%80%99lipophilic-vancomycin-carbohydrate+conjugates%E2%80%99&doi=10.1038%2Fja.2014.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.144%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DTackling%2520vancomycin-resistant%2520bacteria%2520with%25E2%2580%2599lipophilic-vancomycin-carbohydrate%2520conjugates%25E2%2580%2599%26jtitle%3DJ.%2520Antibiot.%26date%3D2015%26volume%3D68%26spage%3D302%26epage%3D312%26doi%3D10.1038%2Fja.2014.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yarlagadda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaddar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paramanandham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shome, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span> </span><span class="NLM_article-title">Membrane disruption and enhanced inhibition of cell-wall biosynthesis: a synergistic approach to tackle vancomycin-resistant bacteria</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">13644</span><span class="NLM_x">–</span> <span class="NLM_lpage">13649</span><span class="refDoi"> DOI: 10.1002/anie.201507567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2Fanie.201507567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26473305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=13644-13649&author=V.+Yarlagaddaauthor=S.+Samaddarauthor=K.+Paramanandhamauthor=B.+R.+Shomeauthor=J.+Haldar&title=Membrane+disruption+and+enhanced+inhibition+of+cell-wall+biosynthesis%3A+a+synergistic+approach+to+tackle+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201507567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Samaddar, Sandip; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">13644-13649</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Resistance to glycopeptide antibiotics, the drugs of choice for life-threatening bacterial infections, is on the rise.  To counter the threat of glycopeptide-resistant bacteria, the authors report development of a new class of semi-synthetic glycopeptide antibiotics, which not only target the bacterial membrane but also display enhanced inhibition of cell-wall biosynthesis through increased binding affinity to their target peptides.  The combined effect of these two mechanisms resulted in improved in vitro activity of two to three orders of magnitude over vancomycin and no propensity to trigger drug resistance in bacteria.  In murine model of kidney infection, the optimized compd. was able to bring bacterial burden down by about 6 logs at 12 mg kg-1 with no obsd. toxicity.  The results furnished emphasize the potential of this class of compds. as future antibiotics for drug-resistant Gram-pos. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdntAtQFj3MrVg90H21EOLACvtfcHk0liBWr1ioazk7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqs7%252FI&md5=6612d63cd53b251565cddd6727df5e9c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507567%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DParamanandham%26aufirst%3DK.%26aulast%3DShome%26aufirst%3DB.%2BR.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DMembrane%2520disruption%2520and%2520enhanced%2520inhibition%2520of%2520cell-wall%2520biosynthesis%253A%2520a%2520synergistic%2520approach%2520to%2520tackle%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D13644%26epage%3D13649%26doi%3D10.1002%2Fanie.201507567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yarlagadda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaddar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span> </span><span class="NLM_article-title">A vancomycin derivative with a pyrophosphate-binding group: a strategy to combat vancomycin-resistant bacteria</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7836</span><span class="NLM_x">–</span> <span class="NLM_lpage">7840</span><span class="refDoi"> DOI: 10.1002/anie.201601621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2Fanie.201601621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVChsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=7836-7840&author=V.+Yarlagaddaauthor=P.+Sarkarauthor=S.+Samaddarauthor=J.+Haldar&title=A+vancomycin+derivative+with+a+pyrophosphate-binding+group%3A+a+strategy+to+combat+vancomycin-resistant+bacteria&doi=10.1002%2Fanie.201601621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria</span></div><div class="casAuthors">Yarlagadda, Venkateswarlu; Sarkar, Paramita; Samaddar, Sandip; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">7836-7840</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Vancomycin, the drug of last resort for Gram-pos. bacterial infections, has also been rendered ineffective by the emergence of resistance in such bacteria.  To combat the threat of vancomycin-resistant bacteria (VRB), the authors report the development of a dipicolyl-vancomycin conjugate (Dipi-van), which leads to enhanced inhibition of cell-wall biosynthesis in VRB and displays in vitro activity that is more than two orders of magnitude higher than that of vancomycin.  Conjugation of the dipicolyl moiety, which is a zinc-binding ligand, endowed the parent drug with the ability to bind to pyrophosphate groups of cell-wall lipids while maintaining the inherent binding affinity for pentapeptide termini of cell-wall precursors.  Furthermore, no detectable resistance was obsd. after several serial passages, and the compd. reduced the bacterial burden by a factor of 5 logs at 12 mg kg-1 in a murine model of VRB kidney infection.  The findings presented stress the potential of the authors' strategy to combat VRB infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsJJjdJGAiGbVg90H21EOLACvtfcHk0liBWr1ioazk7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVChsbo%253D&md5=b954f612802d363f8f1a82ffef27162c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601621%26sid%3Dliteratum%253Aachs%26aulast%3DYarlagadda%26aufirst%3DV.%26aulast%3DSarkar%26aufirst%3DP.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DA%2520vancomycin%2520derivative%2520with%2520a%2520pyrophosphate-binding%2520group%253A%2520a%2520strategy%2520to%2520combat%2520vancomycin-resistant%2520bacteria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D7836%26epage%3D7840%26doi%3D10.1002%2Fanie.201601621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Leonard, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections</span> <span class="citation_source-journal">Pharmacother. J. Hum. Pharmacol. Drug Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1592/phco.28.4.458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1592%2Fphco.28.4.458" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=458-468&author=S.+N.+Leonardauthor=M.+J.+Rybak&title=Telavancin%3A+an+antimicrobial+with+a+multifunctional+mechanism+of+action+for+the+treatment+of+serious+gram-positive+infections&doi=10.1592%2Fphco.28.4.458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1592%2Fphco.28.4.458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1592%252Fphco.28.4.458%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DS.%2BN.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DTelavancin%253A%2520an%2520antimicrobial%2520with%2520a%2520multifunctional%2520mechanism%2520of%2520action%2520for%2520the%2520treatment%2520of%2520serious%2520gram-positive%2520infections%26jtitle%3DPharmacother.%2520J.%2520Hum.%2520Pharmacol.%2520Drug%2520Ther.%26date%3D2008%26volume%3D28%26spage%3D458%26epage%3D468%26doi%3D10.1592%2Fphco.28.4.458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Smith, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Dalbavancin: a novel lipoglycopeptide antibiotic with extended activity against Gram-positive infections</span> <span class="citation_source-journal">Infect. Dis. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1007/s40121-015-0077-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1007%2Fs40121-015-0077-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26341488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC287psFCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=245-258&author=J.+R.+Smithauthor=K.+D.+Robertsauthor=M.+J.+Rybak&title=Dalbavancin%3A+a+novel+lipoglycopeptide+antibiotic+with+extended+activity+against+Gram-positive+infections&doi=10.1007%2Fs40121-015-0077-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections</span></div><div class="casAuthors">Smith Jordan R; Roberts Karrine D; Rybak Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-58</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Dalbavancin is a lipoglycopeptide antibiotic recently approved by the United States Food and Drug Administration (FDA) for acute bacterial skin and skin structure infections (ABSSSIs).  It is active against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), and minimum inhibitory concentrations (MICs) are consistently <0.125 μg/ml, much lower than most other anti-MRSA agents.  Dalbavancin possesses an extended half-life of over 1 week, allowing an initial dose of 1000 mg followed by 500 mg 1 week later to complete a course of therapy for ABSSSI.  It is approximately 95% protein bound and is widely distributed throughout the body, achieving concentrations similar to plasma levels in numerous tissues.  Against MRSA, dalbavancin is 4-8 times more potent than vancomycin in vitro, and limited data suggest it possesses activity against MRSA with reduced susceptibility to vancomycin such as hVISA and VISA.  Dalbavancin also possesses in vitro activity against streptococci and enterococci, although activity against vancomycin-resistant enterococci is lacking.  In phase 3 ABSSSI studies, dalbavancin demonstrated similar activity to vancomycin and provides a more convenient dosing regimen.  Limited phase 2 data suggest dalbavancin also possesses activity in catheter-related bloodstream infections.  Potential further therapeutic uses include conditions that require long-term treatment such as osteomyelitis and infective endocarditis, although data are currently lacking.  The extended half-life of dalbavancin, along with its in vitro activity against gram-positive organisms with reduced susceptibility to other anti-MRSA antibiotics, suggest it could have an exciting clinical role going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUQHmegw0cIe2qxNLjzXe8fW6udTcc2eZ4rusXmA9X07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287psFCntw%253D%253D&md5=47ac79a61c38ea0b6fceac1febc57ff2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs40121-015-0077-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-015-0077-7%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BR.%26aulast%3DRoberts%26aufirst%3DK.%2BD.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DDalbavancin%253A%2520a%2520novel%2520lipoglycopeptide%2520antibiotic%2520with%2520extended%2520activity%2520against%2520Gram-positive%2520infections%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2015%26volume%3D4%26spage%3D245%26epage%3D258%26doi%3D10.1007%2Fs40121-015-0077-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Brade, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Oritavancin: a new lipoglycopeptide antibiotic in the treatment of gram-positive infections</span> <span class="citation_source-journal">Infect. Dis. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1007/s40121-016-0103-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1007%2Fs40121-016-0103-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26831328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC28nmt1aqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=1-15&author=K.+D.+Bradeauthor=J.+M.+Rybakauthor=M.+J.+Rybak&title=Oritavancin%3A+a+new+lipoglycopeptide+antibiotic+in+the+treatment+of+gram-positive+infections&doi=10.1007%2Fs40121-016-0103-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections</span></div><div class="casAuthors">Brade Karrine D; Rybak Jeffrey M; Rybak Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Resistance among Gram-positive organisms has been steadily increasing over the last several years; however, the development of new antibiotics to treat infections caused from these organisms has fallen short of the emergent need.  Specifically, resistance among Staphylococcus aureus and Enterococcus spp. to essential antibiotics is considered a major problem.  Oritavancin is a semisynthetic lipoglycopeptide antibiotic that was recently approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI).  While structurally related to vancomycin, oritavancin also possesses unique mechanisms of action that greatly enhance its antimicrobial potency against multi-drug resistant pathogens including both VanA- and VanB-mediated vancomycin-resistant enterococci.  Owing to the addition of the highly hydrophobic tail group, oritavancin possesses a prolonged half-life ranging from 200-300 h.  Although oritavancin is only currently Food and Drug Administration approved for ABSSSI, this agent may eventually play a role in additional indications where new innovative therapy is needed including bacteremia and deep-seeded, Gram-positive infections such as infective endocarditis or osteomyelitis.  This review will focus on oritavancin's spectrum of activity, mechanisms of action and resistance, pharmacokinetic and pharmacodynamic properties, and the completed and ongoing clinical studies evaluating its use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs2cCxBc27dtTiMd2aNQVUfW6udTcc2eY2a3rIpPH_Obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmt1aqsQ%253D%253D&md5=6d23932cdf873427ca88650b56508b8a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs40121-016-0103-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-016-0103-4%26sid%3Dliteratum%253Aachs%26aulast%3DBrade%26aufirst%3DK.%2BD.%26aulast%3DRybak%26aufirst%3DJ.%2BM.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DOritavancin%253A%2520a%2520new%2520lipoglycopeptide%2520antibiotic%2520in%2520the%2520treatment%2520of%2520gram-positive%2520infections%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2016%26volume%3D5%26spage%3D1%26epage%3D15%26doi%3D10.1007%2Fs40121-016-0103-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Butler, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. A.</span><span> </span><span class="NLM_article-title">Glycopeptide antibiotics: back to the future</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span><span class="refDoi"> DOI: 10.1038/ja.2014.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fja.2014.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=25118105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=631-644&author=M.+S.+Butlerauthor=K.+A.+Hansfordauthor=M.+A.+Blaskovichauthor=R.+Halaiauthor=M.+A.+Cooper&title=Glycopeptide+antibiotics%3A+back+to+the+future&doi=10.1038%2Fja.2014.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide antibiotics: Back to the future</span></div><div class="casAuthors">Butler, Mark S.; Hansford, Karl A.; Blaskovich, Mark A. T.; Halai, Reena; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">631-644</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glycopeptide antibiotics have been a key weapon in the fight against bacterial infections for over half a century, with the progenitors, vancomycin (1) and teicoplanin (2), still used extensively.  The increased occurrence of resistance and the effectiveness of these 'last resort' treatments for Gram-pos. infections has led to the discovery and clin. development of second generation, semisynthetic lipoglycopeptide derivs. such as telavancin (3), dalbavancin (4) and oritavancin (5), which all possess broader spectra of activity and improved pharmacokinetic properties.  Two of these new antibiotics, telavancin (3) and dalbavancin (4), were approved in the past 5 years and the third, oritavancin (5), is awaiting regulatory approval.  In this review, the discovery, development and assocd. resistance of vancomycin (1) and teicoplanin (2), and semi-synthetic glycopeptides, telavancin (3), dalbavancin (4) and oritavancin (5), are detailed.  The clin. implications of glycopeptide resistance, esp. vancomycin (1), as well as the future prospects for current glycopeptide drugs and the development of new glycopeptides are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBXjY3YHnypbVg90H21EOLACvtfcHk0ljH9z5elOFrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ehsrvK&md5=04a3089be94990f1f3891cd6958ae79a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fja.2014.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2014.111%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DHansford%26aufirst%3DK.%2BA.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DHalai%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DGlycopeptide%2520antibiotics%253A%2520back%2520to%2520the%2520future%26jtitle%3DJ.%2520Antibiot.%26date%3D2014%26volume%3D67%26spage%3D631%26epage%3D644%26doi%3D10.1038%2Fja.2014.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kahne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C.</span><span> </span><span class="NLM_article-title">Glycopeptide and lipoglycopeptide antibiotics</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span><span class="refDoi"> DOI: 10.1021/cr030103a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030103a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=425-448&author=D.+Kahneauthor=C.+Leimkuhlerauthor=W.+Luauthor=C.+Walsh&title=Glycopeptide+and+lipoglycopeptide+antibiotics&doi=10.1021%2Fcr030103a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Glycopeptide and Lipoglycopeptide Antibiotics</span></div><div class="casAuthors">Kahne, Dan; Leimkuhler, Catherine; Lu, Wei; Walsh, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">425-448</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on glycopeptide and lipoglycopeptide antibiotics.  Structural features, chem. synthesis, mechanism of action, resistance mechanisms and new directions for treating drug resistance are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBnRcMTFq_cbVg90H21EOLACvtfcHk0ljH9z5elOFrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVaksw%253D%253D&md5=ef3f1a5f07faeacd22c0444d42637fd1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcr030103a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030103a%26sid%3Dliteratum%253Aachs%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DLeimkuhler%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DWalsh%26aufirst%3DC.%26atitle%3DGlycopeptide%2520and%2520lipoglycopeptide%2520antibiotics%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D425%26epage%3D448%26doi%3D10.1021%2Fcr030103a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafai Far, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, J.</span><span> </span><span class="NLM_article-title">Locations of the hydrophobic side chains of lipoglycopeptides bound to the peptidoglycan of Staphylococcus aureus</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3405</span><span class="NLM_x">–</span> <span class="NLM_lpage">3014</span><span class="refDoi"> DOI: 10.1021/bi400054p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400054p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1yls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=3405-3014&author=S.+J.+Kimauthor=K.+S.+Tanakaauthor=E.+Dietrichauthor=A.+Rafai+Farauthor=J.+Schaefer&title=Locations+of+the+hydrophobic+side+chains+of+lipoglycopeptides+bound+to+the+peptidoglycan+of+Staphylococcus+aureus&doi=10.1021%2Fbi400054p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Locations of the Hydrophobic Side Chains of Lipoglycopeptides Bound to the Peptidoglycan of Staphylococcus aureus</span></div><div class="casAuthors">Kim, Sung Joon; Tanaka, Kelly S. E.; Dietrich, Evelyne; Rafai Far, Adel; Schaefer, Jacob</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3405-3414</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycopeptides whose aminosugars have been modified by attachment of hydrophobic side chains are frequently active against vancomycin-resistant microorganisms.  The authors have compared the conformations of six such fluorinated glycopeptides (with side chains of varying length) complexed to cell walls labeled with D-[1-13C]alanine, [1-13C]glycine, and L-[ε-15N]lysine in whole cells of Staphylococcus aureus.  The internuclear distances from 19F of the bound drug to the 13C and 15N labels of the peptidoglycan, and to the natural abundance 31P of lipid membranes and teichoic acids, were detd. by rotational-echo double resonance NMR.  The drugs did not dimerize, and their side chains did not form membrane anchors but instead became essential parts of secondary binding to pentaglycyl bridge segments of the cell-wall peptidoglycan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpXJ9V5BKWPbVg90H21EOLACvtfcHk0lgAcP3C3JoKLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1yls70%253D&md5=a12a172367252e11c4c5166025108ac5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi400054p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400054p%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DTanaka%26aufirst%3DK.%2BS.%26aulast%3DDietrich%26aufirst%3DE.%26aulast%3DRafai%2BFar%26aufirst%3DA.%26aulast%3DSchaefer%26aufirst%3DJ.%26atitle%3DLocations%2520of%2520the%2520hydrophobic%2520side%2520chains%2520of%2520lipoglycopeptides%2520bound%2520to%2520the%2520peptidoglycan%2520of%2520Staphylococcus%2520aureus%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D3405%26epage%3D3014%26doi%3D10.1021%2Fbi400054p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nagarajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schabel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Occolowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Counter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felty-Duckworth, A.</span><span> </span><span class="NLM_article-title">Synthesis and antibacterial evaluation of N-alkyl vancomycins</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.7164/antibiotics.42.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.42.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=2540369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaL1MXmtlemt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1989&pages=63-72&author=R.+Nagarajanauthor=A.+Schabelauthor=J.+Occolowitzauthor=F.+Counterauthor=J.+Ottauthor=A.+Felty-Duckworth&title=Synthesis+and+antibacterial+evaluation+of+N-alkyl+vancomycins&doi=10.7164%2Fantibiotics.42.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antibacterial evaluation of N-alkyl vancomycins</span></div><div class="casAuthors">Nagarajan, R.; Schabel, A. A.; Occolowitz, J. L.; Counter, F. T.; Ott, J. L.; Felty-Duckworth, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">Eighty-one N-alkyl vancomycins I (R = R1 = alkyl; R = alkyl, R1 = H; R = H, R1 = alkyl) were synthesized by reductive alkylation of vancomycin with the appropriate aldehydes.  The N-alkyl vancomycins exhibit greater antibacterial activity than the corresponding N-acyl vancomycins.  I [R = 4-R2C6H4CH2, R1 = H; R2 = H, Bu, BuO, Me(CH2)7, Me(CH2)7O] were the most active compds., with activities up to 5 times that of vancomycin.  The N-alkyl vancomycins also show longer elimination half-lives in rats than vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxcAlYu4y_jLVg90H21EOLACvtfcHk0lgAcP3C3JoKLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtlemt7g%253D&md5=79ef633e1c0c0eaf01fc080663f234ee</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.42.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.42.63%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DR.%26aulast%3DSchabel%26aufirst%3DA.%26aulast%3DOccolowitz%26aufirst%3DJ.%26aulast%3DCounter%26aufirst%3DF.%26aulast%3DOtt%26aufirst%3DJ.%26aulast%3DFelty-Duckworth%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520antibacterial%2520evaluation%2520of%2520N-alkyl%2520vancomycins%26jtitle%3DJ.%2520Antibiot.%26date%3D1989%26volume%3D42%26spage%3D63%26epage%3D72%26doi%3D10.7164%2Fantibiotics.42.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Leadbetter, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fatheree, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karr, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsell, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodwell, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, J. L.</span><span> </span><span class="NLM_article-title">Hydrophobic vancomycin derivatives with improved ADME properties</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.7164/antibiotics.57.326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.57.326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=15303493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2004&pages=326-336&author=M.+R.+Leadbetterauthor=S.+M.+Adamsauthor=B.+Bazziniauthor=P.+R.+Fathereeauthor=D.+E.+Karrauthor=K.+M.+Krauseauthor=B.+M.+Lamauthor=M.+S.+Linsellauthor=M.+B.+Nodwellauthor=J.+L.+Pace&title=Hydrophobic+vancomycin+derivatives+with+improved+ADME+properties&doi=10.7164%2Fantibiotics.57.326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)</span></div><div class="casAuthors">Leadbetter, Michael R.; Adams, Stacy M.; Bazzini, Bettina; Fatheree, Paul R.; Karr, Dane E.; Krause, Kevin M.; Lam, Bernice M. T.; Linsell, Martin S.; Nodwell, Matthew B.; Pace, John L.; Quast, Kelly; Shaw, Jeng-Pyng; Soriano, Elizabeth; Trapp, Sean G.; Villena, Jenny D.; Wu, Terry X.; Christensen, Burton G.; Judice, J. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">326-336</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Novel derivs. of N-decylaminoethylvancomycin (2), contg. appended hydrophilic groups were synthesized and their antibacterial activity and ADME properties were evaluated.  The compds. were prepd. by reacting amines with the C-terminus (C-) of 2 using PyBOP mediated amide formation, or with the resorcinol-like (R-) position of 2 using a Mannich aminomethylation reaction.  These analogs retained the antibacterial activity of 2 against methicillin-resistant staphylococci and vancomycin-resistant enterococci.  Compds. with a neg. charged auxiliary group also exhibited improved ADME properties relative to 2.  In particular, R-phosphonomethylaminomethyl deriv. 21 displayed good in vitro antibacterial activity, high urinary recovery and low distribution to liver and kidney tissues.  Based on these results, 21 was advanced into development as TD-6424, and is currently in human clin. trials.  The generic name telavancin has recently been approved for compd. 21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobrfFAGGvnOLVg90H21EOLACvtfcHk0lgAcP3C3JoKLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12hu7c%253D&md5=7a24e7cda0ffe2f03280f9c7a36fe028</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.57.326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.57.326%26sid%3Dliteratum%253Aachs%26aulast%3DLeadbetter%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%2BM.%26aulast%3DBazzini%26aufirst%3DB.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DKrause%26aufirst%3DK.%2BM.%26aulast%3DLam%26aufirst%3DB.%2BM.%26aulast%3DLinsell%26aufirst%3DM.%2BS.%26aulast%3DNodwell%26aufirst%3DM.%2BB.%26aulast%3DPace%26aufirst%3DJ.%2BL.%26atitle%3DHydrophobic%2520vancomycin%2520derivatives%2520with%2520improved%2520ADME%2520properties%26jtitle%3DJ.%2520Antibiot.%26date%3D2004%26volume%3D57%26spage%3D326%26epage%3D336%26doi%3D10.7164%2Fantibiotics.57.326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Arhin, F. F.; Belley, A.; Far, A. R.; Lehoux, D.; Moeck, G.; Parr, T. R.</span><span> </span><span class="NLM_article-title">Glycopeptides and Lipoglycopeptides</span>. In  <span class="citation_source-book">Antibiot. Discov. Dev.</span>; <span class="NLM_contrib-group">Dougherty, T. J.; Pucci, M. J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1007%2F978-1-4614-1400-1_9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=301-346&author=F.+F.+Arhin&author=A.+Belley&author=A.+R.+Far&author=D.+Lehoux&author=G.+Moeck&author=T.+R.+Parrauthor=T.+J.+Dougherty&author=M.+J.+Pucci&title=Antibiot.+Discov.+Dev."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-1400-1_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-1400-1_9%26sid%3Dliteratum%253Aachs%26aulast%3DArhin%26aufirst%3DF.%2BF.%26atitle%3DGlycopeptides%2520and%2520Lipoglycopeptides%26btitle%3DAntibiot.%2520Discov.%2520Dev.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26pub%3DSpringer%26date%3D2012%26spage%3D301%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Parenti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beretta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arioli, V.</span><span> </span><span class="NLM_article-title">Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.7164/antibiotics.31.276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.31.276" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1978&pages=276-283&author=F.+Parentiauthor=G.+Berettaauthor=M.+Bertiauthor=V.+Arioli&title=Teichomycins%2C+new+antibiotics+from+Actinoplanes+teichomyceticus+nov.+sp&doi=10.7164%2Fantibiotics.31.276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.31.276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.31.276%26sid%3Dliteratum%253Aachs%26aulast%3DParenti%26aufirst%3DF.%26aulast%3DBeretta%26aufirst%3DG.%26aulast%3DBerti%26aufirst%3DM.%26aulast%3DArioli%26aufirst%3DV.%26atitle%3DTeichomycins%252C%2520new%2520antibiotics%2520from%2520Actinoplanes%2520teichomyceticus%2520nov.%2520sp%26jtitle%3DJ.%2520Antibiot.%26date%3D1978%26volume%3D31%26spage%3D276%26epage%3D283%26doi%3D10.7164%2Fantibiotics.31.276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Barna, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddrell, D. M.</span><span> </span><span class="NLM_article-title">Structure elucidation of the teicoplanin antibiotics</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">4895</span><span class="NLM_x">–</span> <span class="NLM_lpage">4902</span><span class="refDoi"> DOI: 10.1021/ja00329a044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00329a044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1984&pages=4895-4902&author=J.+C.+Barnaauthor=D.+H.+Williamsauthor=D.+J.+Stoneauthor=T.+C.+Leungauthor=D.+M.+Doddrell&title=Structure+elucidation+of+the+teicoplanin+antibiotics&doi=10.1021%2Fja00329a044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja00329a044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00329a044%26sid%3Dliteratum%253Aachs%26aulast%3DBarna%26aufirst%3DJ.%2BC.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DStone%26aufirst%3DD.%2BJ.%26aulast%3DLeung%26aufirst%3DT.%2BC.%26aulast%3DDoddrell%26aufirst%3DD.%2BM.%26atitle%3DStructure%2520elucidation%2520of%2520the%2520teicoplanin%2520antibiotics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1984%26volume%3D106%26spage%3D4895%26epage%3D4902%26doi%3D10.1021%2Fja00329a044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Nicas, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flokowitsch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, R.</span><span> </span><span class="NLM_article-title">Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2194</span><span class="NLM_x">–</span> <span class="NLM_lpage">2199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=2194-2199&author=T.+I.+Nicasauthor=D.+L.+Mullenauthor=J.+E.+Flokowitschauthor=D.+A.+Prestonauthor=N.+J.+Snyderauthor=M.+J.+Zweifelauthor=S.+C.+Wilkieauthor=M.+J.+Rodriguezauthor=R.+C.+Thompsonauthor=R.+Cooper&title=Semisynthetic+glycopeptide+antibiotics+derived+from+LY264826+active+against+vancomycin-resistant+enterococci"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicas%26aufirst%3DT.%2BI.%26aulast%3DMullen%26aufirst%3DD.%2BL.%26aulast%3DFlokowitsch%26aufirst%3DJ.%2BE.%26aulast%3DPreston%26aufirst%3DD.%2BA.%26aulast%3DSnyder%26aufirst%3DN.%2BJ.%26aulast%3DZweifel%26aufirst%3DM.%2BJ.%26aulast%3DWilkie%26aufirst%3DS.%2BC.%26aulast%3DRodriguez%26aufirst%3DM.%2BJ.%26aulast%3DThompson%26aufirst%3DR.%2BC.%26aulast%3DCooper%26aufirst%3DR.%26atitle%3DSemisynthetic%2520glycopeptide%2520antibiotics%2520derived%2520from%2520LY264826%2520active%2520against%2520vancomycin-resistant%2520enterococci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D2194%26epage%3D2199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Nagarajan, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of vancomycin-type glycopeptide antibiotics</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.7164/antibiotics.46.1181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.46.1181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=8407579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVSrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=1181-1195&author=R.+Nagarajan&title=Structure-activity+relationships+of+vancomycin-type+glycopeptide+antibiotics&doi=10.7164%2Fantibiotics.46.1181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of vancomycin-type glycopeptide antibiotics</span></div><div class="casAuthors">Nagarajan, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1181-95</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    </div><div class="casAbstract">A review, with 44 refs., on the scope of the structure-activity relations of glycopeptides; on the structure-activity relations of core hexapeptide's amino acids; on the structure-activity relations of semisynthetic glycopeptide antibiotics; and on activity against resistant enterococci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIVM15M_zCRrVg90H21EOLACvtfcHk0lhVOLmlpyTxUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVSrsrk%253D&md5=e094c1b84dea61fe55c8ac9da108bd0a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.46.1181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.46.1181%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationships%2520of%2520vancomycin-type%2520glycopeptide%2520antibiotics%26jtitle%3DJ.%2520Antibiot.%26date%3D1993%26volume%3D46%26spage%3D1181%26epage%3D1195%26doi%3D10.7164%2Fantibiotics.46.1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Pavlov, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazhko, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preobrazhenskaya, M. N.</span><span> </span><span class="NLM_article-title">A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span><span class="refDoi"> DOI: 10.7164/antibiotics.50.509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.7164%2Fantibiotics.50.509" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1997&pages=509-513&author=A.+Y.+Pavlovauthor=E.+I.+Lazhkoauthor=M.+N.+Preobrazhenskaya&title=A+new+type+of+chemical+modification+of+glycopeptides+antibiotics%3A+aminomethylated+derivatives+of+eremomycin+and+their+antibacterial+activity&doi=10.7164%2Fantibiotics.50.509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.50.509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.50.509%26sid%3Dliteratum%253Aachs%26aulast%3DPavlov%26aufirst%3DA.%2BY.%26aulast%3DLazhko%26aufirst%3DE.%2BI.%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%2BN.%26atitle%3DA%2520new%2520type%2520of%2520chemical%2520modification%2520of%2520glycopeptides%2520antibiotics%253A%2520aminomethylated%2520derivatives%2520of%2520eremomycin%2520and%2520their%2520antibacterial%2520activity%26jtitle%3DJ.%2520Antibiot.%26date%3D1997%26volume%3D50%26spage%3D509%26epage%3D513%26doi%3D10.7164%2Fantibiotics.50.509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pathak, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span> </span><span class="NLM_article-title">Site-selective bromination of vancomycin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">6120</span><span class="NLM_x">–</span> <span class="NLM_lpage">6123</span><span class="refDoi"> DOI: 10.1021/ja301566t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja301566t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVWmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=6120-6123&author=T.+P.+Pathakauthor=S.+J.+Miller&title=Site-selective+bromination+of+vancomycin&doi=10.1021%2Fja301566t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Site-Selective Bromination of Vancomycin</span></div><div class="casAuthors">Pathak, Tejas P.; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6120-6123</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the site-selective bromination of vancomycin to produce, with substantial efficiency, previously unknown monobromovancomycins, a dibromovancomycin, and a tribromovancomycin.  The authors document the inherent reactivity of native vancomycin toward N-bromophthalimide.  The authors, then, demonstrate significant rate acceleration and perturbation of the inherent product distribution in the presence of a rationally designed peptide-based promoter.  Alternative site selectivity is obsd. as a function of solvent and replacement of the peptide with guanidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosVbHWpfmmqbVg90H21EOLACvtfcHk0lhVOLmlpyTxUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVWmurc%253D&md5=138dc20f506d36493e1dd6f5e186b0d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja301566t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja301566t%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DT.%2BP.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DSite-selective%2520bromination%2520of%2520vancomycin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D6120%26epage%3D6123%26doi%3D10.1021%2Fja301566t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalman, J. R.</span><span> </span><span class="NLM_article-title">Structural and mode of action studies on the antibiotic vancomycin. Evidence from 270-MHz proton magnetic resonance</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2768</span><span class="NLM_x">–</span> <span class="NLM_lpage">2774</span><span class="refDoi"> DOI: 10.1021/ja00450a058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00450a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1977&pages=2768-2774&author=D.+H.+Williamsauthor=J.+R.+Kalman&title=Structural+and+mode+of+action+studies+on+the+antibiotic+vancomycin.+Evidence+from+270-MHz+proton+magnetic+resonance&doi=10.1021%2Fja00450a058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja00450a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00450a058%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DKalman%26aufirst%3DJ.%2BR.%26atitle%3DStructural%2520and%2520mode%2520of%2520action%2520studies%2520on%2520the%2520antibiotic%2520vancomycin.%2520Evidence%2520from%2520270-MHz%2520proton%2520magnetic%2520resonance%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1977%26volume%3D99%26spage%3D2768%26epage%3D2774%26doi%3D10.1021%2Fja00450a058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Novel inhibitors of staphyloxanthin virulence factor in comparison with linezolid and vancomycin versus methicilin-resistant, linezolid-resistant, and vancomycin-intermediate staphylococcus aureus infections in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">8145</span><span class="NLM_x">–</span> <span class="NLM_lpage">8159</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8145-8159&author=S.+Niauthor=H.+Weiauthor=B.+Liauthor=F.+Chenauthor=Y.+Liuauthor=W.+Chenauthor=Y.+Xuauthor=X.+Qiuauthor=X.+Liauthor=Y.+Luauthor=W.+Liuauthor=L.+Huauthor=D.+Linauthor=M.+Wangauthor=X.+Zhengauthor=F.+Maoauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+inhibitors+of+staphyloxanthin+virulence+factor+in+comparison+with+linezolid+and+vancomycin+versus+methicilin-resistant%2C+linezolid-resistant%2C+and+vancomycin-intermediate+staphylococcus+aureus+infections+in+vivo&doi=10.1021%2Facs.jmedchem.7b00949"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00949%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520inhibitors%2520of%2520staphyloxanthin%2520virulence%2520factor%2520in%2520comparison%2520with%2520linezolid%2520and%2520vancomycin%2520versus%2520methicilin-resistant%252C%2520linezolid-resistant%252C%2520and%2520vancomycin-intermediate%2520staphylococcus%2520aureus%2520infections%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8145%26epage%3D8159%26doi%3D10.1021%2Facs.jmedchem.7b00949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Duthie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, L. L.</span><span> </span><span class="NLM_article-title">Staphylococcal coagulase: mode of action and antigenicity</span> <span class="citation_source-journal">Microbiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1099/00221287-6-1-2-95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1099%2F00221287-6-1-2-95" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1952&pages=95-107&author=E.+Duthieauthor=L.+L.+Lorenz&title=Staphylococcal+coagulase%3A+mode+of+action+and+antigenicity&doi=10.1099%2F00221287-6-1-2-95"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1099%2F00221287-6-1-2-95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F00221287-6-1-2-95%26sid%3Dliteratum%253Aachs%26aulast%3DDuthie%26aufirst%3DE.%26aulast%3DLorenz%26aufirst%3DL.%2BL.%26atitle%3DStaphylococcal%2520coagulase%253A%2520mode%2520of%2520action%2520and%2520antigenicity%26jtitle%3DMicrobiology%26date%3D1952%26volume%3D6%26spage%3D95%26epage%3D107%26doi%3D10.1099%2F00221287-6-1-2-95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1038/nchembio.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fnchembio.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26780405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=174-179&author=F.+Chenauthor=H.+Diauthor=Y.+Wangauthor=Q.+Caoauthor=B.+Xuauthor=X.+Zhangauthor=N.+Yangauthor=G.+Liuauthor=C.-G.+Yangauthor=Y.+Xu&title=Small-molecule+targeting+of+a+diapophytoene+desaturase+inhibits+S.+aureus+virulence&doi=10.1038%2Fnchembio.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span></div><div class="casAuthors">Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-179</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance.  In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing.  Here we show that naftifine, a US Food and Drug Administration (FDA)-approved antifungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concns.  This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis.  We found that naftifine attenuated the virulence of a variety of clin. S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models.  Specifically, we detd. that naftifine is a lead compd. for potent CrtN inhibitors.  In sum, these findings reveal that naftifine could serve as a chem. probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3544UnQ977LVg90H21EOLACvtfcHk0lihZa2K3Rk8MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D&md5=77be3d6b1b252ea24f011b711f348130</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.-G.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DSmall-molecule%2520targeting%2520of%2520a%2520diapophytoene%2520desaturase%2520inhibits%2520S.%2520aureus%2520virulence%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D174%26epage%3D179%26doi%3D10.1038%2Fnchembio.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuzawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span> </span><span class="NLM_article-title">Whole genome sequencing of methicillin-resistant Staphylococcus aureus</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1225-1240&author=M.+Kurodaauthor=T.+Ohtaauthor=I.+Uchiyamaauthor=T.+Babaauthor=H.+Yuzawaauthor=I.+Kobayashiauthor=L.+Cuiauthor=A.+Oguchiauthor=K.-i.+Aokiauthor=Y.+Nagai&title=Whole+genome+sequencing+of+methicillin-resistant+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DI.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DYuzawa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DI.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DOguchi%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DK.-i.%26aulast%3DNagai%26aufirst%3DY.%26atitle%3DWhole%2520genome%2520sequencing%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1225%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span> </span><span class="NLM_article-title">vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4643</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span><span class="refDoi"> DOI: 10.1128/AAC.01710-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1128%2FAAC.01710-09" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4643-4647&author=X.+Xuauthor=D.+Linauthor=G.+Yanauthor=X.+Yeauthor=S.+Wuauthor=Y.+Guoauthor=D.+Zhuauthor=F.+Huauthor=Y.+Zhangauthor=F.+Wang&title=vanM%2C+a+new+glycopeptide+resistance+gene+cluster+found+in+Enterococcus+faecium&doi=10.1128%2FAAC.01710-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FAAC.01710-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01710-09%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DvanM%252C%2520a%2520new%2520glycopeptide%2520resistance%2520gene%2520cluster%2520found%2520in%2520Enterococcus%2520faecium%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4643%26epage%3D4647%26doi%3D10.1128%2FAAC.01710-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wardenburg, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span> </span><span class="NLM_article-title">Vaccine protection against Staphylococcus aureus pneumonia</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1084/jem.20072208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1084%2Fjem.20072208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2008&pages=287-294&author=J.+B.+Wardenburgauthor=O.+Schneewind&title=Vaccine+protection+against+Staphylococcus+aureus+pneumonia&doi=10.1084%2Fjem.20072208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1084%2Fjem.20072208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20072208%26sid%3Dliteratum%253Aachs%26aulast%3DWardenburg%26aufirst%3DJ.%2BB.%26aulast%3DSchneewind%26aufirst%3DO.%26atitle%3DVaccine%2520protection%2520against%2520Staphylococcus%2520aureus%2520pneumonia%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2008%26volume%3D205%26spage%3D287%26epage%3D294%26doi%3D10.1084%2Fjem.20072208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Perkins, H.</span><span> </span><span class="NLM_article-title">Specificity of combination between mucopeptide precursors and vancomycin or ristocetin</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1042/bj1110195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1042%2Fbj1110195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=5763787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaF1MXls1anug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1969&pages=195-205&author=H.+Perkins&title=Specificity+of+combination+between+mucopeptide+precursors+and+vancomycin+or+ristocetin&doi=10.1042%2Fbj1110195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of combination between mucopeptide precursors and Vancomycin or ristocetin</span></div><div class="casAuthors">Perkins, Harold R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-205</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Vancomycin and ristocetin formed complexes on being mixed with mucopeptide precursors from various bacteria, as shown by chromatog., electrophoresis, and differential uv spectra.  Equimolar proportions of antibiotic and peptide were present.  The specificity of the reaction was studied and the smallest mol. found to react with acetyl-D-alanyl-D-alanine.  This C-terminal dipeptide sequence must be present for complex formation; change of configuration or esterification prevented it.  Modified vancomycins that retained antibiotic activity also combined with appropriate peptides.  The dissocn. consts. of the more stable complexes were estd. from the differential-absorption results.  The relation of complex formation to antibiotic action was discussed.  Penicillin, supposed to be an analog of acetyl-D-alanyl-D-alanine, also modified the spectrum of vancomycin; so, too, did Na benzylpenicilloate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeA5bQWXPS7Vg90H21EOLACvtfcHk0ljoFVdvWMYBtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXls1anug%253D%253D&md5=02c4bc1f850196e20f1acebe06dbb56a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1042%2Fbj1110195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1110195%26sid%3Dliteratum%253Aachs%26aulast%3DPerkins%26aufirst%3DH.%26atitle%3DSpecificity%2520of%2520combination%2520between%2520mucopeptide%2520precursors%2520and%2520vancomycin%2520or%2520ristocetin%26jtitle%3DBiochem.%2520J.%26date%3D1969%26volume%3D111%26spage%3D195%26epage%3D205%26doi%3D10.1042%2Fbj1110195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hash, J. H.</span><span> </span><span class="NLM_article-title">Antibiotic mechanisms</span> <span class="citation_source-journal">Annu. Rev. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1146/annurev.pa.12.040172.000343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1146%2Fannurev.pa.12.040172.000343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1972&pages=35-56&author=J.+H.+Hash&title=Antibiotic+mechanisms&doi=10.1146%2Fannurev.pa.12.040172.000343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pa.12.040172.000343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pa.12.040172.000343%26sid%3Dliteratum%253Aachs%26aulast%3DHash%26aufirst%3DJ.%2BH.%26atitle%3DAntibiotic%2520mechanisms%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%26date%3D1972%26volume%3D12%26spage%3D35%26epage%3D56%26doi%3D10.1146%2Fannurev.pa.12.040172.000343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Nitanai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanamaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span> </span><span class="NLM_article-title">Crystal structures of the complexes between vancomycin and cell-wall precursor analogs</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">1422</span><span class="NLM_x">–</span> <span class="NLM_lpage">1432</span><span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1016%2Fj.jmb.2008.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=18976660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=1422-1432&author=Y.+Nitanaiauthor=T.+Kikuchiauthor=K.+Kakoiauthor=S.+Hanamakiauthor=I.+Fujisawaauthor=K.+Aoki&title=Crystal+structures+of+the+complexes+between+vancomycin+and+cell-wall+precursor+analogs&doi=10.1016%2Fj.jmb.2008.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs</span></div><div class="casAuthors">Nitanai, Yasushi; Kikuchi, Takanori; Kakoi, Kouji; Hanamaki, Shinji; Fujisawa, Ikuhide; Aoki, Katsuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1422-1432</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The crystal structures of three vancomycin complexes with two vancomycin-sensitive cell-wall precursor analogs (diacetyl-Lys-D-Ala-D-Ala and acetyl-D-Ala-D-Ala) and a vancomycin-resistant cell-wall precursor analog (diacetyl-Lys-D-Ala-D-lactate) were detd. at at. resolns. of 1.80 Å, 1.07 Å, and 0.93 Å, resp.  These structures not only reconfirm the "back-to-back" dimerization of vancomycin monomers and the ligand-binding scheme proposed by previous expts. but also show important structural features of strategies for the generation of new glycopeptide antibiotics.  These structural features involve a water-mediated antibiotic-ligand interaction and supramol. structures such as "side-by-side" arranged dimer-to-dimer structures, in addn. to ligand-mediated and "face-to-face" arranged dimer-to-dimer structures.  In the diacetyl-Lys-D-Ala-D-lactate complex, the interat. O···O distance between the carbonyl oxygen of the fourth residue of the antibiotic backbone and the ester oxygen of the D-lactate moiety of the ligand is clearly longer than the corresponding N-H···O hydrogen-bonding distance obsd. in the two other complexes due to electrostatic repulsion.  In addn., two neighboring hydrogen bonds are concomitantly lengthened.  These observations provide, at least in part, a mol. basis for the reduced antibacterial activity of vancomycin toward vancomycin-resistant bacteria with cell-wall precursors terminating in -D-Ala-D-lactate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFyNh5WabH1rVg90H21EOLACvtfcHk0ljoFVdvWMYBtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSmsL8%253D&md5=bb8666ff0899c33055430364c559905a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DNitanai%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DKakoi%26aufirst%3DK.%26aulast%3DHanamaki%26aufirst%3DS.%26aulast%3DFujisawa%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DK.%26atitle%3DCrystal%2520structures%2520of%2520the%2520complexes%2520between%2520vancomycin%2520and%2520cell-wall%2520precursor%2520analogs%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D1422%26epage%3D1432%26doi%3D10.1016%2Fj.jmb.2008.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Nakayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N-and C-terminus substituent effects of the aglycon substrate</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3572</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span><span class="refDoi"> DOI: 10.1021/ol501568t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol501568t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3572-3575&author=A.+Nakayamaauthor=A.+Okanoauthor=Y.+Fengauthor=J.+C.+Collinsauthor=K.+C.+Collinsauthor=C.+T.+Walshauthor=D.+L.+Boger&title=Enzymatic+glycosylation+of+vancomycin+aglycon%3A+completion+of+a+total+synthesis+of+vancomycin+and+N-and+C-terminus+substituent+effects+of+the+aglycon+substrate&doi=10.1021%2Fol501568t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic Glycosylation of Vancomycin Aglycon: Completion of a Total Synthesis of Vancomycin and N- and C-Terminus Substituent Effects of the Aglycon Substrate</span></div><div class="casAuthors">Nakayama, Atsushi; Okano, Akinori; Feng, Yiqing; Collins, James C.; Collins, Karen C.; Walsh, Christopher T.; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3572-3575</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Studies on the further development of the sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and the observation of unusual, perhaps unexpected, aglycon substrate substituent effects on the rate and efficiency of the initial glycosylation reaction are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgw_oFOesV7Vg90H21EOLACvtfcHk0ljoFVdvWMYBtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentL%252FF&md5=78079c4fabe751b8ec43a719545c9229</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fol501568t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol501568t%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DA.%26aulast%3DOkano%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DCollins%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DK.%2BC.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DEnzymatic%2520glycosylation%2520of%2520vancomycin%2520aglycon%253A%2520completion%2520of%2520a%2520total%2520synthesis%2520of%2520vancomycin%2520and%2520N-and%2520C-terminus%2520substituent%2520effects%2520of%2520the%2520aglycon%2520substrate%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D3572%26epage%3D3575%26doi%3D10.1021%2Fol501568t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castle, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseleur, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Q.</span><span> </span><span class="NLM_article-title">Total synthesis of the vancomycin aglycon</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">10004</span><span class="NLM_x">–</span> <span class="NLM_lpage">10011</span><span class="refDoi"> DOI: 10.1021/ja992577q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja992577q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXms1ejsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=10004-10011&author=D.+L.+Bogerauthor=S.+Miyazakiauthor=S.+H.+Kimauthor=J.+H.+Wuauthor=S.+L.+Castleauthor=O.+Loiseleurauthor=Q.+Jin&title=Total+synthesis+of+the+vancomycin+aglycon&doi=10.1021%2Fja992577q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of the Vancomycin Aglycon</span></div><div class="casAuthors">Boger, Dale L.; Miyazaki, Susumu; Kim, Seong Heon; Wu, Jason H.; Castle, Steven L.; Loiseleur, Olivier; Jin, Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10004-10011</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Full details of a diastereoselective total synthesis of the vancomycin aglycon are described.  Two key arom. nucleophilic substitution macrocyclizations with formation of the 16-membered diaryl ethers were enlisted for sequential CD and DE ring formations, an effective macrolactamization was developed for closure of the 12-membered biaryl AB ring system, and the defined order of CD, AB, and DE ring closures permitted selective thermal atropisomerism of the newly formed ring systems or their immediate precursors.  This indirect control of the atropisomer stereochem. allowed all synthetic material to be funneled into the one of eight atropdiastereomers characterizing the natural product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouXVlO_mY9LrVg90H21EOLACvtfcHk0li_tKMwTr2u3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXms1ejsbY%253D&md5=2fea24bc82eab355f5a0fef63bd8ef76</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja992577q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja992577q%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DWu%26aufirst%3DJ.%2BH.%26aulast%3DCastle%26aufirst%3DS.%2BL.%26aulast%3DLoiseleur%26aufirst%3DO.%26aulast%3DJin%26aufirst%3DQ.%26atitle%3DTotal%2520synthesis%2520of%2520the%2520vancomycin%2520aglycon%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D10004%26epage%3D10011%26doi%3D10.1021%2Fja992577q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorson, J. S.</span><span> </span><span class="NLM_article-title">Antibiotic optimization via in vitro glycorandomization</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span><span class="refDoi"> DOI: 10.1038/nbt909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1038%2Fnbt909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=14608364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1GltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=1467-1469&author=X.+Fuauthor=C.+Albermannauthor=J.+Jiangauthor=J.+Liaoauthor=C.+Zhangauthor=J.+S.+Thorson&title=Antibiotic+optimization+via+in+vitro+glycorandomization&doi=10.1038%2Fnbt909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic optimization via in vitro glycorandomization</span></div><div class="casAuthors">Fu, Xun; Albermann, Christoph; Jiang, Jiqing; Liao, Jianchun; Zhang, Changsheng; Thorson, Jon S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1467-1469</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In nature, the attachment of sugars to small mols. is often used to mediate targeting, mechanism of action and/or pharmacol.  As an alternative to pathway engineering or total synthesis, we report a useful method, in vitro glycorandomization (IVG), to diversify the glycosylation patterns of complex natural products.  We have used flexible glycosyltransferases on nucleotide diphospho-sugar (NDP-sugar) libraries to generate glyco-randomized natural products and then applied chemoselective ligation to produce mono-glycosylated vancomycins that rival vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoudm6jphj2DrVg90H21EOLACvtfcHk0li_tKMwTr2u3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1GltLg%253D&md5=9f0bdf5299ecd81eeac723dd08be3415</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnbt909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt909%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DAlbermann%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DThorson%26aufirst%3DJ.%2BS.%26atitle%3DAntibiotic%2520optimization%2520via%2520in%2520vitro%2520glycorandomization%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26spage%3D1467%26epage%3D1469%26doi%3D10.1038%2Fnbt909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ritter, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mong, K. K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. H.</span><span> </span><span class="NLM_article-title">A Programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: a case study of vancomycin</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4660</span><span class="refDoi"> DOI: 10.1002/anie.200351534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2Fanie.200351534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=4657-4660&author=T.+K.+Ritterauthor=K.+K.+T.+Mongauthor=H.+Liuauthor=T.+Nakataniauthor=C.+H.+Wong&title=A+Programmable+one-pot+oligosaccharide+synthesis+for+diversifying+the+sugar+domains+of+natural+products%3A+a+case+study+of+vancomycin&doi=10.1002%2Fanie.200351534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: A case study of vancomycin</span></div><div class="casAuthors">Ritter, Thomas K.; Mong, Kwok-Kong T.; Liu, Haitian; Nakatani, Takuji; Wong, Chi-Huey</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">4657-4660</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The present communication establishes an efficient glycosylation technique for attaching oligosaccharides to a protected vancomycin aglycon.  The deprotected vancomycin oligosaccharide derivs. were tested for growth inhibition of the Van A strain, however, none of the compds. had antibacterial activity up to 100 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtCJWCgPNIY7Vg90H21EOLACvtfcHk0li_tKMwTr2u3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12ksr4%253D&md5=f808afc9fe07b957e4833a540a6a9e1b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351534%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DT.%2BK.%26aulast%3DMong%26aufirst%3DK.%2BK.%2BT.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DNakatani%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DA%2520Programmable%2520one-pot%2520oligosaccharide%2520synthesis%2520for%2520diversifying%2520the%2520sugar%2520domains%2520of%2520natural%2520products%253A%2520a%2520case%2520study%2520of%2520vancomycin%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D4657%26epage%3D4660%26doi%3D10.1002%2Fanie.200351534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Nicolaou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winssinger, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koumbis, A. E.</span><span> </span><span class="NLM_article-title">Total synthesis of vancomycin—Part 4: Attachment of the sugar moieties and completion of the synthesis</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2648</span><span class="NLM_x">–</span> <span class="NLM_lpage">2667</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3765(19990903)5:9<2648::AID-CHEM2648>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVKltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=2648-2667&author=K.+Nicolaouauthor=H.+J.+Mitchellauthor=N.+F.+Jainauthor=T.+Bandoauthor=R.+Hughesauthor=N.+Winssingerauthor=S.+Natarajanauthor=A.+E.+Koumbis&title=Total+synthesis+of+vancomycin%E2%80%94Part+4%3A+Attachment+of+the+sugar+moieties+and+completion+of+the+synthesis&doi=10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Total synthesis of vancomycin-part 4: attachment of the sugar moieties and completion of the synthesis</span></div><div class="casAuthors">Nicolaou, K. C.; Mitchell, Helen J.; Jain, Nareshkumar F.; Bando, Toshikazu; Hughes, Robert; Winssinger, Nicolas; Natarajan, Swaminathan; Koumbis, Alexandros E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2648-2667</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The total synthesis of vancomycin is described.  The successful plan for this synthesis involves sequential and stereoselective coupling of vancomycin aglycon acceptor I (TBS = Me3CSiMe2, Cbz = PhCH2O2C) and glycosyl donors, trichloroacetimidate II (Alloc = allyloxycarbonyl) and glycosyl fluoride III.  Acceptor I was synthesized from vancomycin aglycon, which was derived both by total synthesis and by semisynthesis from vancomycin itself.  The vancosamine deriv. III was obtained by total synthesis while the glycosyl deriv. II was prepd. from glucal.  A no. of glycosidation model studies, carried out in order to establish the final route to vancomycin, are also described and so are a no. of failed attempts to secure the target mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroJ_Pl47gGobVg90H21EOLACvtfcHk0lgGYkwa34Q1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVKltrc%253D&md5=9a72a07019ab4f85459799f79e8cfd39</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252819990903%25295%253A9%253C2648%253A%253AAID-CHEM2648%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%26aulast%3DMitchell%26aufirst%3DH.%2BJ.%26aulast%3DJain%26aufirst%3DN.%2BF.%26aulast%3DBando%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DWinssinger%26aufirst%3DN.%26aulast%3DNatarajan%26aufirst%3DS.%26aulast%3DKoumbis%26aufirst%3DA.%2BE.%26atitle%3DTotal%2520synthesis%2520of%2520vancomycin%25E2%2580%2594Part%25204%253A%2520Attachment%2520of%2520the%2520sugar%2520moieties%2520and%2520completion%2520of%2520the%2520synthesis%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D1999%26volume%3D5%26spage%3D2648%26epage%3D2667%26doi%3D10.1002%2F%28SICI%291521-3765%2819990903%295%3A9%3C2648%3A%3AAID-CHEM2648%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Yoganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span> </span><span class="NLM_article-title">Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2367</span><span class="NLM_x">–</span> <span class="NLM_lpage">2377</span><span class="refDoi"> DOI: 10.1021/jm501872s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501872s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2367-2377&author=S.+Yoganathanauthor=S.+J.+Miller&title=Structure+diversification+of+vancomycin+through+peptide-catalyzed%2C+site-selective+lipidation%3A+a+catalysis-based+approach+to+combat+glycopeptide-resistant+pathogens&doi=10.1021%2Fjm501872s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens</span></div><div class="casAuthors">Yoganathan, Sabesan; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2367-2377</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The emergence of antibiotic-resistant infections highlights the need for novel antibiotic leads, perhaps with a broader spectrum of activity.  Herein, the authors disclose a semisynthetic, catalytic approach for structure diversification of vancomycin.  The authors have identified three unique peptide catalysts that exhibit site-selectivity for the lipidation of the aliph. hydroxyls on vancomycin, generating three new derivs.  Incorporation of lipid chains into the vancomycin scaffold provides promising improvement of its bioactivity against vancomycin-resistant enterococci (Van A and Van B phenotypes of VRE).  The MICs for the new derivs. against MRSA and VRE (Van B phenotype) range from 0.12 to 0.25 μg/mL.  The authors have also performed a structure-activity relationship (SAR) study to investigate the effect of lipid chain length at the newly accessible G4-OH derivatization site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBqmVrTjYNT7Vg90H21EOLACvtfcHk0lgGYkwa34Q1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ht7Y%253D&md5=9aafed77399f231be3dbd0d9d878eafb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm501872s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501872s%26sid%3Dliteratum%253Aachs%26aulast%3DYoganathan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DStructure%2520diversification%2520of%2520vancomycin%2520through%2520peptide-catalyzed%252C%2520site-selective%2520lipidation%253A%2520a%2520catalysis-based%2520approach%2520to%2520combat%2520glycopeptide-resistant%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2367%26epage%3D2377%26doi%3D10.1021%2Fjm501872s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Skaar, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humayun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBord, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span> </span><span class="NLM_article-title">Iron-source preference of Staphylococcus aureus infections</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1626</span><span class="NLM_x">–</span> <span class="NLM_lpage">1628</span><span class="refDoi"> DOI: 10.1126/science.1099930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1126%2Fscience.1099930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=15361626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlGrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1626-1628&author=E.+P.+Skaarauthor=M.+Humayunauthor=T.+Baeauthor=K.+L.+DeBordauthor=O.+Schneewind&title=Iron-source+preference+of+Staphylococcus+aureus+infections&doi=10.1126%2Fscience.1099930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-Source Preference of Staphylococcus aureus Infections</span></div><div class="casAuthors">Skaar, Eric P.; Humayun, Munir; Bae, Taeok; DeBord, Kristin L.; Schneewind, Olaf</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5690</span>),
    <span class="NLM_cas:pages">1626-1629</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Although bacteria use different iron compds. in vitro, the possibility that microbes distinguish between these iron sources during infection has hitherto not been examd.  We applied stable isotope labeling to detect source-specific iron by mass spectrometry and show that Staphylococcus aureus preferentially imports heme iron over transferrin iron.  By combining this approach with computational genome anal., we identified hts (heme transport system), a gene cluster that promotes preferred heme iron import by S. aureus.  Heme iron scavenging by means of hts is required for staphylococcal pathogenesis in animal hosts, indicating that heme iron is the preferred iron source during the initiation of infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb8l4raVy9v7Vg90H21EOLACvtfcHk0lgGYkwa34Q1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlGrsrs%253D&md5=39cfa45f85b78d39b0c0162e65d5ed79</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099930%26sid%3Dliteratum%253Aachs%26aulast%3DSkaar%26aufirst%3DE.%2BP.%26aulast%3DHumayun%26aufirst%3DM.%26aulast%3DBae%26aufirst%3DT.%26aulast%3DDeBord%26aufirst%3DK.%2BL.%26aulast%3DSchneewind%26aufirst%3DO.%26atitle%3DIron-source%2520preference%2520of%2520Staphylococcus%2520aureus%2520infections%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1626%26epage%3D1628%26doi%3D10.1126%2Fscience.1099930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Corbin, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dattilo, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerads, R.</span><span> </span><span class="NLM_article-title">Metal chelation and inhibition of bacterial growth in tissue abscesses</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">962</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span><span class="refDoi"> DOI: 10.1126/science.1152449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1126%2Fscience.1152449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=18276893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslOmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=962-965&author=B.+D.+Corbinauthor=E.+H.+Seeleyauthor=A.+Raabauthor=J.+Feldmannauthor=M.+R.+Millerauthor=V.+J.+Torresauthor=K.+L.+Andersonauthor=B.+M.+Dattiloauthor=P.+M.+Dunmanauthor=R.+Gerads&title=Metal+chelation+and+inhibition+of+bacterial+growth+in+tissue+abscesses&doi=10.1126%2Fscience.1152449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses</span></div><div class="casAuthors">Corbin, Brian D.; Seeley, Erin H.; Raab, Andrea; Feldmann, Joerg; Miller, Michael R.; Torres, Victor J.; Anderson, Kelsi L.; Dattilo, Brian M.; Dunman, Paul M.; Gerads, Russell; Caprioli, Richard M.; Nacken, Wolfgang; Chazin, Walter J.; Skaar, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5865</span>),
    <span class="NLM_cas:pages">962-965</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Bacterial infection often results in the formation of tissue abscesses, which represent the primary site of interaction between invading bacteria and the innate immune system.  The authors identify the host protein calprotectin as a neutrophil-dependent factor expressed inside Staphylococcus aureus abscesses.  Neutrophil-derived calprotectin inhibited S. aureus growth through chelation of nutrient Mn2+ and Zn2+: an activity that results in reprogramming of the bacterial transcriptome.  The abscesses of mice lacking calprotectin were enriched in metal, and staphylococcal proliferation was enhanced in these metal-rich abscesses.  These results demonstrate that calprotectin is a crit. factor in the innate immune response to infection and define metal chelation as a strategy for inhibiting microbial growth inside abscessed tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrho6DiscZvXrVg90H21EOLACvtfcHk0lg6kN5RECut4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslOmt7g%253D&md5=8803ab1a0e6b6444d38945d02bd170db</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1126%2Fscience.1152449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1152449%26sid%3Dliteratum%253Aachs%26aulast%3DCorbin%26aufirst%3DB.%2BD.%26aulast%3DSeeley%26aufirst%3DE.%2BH.%26aulast%3DRaab%26aufirst%3DA.%26aulast%3DFeldmann%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BR.%26aulast%3DTorres%26aufirst%3DV.%2BJ.%26aulast%3DAnderson%26aufirst%3DK.%2BL.%26aulast%3DDattilo%26aufirst%3DB.%2BM.%26aulast%3DDunman%26aufirst%3DP.%2BM.%26aulast%3DGerads%26aufirst%3DR.%26atitle%3DMetal%2520chelation%2520and%2520inhibition%2520of%2520bacterial%2520growth%2520in%2520tissue%2520abscesses%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D962%26epage%3D965%26doi%3D10.1126%2Fscience.1152449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Thammavongsa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missiakas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span> </span><span class="NLM_article-title">Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span><span class="refDoi"> DOI: 10.1126/science.1242255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1126%2Fscience.1242255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=863-866&author=V.+Thammavongsaauthor=D.+M.+Missiakasauthor=O.+Schneewind&title=Staphylococcus+aureus+degrades+neutrophil+extracellular+traps+to+promote+immune+cell+death&doi=10.1126%2Fscience.1242255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1126%2Fscience.1242255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1242255%26sid%3Dliteratum%253Aachs%26aulast%3DThammavongsa%26aufirst%3DV.%26aulast%3DMissiakas%26aufirst%3DD.%2BM.%26aulast%3DSchneewind%26aufirst%3DO.%26atitle%3DStaphylococcus%2520aureus%2520degrades%2520neutrophil%2520extracellular%2520traps%2520to%2520promote%2520immune%2520cell%2520death%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D863%26epage%3D866%26doi%3D10.1126%2Fscience.1242255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Thomer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneewind, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missiakas, D.</span><span> </span><span class="NLM_article-title">Pathogenesis of Staphylococcus aureus bloodstream infections</span> <span class="citation_source-journal">Annu. Rev. Pathol.: Mech. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1146/annurev-pathol-012615-044351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1146%2Fannurev-pathol-012615-044351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=26925499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsVGls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=343-364&author=L.+Thomerauthor=O.+Schneewindauthor=D.+Missiakas&title=Pathogenesis+of+Staphylococcus+aureus+bloodstream+infections&doi=10.1146%2Fannurev-pathol-012615-044351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of Staphylococcus aureus Bloodstream Infections</span></div><div class="casAuthors">Thomer, Lena; Schneewind, Olaf; Missiakas, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">343-364</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Staphylococcus aureus, a Gram-pos. bacterium colonizing nares, skin, and the gastrointestinal tract, frequently invades the skin, soft tissues, and bloodstreams of humans.  Even with surgical and antibiotic therapy, bloodstream infections are assocd. with significant mortality.  The secretion of coagulases, proteins that assoc. with and activate the host hemostatic factor prothrombin, and the bacterial surface display of agglutinins, proteins that bind polymd. fibrin, are key virulence strategies for the pathogenesis of S. aureus bloodstream infections, which culminate in the establishment of abscess lesions.  Pathogen-controlled processes, involving a wide spectrum of secreted factors, are responsible for the recruitment and destruction of immune cells, transforming abscess lesions into purulent exudate, with which staphylococci disseminate to produce new infectious lesions or to infect new hosts.  Research on S. aureus bloodstream infections is a frontier for the characterization of protective vaccine antigens and the development of immune therapeutics aiming to prevent disease or improve outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGhH0dC352ErVg90H21EOLACvtfcHk0lg6kN5RECut4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsVGls7Y%253D&md5=ad76dd0cd2eb55de0e8cc24cc1b0fd44</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-012615-044351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-012615-044351%26sid%3Dliteratum%253Aachs%26aulast%3DThomer%26aufirst%3DL.%26aulast%3DSchneewind%26aufirst%3DO.%26aulast%3DMissiakas%26aufirst%3DD.%26atitle%3DPathogenesis%2520of%2520Staphylococcus%2520aureus%2520bloodstream%2520infections%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2016%26volume%3D11%26spage%3D343%26epage%3D364%26doi%3D10.1146%2Fannurev-pathol-012615-044351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Fowler, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laemmerhold, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. J.</span><span> </span><span class="NLM_article-title">Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9755</span><span class="NLM_x">–</span> <span class="NLM_lpage">9761</span><span class="refDoi"> DOI: 10.1021/ja302692j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja302692j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVertLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9755-9761&author=B.+S.+Fowlerauthor=K.+M.+Laemmerholdauthor=S.+J.+Miller&title=Catalytic+site-selective+thiocarbonylations+and+deoxygenations+of+vancomycin+reveal+hydroxyl-dependent+conformational+effects&doi=10.1021%2Fja302692j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Site-Selective Thiocarbonylation and Deoxygenation of Vancomycin Reveal Hydroxyl-Dependent Conformational Effects</span></div><div class="casAuthors">Fowler, Brandon S.; Laemmerhold, Kai M.; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9755-9761</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have examd. peptide-based catalysts for the site-selective thiocarbonylation of a protected form of vancomycin.  Several catalysts were identified that either enhanced or altered the inherent selectivity profile exhibited by the substrate.  Two catalysts, one identified through screening and another through rational design, were demonstrated to be effective on 0.50-g scale.  Deoxygenations led ultimately to two new deoxy-vancomycin derivs., and surprising conformational consequences of deoxygenation were revealed for one of the new compds.  These effects were mirrored in the biol. activities of the new analogs and support a structural role for certain hydroxyls in the native structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV5d_OHFytr7Vg90H21EOLACvtfcHk0lg6kN5RECut4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVertLY%253D&md5=3512a3128c79aa4478738e8135da80ca</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja302692j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja302692j%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DB.%2BS.%26aulast%3DLaemmerhold%26aufirst%3DK.%2BM.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DCatalytic%2520site-selective%2520thiocarbonylations%2520and%2520deoxygenations%2520of%2520vancomycin%2520reveal%2520hydroxyl-dependent%2520conformational%2520effects%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9755%26epage%3D9761%26doi%3D10.1021%2Fja302692j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sardzik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissenborn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitsch, S. L.</span><span> </span><span class="NLM_article-title">Preparation of aminoethyl glycosides for glycoconjugation</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.3762/bjoc.6.81</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.3762%2Fbjoc.6.81" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=20978609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A280%3ADC%252BC3cbisFWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=699-703&author=R.+Sardzikauthor=G.+T.+Nobleauthor=M.+J.+Weissenbornauthor=A.+Martinauthor=S.+J.+Webbauthor=S.+L.+Flitsch&title=Preparation+of+aminoethyl+glycosides+for+glycoconjugation&doi=10.3762%2Fbjoc.6.81"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of aminoethyl glycosides for glycoconjugation</span></div><div class="casAuthors">Sardzik Robert; Noble Gavin T; Weissenborn Martin J; Martin Andrew; Webb Simon J; Flitsch Sabine L</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein journal of organic chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The synthesis of a number of aminoethyl glycosides of cell-surface carbohydrates, which are important intermediates for glycoarray synthesis, is described.  A set of protocols was developed which provide these intermediates, in a short number of steps, from commercially available starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmChyM5fOTzt-cVm4E2RlLfW6udTcc2ebjJWIkIXkQE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbisFWmsA%253D%253D&md5=e8187f6e705c8dbef6fa02d7440cf5ce</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.6.81&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.6.81%26sid%3Dliteratum%253Aachs%26aulast%3DSardzik%26aufirst%3DR.%26aulast%3DNoble%26aufirst%3DG.%2BT.%26aulast%3DWeissenborn%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DS.%2BJ.%26aulast%3DFlitsch%26aufirst%3DS.%2BL.%26atitle%3DPreparation%2520of%2520aminoethyl%2520glycosides%2520for%2520glycoconjugation%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2010%26volume%3D6%26spage%3D699%26epage%3D703%26doi%3D10.3762%2Fbjoc.6.81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wikler, M. A.</span> <span class="citation_source-book">Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement</span>. <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute (CLSI)</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1&author=M.+A.+Wikler&title=Performance+standards+for+antimicrobial+susceptibility+testing%3A+eighteenth+informational+supplement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWikler%26aufirst%3DM.%2BA.%26btitle%3DPerformance%2520standards%2520for%2520antimicrobial%2520susceptibility%2520testing%253A%2520eighteenth%2520informational%2520supplement%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%2520%2528CLSI%2529%26date%3D2008%26volume%3D28%26spage%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Ishiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, K.</span><span> </span><span class="NLM_article-title">A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability</span> <span class="citation_source-journal">Talanta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span><span class="refDoi"> DOI: 10.1016/S0039-9140(97)00017-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1016%2FS0039-9140%2897%2900017-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=18966866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK2sXktVWgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1997&pages=1299-1305&author=M.+Ishiyamaauthor=Y.+Miyazonoauthor=K.+Sasamotoauthor=Y.+Ohkuraauthor=K.+Ueno&title=A+highly+water-soluble+disulfonated+tetrazolium+salt+as+a+chromogenic+indicator+for+NADH+as+well+as+cell+viability&doi=10.1016%2FS0039-9140%2897%2900017-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability</span></div><div class="casAuthors">Ishiyama, Munetaka; Miyazono, Yoko; Sasamoto, Kazumi; Ohkura, Yosuke; Ueno, Keiyu</div><div class="citationInfo"><span class="NLM_cas:title">Talanta</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1299-1305</span>CODEN:
                <span class="NLM_cas:coden">TLNTA2</span>;
        ISSN:<span class="NLM_cas:issn">0039-9140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A highly water sol. disulfonated tetrazolium salt, 4-[3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt, was synthesized.  The compd. is reduced by NADH in good yields at neutral pHs in the presence of 1-methoxy PMS to produce the corresponding formazan dye that absorbs at 460 nm.  The formation is sol. to water at concn. higher than 0.1 M.  The tetrazolium salt thus proved to be useful as a sensitive chromogenic indicator for NADH.  It is also applicable to cell proliferation assays as a cell viability indicator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI2x91OFXFt7Vg90H21EOLACvtfcHk0lhfSmgTMiOoJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktVWgsL0%253D&md5=2437761bdc9555b821a07b698240bf5c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0039-9140%2897%2900017-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-9140%252897%252900017-9%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DM.%26aulast%3DMiyazono%26aufirst%3DY.%26aulast%3DSasamoto%26aufirst%3DK.%26aulast%3DOhkura%26aufirst%3DY.%26aulast%3DUeno%26aufirst%3DK.%26atitle%3DA%2520highly%2520water-soluble%2520disulfonated%2520tetrazolium%2520salt%2520as%2520a%2520chromogenic%2520indicator%2520for%2520NADH%2520as%2520well%2520as%2520cell%2520viability%26jtitle%3DTalanta%26date%3D1997%26volume%3D44%26spage%3D1299%26epage%3D1305%26doi%3D10.1016%2FS0039-9140%2897%2900017-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Tominaga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohseto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span> </span><span class="NLM_article-title">A water-soluble tetrazolium salt useful for colorimetric cell viability assay</span> <span class="citation_source-journal">Anal. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1039/a809656b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=10.1039%2Fa809656b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;key=1%3ACAS%3A528%3ADyaK1MXotVynsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=47-50&author=H.+Tominagaauthor=M.+Ishiyamaauthor=F.+Ohsetoauthor=K.+Sasamotoauthor=T.+Hamamotoauthor=K.+Suzukiauthor=M.+Watanabe&title=A+water-soluble+tetrazolium+salt+useful+for+colorimetric+cell+viability+assay&doi=10.1039%2Fa809656b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A water-soluble tetrazolium salt useful for colorimetric cell viability assay</span></div><div class="casAuthors">Tominaga, Hideyuki; Ishiyama, Munetaka; Ohseto, Fumio; Sasamoto, Kazumi; Hamamoto, Tomoyuki; Suzuki, Keiji; Watanabe, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">ANCOFE</span>;
        ISSN:<span class="NLM_cas:issn">1359-7337</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The application of a tetrazolium salt, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium, monosodium salt (WST-8), to cell viability assays and in vitro drug sensitivity tests is described.  With a higher sensitivity as a chromogenic indicator for cell viability compared with conventional tetrazolium salts, WST-8 produced results of cell viability and IC50 values that were in good agreement, resp., with the MTT method and [3H]thymidine uptake method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLbzO9lH4ArVg90H21EOLACvtfcHk0lhfSmgTMiOoJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVynsw%253D%253D&md5=6a9501b64f5f9678040f6a14f056c2c6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2Fa809656b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa809656b%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DH.%26aulast%3DIshiyama%26aufirst%3DM.%26aulast%3DOhseto%26aufirst%3DF.%26aulast%3DSasamoto%26aufirst%3DK.%26aulast%3DHamamoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DM.%26atitle%3DA%2520water-soluble%2520tetrazolium%2520salt%2520useful%2520for%2520colorimetric%2520cell%2520viability%2520assay%26jtitle%3DAnal.%2520Commun.%26date%3D1999%26volume%3D36%26spage%3D47%26epage%3D50%26doi%3D10.1039%2Fa809656b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FVM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FVM','PDB','1FVM'); return false;">PDB: 1FVM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i86"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01345">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00171"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01345">10.1021/acs.jmedchem.7b01345</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">NMR detection, synthesis, and antibacterial assay of <b>58</b>–<b>63</b>, synthetic procedures of intermediates and Telavancin, and NMR, MS, and HPLC spectra of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Binding model of <b>46</b> and ligand Ac<sub>2</sub>Lys-<i>d</i>Ala-<i>d</i>Ala (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings of all target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_001.pdf">jm7b01345_si_001.pdf (19.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_002.pdb">jm7b01345_si_002.pdb (23.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01345/suppl_file/jm7b01345_si_003.csv">jm7b01345_si_003.csv (20.03 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01345&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01345%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01345" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac16abfd2258d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
